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Insight into the Cellular Alterations Required for Establishing Opportunistic 
Pseudomonas aeruginosa Infections 
 
Dacie R. Bridge 
 
The Gram-negative, opportunistic pathogen Pseudomonas aeruginosa (Pa) is responsible for 
causing disease of high morbidity and mortality in individuals who are immunocompromised, 
suffer from damaged epithelial barriers, and who have cystic fibrosis. However, the underlying 
host cell compromise that allows the establishment of Pa infections remains unknown and is of 
importance to the development of novel strategies that interrupt Pa infections. The type III 
secretion system (T3S) allows the direct translocation of bacterial effectors into the host cell 
cytosol, and in this study was used first, to identify host cell properties involved in the initiation 
of Pa infections, and then second, to dissect the Pa infectious process. Using the T3S effector 
ExoS to monitor T3S translocation and the initiation of Pa infections in HT-29 epithelial cells, we 
identified a relationship between leading edge focal complex adhesion properties involved in 
cell migration and sensitivity to Pa-T3S. Highly migratory T24 epithelial cells were used to 
further explore the role of host cell migration in Pa infections, using manipulations of ExoS 
GTPase activating (GAP) and ADP-ribosyltransferase (ADPRT) activities to manipulate T3S. 
These studies allowed dissection of the Pa infectious process, and found that Pa expressing 
wild type ExoS preferentially bound to the leading edge of T24 cells, where ExoS GAP activity 
interfered with Pa internalization, and ExoS ADPRT activity interrupted actin-plasma membrane 
associations required for T3S translocation. Interestingly, both toxic events limited the Pa 
infectious process. Further studies of MTC, MTLn3, and MDCK epithelial cells identified a 
reciprocal relationship between Rac1 and Rho activation at the leading edge and Pa 
internalization and T3S translocation efficiency. Together, the studies in this dissertation 
highlight the role of actin-plasma membrane associations and Rho-GTPases in directing T3S 
translocation and the Pa infectious process, and the ability of Pa to hijack these factors during 
cell migration. Our studies in turn are consistent with cell migration properties induced in 
response to tissue damage being the cellular compromise that leads to the initiation of Pa 
infections, and that effectors such as ExoS are able to interrupt these same properties to limit 
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Pseudomonas aeruginosa (Pa) is a ubiquitous, Gram-negative, opportunistic pathogen that has 
the capability of establishing numerous types of acute and chronic infections associated with 
severe morbidity and mortality. As an opportunistic pathogen, Pa infections do not exhibit cell or 
tissue specificity, and disease occurs only in patients who are immunocompromised, suffer 
from damaged epithelial barriers, or have cystic fibrosis (CF). The multitude of Pa induced 
infections and the high patient mortality rate associated with this bacterium make it a large 
human health concern.   
During acute infections, Pa is the leading cause of Gram-negative nosocomial pneumonia that 
is associated with an approximate 60% mortality rate, which increases in patients who have 
ventilator-associated pneumonia (VAP) (253-255). Mechanically-ventilated patients with 
underlying chronic pulmonary disease who survive an initial episode of Pa pneumonia are 
highly susceptible to recurrent infection (294). Risk factors for nosocomial pneumonia include: 
previous antibiotic treatment which alter normal flora, the duration of mechanical ventilation, 
length of hospital stay, age, and severity of preexisting disease (summarized in (130)). 
Pa is the third most prominent pathogen in nosocomial catheter-associated urinary tract 
infections (UTI) (152) and has been reported to cause approximately 35% of long-term 
catheter-associated UTIs (266). UTIs are initiated when bacteria are introduced into the bladder 
at the time of catheterization. Pseudomonas then takes advantage of the damage to the 
urethral and bladder mucosal surfaces to establish infection (reviewed in (209)). Reoccurrence 
of UTIs are attributed to biofilm that develops on indwelling catheters to protect bacteria from 
the host immune response (reviewed in (209))(24)). The presence of iron limiting conditions in 
the urinary tract, Pseudomonas virulence factors, and high antibiotic resistance of 
Pseudomonas also appear to contribute to disease severity (reviewed in (209)).  
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Pa bloodstream infections have a crude mortality rate that ranges from 33-61%, placing it 
second among all pathogens in terms of fatalities (189, 325, 335). Thirty-five to 50% of deaths 
related to Pa bloodstream infections occur within the first few days of onset. Treatment of these 
infections is complicated by high levels of antibiotic resistance (74). In this regard, 87% of 
patients with a Pa bloodstream infection have had prior antimicrobial treatment (reviewed in 
(316)). Catheterization, drainage tubes, and mechanical intubation, all of which disrupt the 
integrity of epithelial cell barriers, together with septic shock and the initial site of infection are 
additional risk factors mortality (reviewed in (316)). Underlying disease, such as malignancy, 
diabetes, and renal failure have been found in 90% of patients who acquire a Pa bloodstream 
infection (reviewed in (316)). Individuals with severe burn wounds are also highly susceptible to 
Pa septicemia due to prolonged healing times and the ubiquitous nature of Pa. 
Another problematic infection associated with Pa is ulcerative keratitis. Pa has been identified 
as the most prominent cause of contact lens-related microbial keratitis and corneal ulcer 
formation, accounting for up to two thirds of infections (8, 43, 105, 164, 239). Contact lens wear 
is a predisposing factor for Pa-induced corneal infection by facilitating Pa binding to the corneal 
epithelium, where it can then invade, replicate, and cause severe infection (86, 260, 261). Due 
to increased antibiotic resistance, proper treatment of Pa corneal infections is crucial to prevent 
decreased vision, permanent damage to the ocular tissues, and in extreme cases, removal of 
the infected tissue (350).    
Pseudomonas infections acquire a different phenotype in the lung of CF patients, where chronic 
Pa lung infections remain the leading cause of death. CF is an autosomal recessive disease 
that affects multiple tissues and organs due to a mutation in the cystic fibrosis transmembrane 
conductance regulator (CFTR) (reviewed in (190)). Thickening of mucosal secretions in the 
lung, due to decreased salt transport, provides an ideal environment for Pa (reviewed in (190)). 
In the CF lung, Pa infections are characterized by over-production of the exopolysaccharide, 
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alginate, and growth of the bacteria in a biofilm state. CF Pa lung infections tend to last the 
lifetime of the individual. Studies have shown that Pa may adapt to CF lung conditions over 
time, as strains isolated years after lung colonization are remarkably different from the initial 
colonizing Pa strains due to down-regulation of virulence factors, such as the type III secretion 
(T3S) system, flagella, pili, and lipopolysaccharide (LPS) (reviewed in (141))(151, 183). 
Production of alginate and down-regulation of virulence factors by Pa is thought to contribute to 
bacterial survival within the CF lung.         
The increased severity and high mortality of opportunistic Pa infections is due to the propensity 
of Pa to develop high levels of antibiotic resistance (42). Multi-drug resistant (MDR) Pa strains 
have been shown to be transmitted from patient to patient in a clinical setting (44, 274) and are 
associated with particularly severe outcomes (10, 126). Risk factors for a MDR Pa infection 
include being immobile, intensive care treatment, and the presence of invasive medical 
devices, which disrupt protective epithelial barriers. Additionally, it was observed that if patients 
survived an MDR Pa infection, their functional capabilities were hindered, and these individuals 
often had to enter a rehabilitation or permanent care facility upon hospital discharge (10).  
The ubiquitous nature of Pa, high antibiotic-resistance, and the ability of Pa to form biofilm 
results in difficulties eradicating the source of infection, particularly in the hospital setting 
(reviewed in (157)). Pa has been isolated from sources such as unopened distilled water 
bottles, showers, toothbrushes, water baths, infant feeding basins, cleaning equipment, and 
respiratory therapy equipment, which supports the notion that infection control is extremely 
critical in reducing the number of nosocomial Pa infections (reviewed in (157)). For example, 
two separate outbreaks of MDR Pa in intensive care units (ICU) could only be terminated when 
all of the sinks were replaced in the ICU (reviewed in (157))(23, 143). Another MDR Pa 
outbreak in a neonatal ICU resulted in the death of 16 babies and was attributed to the length of 
 
 5
the nurse’s fingernails. Despite newly implemented hygiene control measures after the 
outbreak, infection was not completely eliminated (reviewed in (157))(210).   
Together these studies highlight the diversity and severity of Pa infection, which is further 
complicated by incomplete resolution of infection due to MDR, Pa biofilm formation, and the 
difficulty in eradicating the environmental source of Pa. Another complication in the prevention 
and treatment of opportunistic Pseudomonas infections is that the host cell factor that allows for 
the initiation of infection in so many tissue types is unknown, as polarized epithelial monolayers 
are resistant to Pa infection. The goal of the current set of studies was to identify the eukaryotic 
cellular alteration that is responsible for the initiation of Pseudomonas infection for use towards 
the design of anti-Pseudomonal strategies.  
Pseudomonas Virulence Factors 
While MDR is an important factor in resolution of Pa infections, the pathogenicity of Pa 
infections also relates to Pa’s vast repertoire of virulence factors (130). The first infections 
attributed to Pseudomonas were described in the mid-1800s (reviewed in (190)) where Sedillot 
observed a blue-green color on surgical dressings from patients. Later, rod-shaped structures 
were observed in pus that had a blue-green tinge. Due to the blue-green tinge associated with 
infection, Pseudomonas was first given the name Bacillus pyocyaneus by Gessard in 1882. 
This blue-green tinge was later attributed to production of the pigment pyocyanin, a Pa 
metabolite which causes oxidative-stress related damage (reviewed in (161)).    
Pseudomonas maintains a broad array of virulence factors that allow it to survive and produce 
disease at any site within a host, provided that it is not cleared by the immune system. Included 
amongst its virulence factors are cell-associated: flagella, pili, non-pili adhesins, and LPS, as 
well as secreted: hemolysins, proteases, and exotoxin A (317). Pa use the propeller, or cork-
screw-like, swimming motility produced by flagella to localize to a site of colonization within the 
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host and can function in tethering Pa to epithelial cells (reviewed in (161)). Flagella are 
immunogenic and activate NF-κβ via interactions with host Toll-like receptors (TLR) (reviewed 
in (161)). Pili are responsible for a twitching motility, which allows the bacterium to spread along 
a surface and contributes to host colonization (reviewed in (161)). Studies by Franklin et al. 
showed that a piliated Pa strain was able to adhere to cilia of freshly isolated human tracheal 
epithelial cells, further highlighting the role of pili in adhesion to host cells (94). The role of 
flagella and pili in Pa pathogenesis are supported by studies showing that Pa strains with 
mutations in either result in decreased virulence in animal models of infection (reviewed in 
(161))(281)).  
LPS, or endotoxin, is a component of Gram-negative bacterial outer membranes and is 
comprised of: (1) a hydrophobic Lipid A domain, which inserts into the bacterial membrane; (2) 
a hydrophilic tail made of core polysaccharide; and (3) the O-specific polysaccharide (262). 
Variability within the O-polysaccharide is used to serotype all Gram-negative bacteria. Currently 
there are 20 known LPS serotypes in Pa that can be used to help identify the source of the 
isolate (177, 252, 327). For example, serotypes P4, P5, P6, P11, and P12 have been identified 
as the predominant serotypes in Pa urinary tract infections, whereas serotype P1 has been 
associated with both CF and urinary tract Pa isolates (306, 327, 332). Like flagella, LPS is 
highly immunogenic and contributes to disease through Lipid A activation of TLR4, which 
results in septic shock (reviewed in (161)).  
Alginate is a cell-associated virulence factor produced by Pa in the CF lung during chronic 
infection and is comprised of repeating beta-D-mannuronic and alpha-L-glucuronic acid 
polymers (reviewed in (209)). Mutations in the mucA, mucB, and mucD genes (120) results in 
production of alginate, which transitions Pa to a mucoid state. Alginate production by Pa results 
in an increase in disease severity, protects Pa from clearance and antibiotic treatment, and may 
attenuate the host’s immune response to the bacterium. 
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Protein Secretion Systems 
In addition to its cell-associated virulence factors, Pa is able to secrete multiple factors through 
five of seven known Gram-negative bacterial secretion systems. Protein secretion by Gram-
negative bacteria requires transport across two hydrophobic membranes, the cytoplasmic or 
inner membrane and the outer membrane, and through an aqueous periplasmic space that 
separates the two membranes. The five secretion systems utilized by Pa in its infectious 




















Figure 1. Pseudomonas Secretion Systems. Representation of the five bacterial secretion 
systems utilized by Pa.  
The image appears by permission of Elsevier Limited. The figure was originally published in the 
article “Protein secretion systems in Pseudomonas aeruginosa: A wealth of pathogenic 
weapons” (2010). International Journal of Medical Microbiology. 300(8):534-543 authored by S. 
Bleves et al.   
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Type I secretion 
The type I secretion (T1S) system is an adenosine triphosphate (ATP)-binding cassette (ABC) 
transporter (Fig.1). Proteins secreted through T1S require a non-cleavable, C-terminal 
secretory signal that interacts with a nucleotide binding domain on the transporter. Upon 
interaction between the signal sequence and the nucleotide binding domain, a conformational 
change occurs to promote hydrolysis of ATP. ATP hydrolysis is used to transport the protein 
through the secretion system and out of the cell. For example, Pa uses the T1S system for 
secretion of alkaline proteases and haemophores. Alkaline proteases are responsible for 
digesting the host protein fibrin, inactivate complement, and are utilized by Pa in corneal 
infections (reviewed in (161)). Haemophores bind to haem in haemoglobin and serve as iron 
scavengers for Pa in conditions of low iron, which is used for Pa growth and survival (reviewed 
in (27)).  
Type II secretion  
The Pa-type II secretion (T2S) system is used to secrete the majority of proteins from Pa and 
allows protein folding to occur in the periplasmic space prior to traversal across the outer 
membrane. Proteins are guided to the T2S system by a signal sequence that may contain an 
unknown conformation secretion motif, as there is no recognized conserved linear motif. The 
T2S apparatus is similar to the type IV pili assembly apparatus, and like the T3S, is a 
nanostructure that consists of three components: (1) a protein platform in the inner membrane 
containing an ATP dependent motor (ATPase); (2) a fimbrillar or pseudopilus structure that 
pushes the folded proteins out of the cell; and (3) a channel that forms in the outer bacterial 
membrane (Fig. 1)(reviewed in (27)). Pa utilizes two T2S systems, Xcp and Hxc during 
infection.  
The Pa Xcp system is responsible for the secretion of the following enzymes: (1) elastase or 
LasB, a metalloproteinase that targets elastin in lung tissue, breaking down tight junctions and 
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thus promoting epithelial permeability as well as catalyzing cleavage of surfactant proteins A 
and D in the lungs and inactivating complement to decrease the host immune response 
(reviewed in (27, 161)); (2) LasA, an elastase that combines its activity with LasB to destroy the 
extracellular matrix (ECM), enhancing syndecan-1 shedding (reviewed in (334))(211); (3) the 
aminopeptidase PaAP or protease IV, is important in corneal infection and in cleavage of 
surfactant proteins in the lung (reviewed in (27)); (4) phospholipase C degrades eukaryotic cell 
membrane phospholipids, can suppress neutrophilic oxidative burst, and may have a role in 
inactivation of lung surfactants (reviewed in (187)); and (5) the adenosine diphosphate (ADP)-
ribosyltransferase exotoxin A (ToxA) (230). ToxA is an AB toxin that interacts with low density 
lipoprotein receptor-related protein on the host cell surface and following internalization ADP-
ribosylates elongation factor-2, thus inhibiting protein synthesis and causing host cell death 
(146, 165). Currently, the alkaline phosphatase LapA is the only known protein secreted via the 
Hxc T2S system. Expression of the Pa-T2S system and secreted products is controlled via 
quorum sensing. Transcription and secretion of proteins by the T2S system only occurs 
following significant proliferation and accumulation of the bacteria (228, 286, 329). It is believed 
that the production of elastases and proteinases, which break down the host cell ECM, may 
allow for Pa dissemination from the initial site of colonization (183).     
Type V secretion  
Similar to T2S, type V secretion (T5S) is a two-stage process. Proteins are first transported 
across the inner membrane utilizing a sec-dependent export apparatus, and then transported 
across the outer bacterial membrane through a β-barrel pore (Fig. 1). Proteins may remain 
attached to the outer surface of the bacterium, or can be secreted into the extracellular medium 
following proteolytic cleavage. Autotransporters and two-partner secretion are the two subtypes 
of Pa-T5S (reviewed in (27)).  
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Autotransporters contain a signal peptide at the N-terminus, a ‘passenger’ domain containing 
the catalytic activity, and a β-domain at the C-terminus. Once the protein is transported through 
the inner membrane using the signal sequence, the protein is cleaved and the C-terminal β-
domain inserts into the outer membrane forming a β-barrel pore. In Pa, EstA is the only 
identified autotransporter and is involved in the production of rhamnoplipids, a surfactant with a 
glycolipid structure that can disrupt ciliary function (139). EstA remains attached to the bacterial 
surface following secretion and is involved in motility, as estA mutants have been shown to be 
deficient in twitching, swarming, and swimming motilities (reviewed in (27)).   
Two-partner secretion is also a two step process; however it requires two proteins, TpsA and 
TpsB. Both proteins are transported across the inner membrane using a sec-dependent export 
apparatus. TpsA is first synthesized as a pre-protein which matures into a pro-protein. TpsB 
then inserts into the outer membrane where it recruits TpsA. Once in the outer membrane, 
TpsA is cleaved into a mature protein and can either remain attached to the bacterial surface or 
can be cleaved and released into the extracellular space. LepA, a protease responsible for 
activation of NF-κβ, CupB3, which takes part in fimbriae synthesis, and CupB5, a 
hemagglutinin-like protein, are all secreted by Pa using two-partner secretion (reviewed in (27)).  
Type VI secretion 
The type VI secretion (T6S) system, recently discovered in Vibrio, secretes proteins in a one 
step fashion and is believed to require host cell contact for protein translocation (Fig.1). While 
less is known about T6S secretion due to its recent discovery, it is known that there are three 
T6S system loci in the Pa genome, termed HSI-I, HSI-II, and HSI-III. Hcp1 is the only known 
substrate secreted by the Pa-T6S system. Notably, Hcp1 has been detected in the lungs of CF 
patients and the T6S system is believed to play an important role in Pa lung infections in CF 
patients (reviewed in (27)).  
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Pseudomonas-Type III secretion    
The T3S system is a common virulence mechanism used by numerous Gram-negative bacteria 
such as Salmonella, Shigella, Escherichia coli, Yersinia, and Pa (reviewed in (51)). T3S was 
initially discovered in Yersinia and the T3S structural apparatus includes: (1) the injectisome, a 
syringe-like nanostructure; (2) a needle; and (3) the translocon, a bacterial formed channel in 
the host cell plasma membrane (Fig.1). Once fully assembled, a continuous channel is formed 
between the bacterial cytoplasm and the host cell. This conduit provides bacteria the advantage 
of manipulating host cell function through the direct translocation of bacterial effector proteins 
from the bacterial cytoplasm into the host cell, thus bypassing the host immune response. 
Unlike the T2S system, T3S is sec-independent and T3S effectors act rapidly on the host, 
independent of significant bacterial proliferation (183). Pa-T3S is believed to be an initiating 
factor in the establishment of both acute and chronic Pa infections. Once infection is 
established using T3S, Pa can then use virulence factors secreted by the other four secretion 
systems to disseminate from the site of colonization.    
Role of the type III secretion system in infection 
Clinical studies have shown that patients with acute lung infection caused by T3S-expressing 
Pa isolates have a poorer clinical prognosis than those infected with strains not expressing the 
T3S system (130, 269, 296). Furthermore, analysis of Pa isolates in endotracheal aspirates 
from patients with respiratory infections, but were not categorized as having VAP, had the 
ability to secrete type III proteins, and was associated with increased mortality (356). The 
expression of T3S proteins was also found to contribute to an increase in morbidity and 
mortality in patients with Pa bloodstream infections (73). Of 85 patients with a Pa bloodstream 
infection, 37 (44%) had Pa isolates expressing type III proteins, 16 (43%) of which progressed 
to septic shock. Within the first 48 hrs following the onset of septic shock, these patients 
required vasopressin and hydrocortisone more often, and required higher doses of 
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norepinephrine compared to septic patients with non-T3S expressing Pa isolates. The 30-day 
crude mortality rate for patients with Pa bloodstream infections expressing T3S proteins was 
46%, an increase of 14% over the overall crude mortality rate, and an increase of 25% over 
patients with isolates that did not express T3S proteins (73). Taken together, this study 
suggests that risk factors for increased mortality in Pa bloodstream infections should include 
the T3S system (73). 
In vivo animal studies have shown that Pa strains with mutations in T3S regulation or the T3S 
secretion apparatus are less virulent than isogenic wild type strains (170, 204, 333). Moreover, 
the role of the T3S system in infection was found in both in vivo mouse studies and in epithelial 
and phagocytic cell line studies where deletion of T3S needle tip protein pcrV (or lcrV from 
Yersinia) resulted in attenuation in virulence (reviewed in (279)). Like LcrV, passive and active 
immunization against PcrV was demonstrated to protect against Pa-T3S infection (142, 212, 
282). PcrV has been shown to be expressed by most clinical isolates, furthermore, infection 
with a Pa strain expressing PcrV without the T3S effectors ExoS or ExoU still results in 
infections associated with high morbidity and mortality (1, 75, 269, 356). Therefore, the Pa-T3S 
system and the needle tip protein PcrV make attractive targets for anti-Pseudomonal therapy.  
Expression of Pa-T3S during infection was believed to be regulated by the nature of the Pa 
infection itself, in that expression of T3S genes occurred primarily in acute infections, while 
alginate and biofilm genes predominate during chronic Pa infections (117, 323, 344). It is 
postulated that the Pa-T3S system is involved in the initial stages of Pa infection and is 
responsible for tissue damage and protection against host immune factors (191). As a chronic 
Pa infection develops, T3S is believed to be down-regulated. However, studies over the last 
several years indicate that T3S may have a more prominent role in chronic Pa lung infections 
than previously thought (57, 208, 269).  
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In this regard, it is believed that CF patients initially acquire Pa from the surrounding 
environment where it is ubiquitous (265). Jain et al showed that 90% of environmental strains 
were identified as T3S positive while only 12% of Pa CF isolates were T3S positive (151). This 
observed difference between T3S phenotypes from environmental and CF isolates does not 
seem to be due to a lack of T3S effector genes, as there was no difference in the distribution of 
effector genes (82). Consistent with a low percent of CF isolates expressing T3S, several in 
vitro studies showed that only a limited number of Pa CF isolates were able to effectively 
secrete T3S effectors under T3S-inducing conditions as well as induce T3S-dependent cell 
death (55, 57, 269). This T3S negative phenotype by CF isolates could be reversed to a T3S 
positive phenotype through overproduction of the T3S regulator ExsA, thus indicating that T3S 
could still be functional under certain conditions (55). Two additional clinical studies have 
detected serum antibodies to T3S components from both adolescent and adult CF patients, 
indicating that T3S was still present and potentially functional during the later stages of chronic 
infection (18, 213). The presence of Pa-T3S was also found in the co-culture biofilm of CF 
isolated airway epithelial cells. In this instance, mutation of Pa-T3S genes resulted in reduced 
biofilm toxicity (13, 169). To determine what occurs between initial Pa colonization and later 
time-points, two independent studies collected serial Pa isolates from CF patients over a three 
or a 15 year period (151, 183). Both studies showed that the later Pa isolates were clonal 
descendents from the initial T3S positive colonizing isolates. While these isolates gradually lost 
T3S capabilities as time progressed, some of the later isolates from the three year study 
remained T3S positive, possibly indicating a reason for positive serum antibodies to T3S 
components (151).  
Taken together, these results indicate that CF patients acquire Pa with functional T3S systems 
from the environment. Once inside the CF lung, Pa alters its virulence profile, where T3S genes 
become down-regulated and alginate and biofilm related genes become up-regulated (151, 
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183). While T3S expression has been shown to be gradually lost during a chronic infection, the 
presence of T3S in a small percent of isolates indicates that the reciprocal regulatory 
mechanism between T3S genes and biofilm genes is not 100% mutually exclusive as was 
previously hypothesized. More importantly, these studies show that Pa isolates expressing the 
T3S system are present during initial Pa colonization of the CF lung, and thus support the role 
of T3S in the establishment of infection (48). What remains unknown is why a small percent of 
Pa isolates retain their T3S properties during the chronic stage of infection.  
Pa-T3S is believed to be an initiating factor in the establishment of both acute and chronic Pa 
infections and can be induced in vitro under low calcium conditions or in vivo by host cell 
contact (92, 311, 315). As such, developing an understanding of the Pa-T3S translocation 
process is integral to the development of therapeutic strategies that interrupt this early stage in 
the Pa infectious process (reviewed in (129))(322). A great deal is known about the regulation, 
structural apparatus, and effectors of the Pa-T3S system; however, how the translocon channel 
inserts into the membrane and how the host cell contributes to Pa-T3S remains unknown. 
Therefore, the goal of the studies presented in this dissertation was to identify the eukaryotic 
cellular alteration that facilitates T3S translocon insertion into the host cell membrane which is 
responsible for the initiation of Pa-T3S and the establishment of Pa infection. 
Regulation 
The Pa-T3S regulon is chromosomally located and includes more than 42 regulatory, structural, 
and secretory loci contained within five operons (92). Genes encoding translocated effectors 
and chaperones are located at different sites on the Pa chromosome (Fig. 2A).  ExsA, a 
transcriptional activator, is the master regulator of Pa-T3S (37, 92, 93). ExsA is a member of 
the AraC/XylS family, and as part of the ExsADCE regulatory cascade, activates transcription 
by binding to 10 identified promoters containing the consensus sequence TNAAAANA (Fig. 2A) 
(313, 342, 348). Transcription of T3S genes is blocked by several factors including the anti-
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activator ExsD, which binds to the N-terminus of ExsA (Fig. 2C, left panel), PtrA, which blocks 
the functional activity of ExsA, and MgtE, which is proposed to block T3S cytotoxicity via its 
structure (14, 60, 123, 203). The proposed model for transcriptional regulation is such that 
when Pa contacts the host cell or is in the presence of low calcium, ExsE is secreted by the 
bacteria (Figs. 2B and C, right panel). Decreased levels of ExsE free ExsC, an anti-anti-
activator, to bind to ExsD. Binding of ExsC to ExsD, disassociates ExsD from the inactive 
complex it forms with ExsA and allows ExsA to bind to its promoters, activating transcription 
(Fig. 2C right panel) (reviewed in (240))(60, 258, 311, 312). Activation of this regulatory 
cascade results in an increased expression of all T3S related genes and additionally results in 
the production of functional injectisomes (348). This coupling of transcription and secretion 
results in inhibitory feedback mechanisms that have been shown to occur by secretion of 
negative regulatory factors, sequestration of co-activators, or sequestration of anti-activators as 











Figure 2. Pa-T3S transcriptional regulation. a) More than 42 structural and functional genes 
make up the Pa-T3S regulon and are chromosomally located. The genes for the Pa-T3S 
effector proteins are located at a different site on the chromosome than the ExoS regulon. The 
ExsADCE operon is responsible for transcriptional regulation of all structural and secretory 
genes and its mechanism of action is diagramed in c.  b) Shows the assembled T3S system 
and exoenzymes S, T, and U bound to their chaperones inside the Pa cytosol. Once ExsE is 
secreted, translocation of the effectors through the needle into the host cell cytosol can occur. 
c) Left panel: Under conditions of high calcium or in the absence of host cell contact, 
transcription is blocked by binding of the anti-activator ExsD to ExsA and the anti-anti-activator 
ExsC to ExsE. Right panel: When calcium levels are reduced or upon host cell contact, ExsE 
is secreted by the bacteria and ExsC is free to bind to ExsD which causes the release of ExsA. 
ExsA in turn binds to its promoters, allowing RNA polymerase (RNAP) to bind initiating 
transcription.    
This image appears by permission of the Nature Publishing Group. The figure was originally 
published in the article “The type III secretion system of Pseudomonas aeruginosa: infection by 















T3S structural apparatus 
There are seven families of T3S systems in Gram-negative bacteria. Originally visualized in 
Salmonella (168), the T3S injectisome, or needle complex, is a macromolecular structure that 
spans both the bacterial inner and outer membranes, as well as the aqueous periplasmic 
space. While the T3S injectisome differs slightly among Gram-negative bacteria, the 
injectisome is believed to be a common component of T3S systems, as both the genes and 
organization of the loci are conserved (reviewed in (308)) (29, 58, 288). Some bacterial species 
such as Salmonella, Shigella, or Burkholderia contain two or more T3S systems for their 
infectious processes. Differences that occur among bacterial T3S systems relates to the 
bacteria’s environment and infectious processes.  
The Pa-T3S system is a member of the Ysc family, Yersinia Yop secretion system (Table I) 
(reviewed in (308). Despite Yersinia and Pa belonging to the same family, Yersinia Ysc T3S 
differs from Pa-T3S in that its structural and regulatory genes are plasmid-encoded (reviewed in 
(308))(92)). Other T3S systems include: (1) the Inv-Mxi-Spa T3S family of Salmonella, Shigella, 
and Burkholderia, which triggers actin polymerization and promotes bacterial internalization 
(Table I); (2) the Ssa-Esc T3S family of Shigella and E. coli that promotes intracellular survival 
by preventing endocytic trafficking, and allows for adherence to and effacement of intestinal 
villi, respectively (Table I); (3) the Hrc-Hrp1 and (4) Hrc-Hrp2 families of T3S systems found in 
plant pathogens; (5) the Chlamydiales system which promotes intracellular survival; and (6) the 
Rhizobiales system that favors nodule formation or prevents bacterial-root colonization in 






Table I. Type III secretion proteins by bacterial species. 
 Pa Yersinia Shigella Salmonella Burkholderia E. coli 
T3S Family Ysc Ysc 
Inv-Mxi-Spa 
Ssa-Esc 




























YscF MxiH* PrgI*  EscF* 
Molecular Ruler: PscP YscP Spa32* InvJ*   
Translocon 
Chaperone: 









    
* Not discussed in the text.  









The T3S injectisome is comprised of more than 20 proteins. The total number of proteins varies 
by bacterial species, but nine proteins are conserved between known injectisomes. Eight of the 
structural T3S proteins are also recognized to be shared with the flagellar apparatus (84, 319, 
336). Because of the shared components, several studies have shown that the flagellar hook-
basal body apparatus and T3S injectisomes share structural and functionality similarity (Fig. 3) 
(30, 168). Despite these similarities, phylogenetically, the flagellar apparatus components 
cluster separately from their T3S injectisome counterparts, indicating that the two structures 
have derived from a common evolutionary origin (reviewed in (308)).   
Much of what is known about T3S injectisomes has been determined through studies of 
Salmonella, Shigella, and E. coli (140, 197, 284, 300). The T3S basal body is made of two rings 
joined by a narrow cylinder which connect to the base of the needle (reviewed in (49)). Cryo-
electron microscopy (EM) studies of the Salmonella basal body show that the outer membrane 
unit, or ‘secretin,’ contains three rings and is a 15-mer structure. The inner membrane unit is 
composed of one 24-mer ring (284). The C-terminus of the outer membrane ring is embedded 
within the outer membrane, while the N-terminus is located within the periplasm (reviewed in 
(331)). The inner rod, or ‘socket,’ connects the inner membrane ring with the third outer 
membrane ring, contains 12-fold symmetry, and is 2-3 nm in diameter (reviewed in (49, 331). 
Both periplasmic domains of the outer and inner membrane rings have high structural similarity 
(reviewed in (331)). Data indicate that a cytosolic or C-ring, which is present within the flagellar 
apparatus, may be present at the base of injectisome, but this has yet to be identified by cryo-
EM (reviewed in (49)). The entry point for proteins from the cytosol into the basal body is the 
cup, which works in conjunction with an ATPase that exports proteins through the secretion 
apparatus in an ATP-dependent fashion (reviewed in (49))(284). Secretion of proteins from the 
basal body into the host cell is facilitated by the needle, which is connected to the outer 
membrane ring and protrudes from the bacterial surface.  
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Figure 3. Schematic comparison of the type III secretion injectisome and the flagellum. 
Schematic of the needle-containing T3S system (TTSS) apparatus (left), as found in bacterial 
pathogens of animals, and the flagellum (right). The T3S system needle is positioned on outer 
membrane and inner membrane rings, as is the flagellum. For the T3S system, proteins that are 
conserved in the flagellar apparatus are indicated without parentheses while those that are not 
conserved in the flagellar apparatus are enclosed in parentheses. Question marks indicate 
uncertain localization of proteins. Yersinia proteins are indicated for the T3S system, except for 
the inner membrane ring, for which Salmonella proteins are denoted. For the flagellar system, 
proteins that are conserved in the T3S system are indicated without parentheses and proteins 
that are not conserved in the T3S system are enclosed in parentheses. Effector proteins of the 
T3S system are thought to travel from the bacterial cytosol through the two rings and the needle 
and to cross into the host cell cytoplasm through pores formed in the host cell plasma 
membrane by T3S system translocator proteins. The T3S system needle is ~100-fold shorter 
than the flagellum. 
The image and figure legend appear with permission from the American Society for 
Microbiology. The figure is part (A) of a three part figure and was originally published in the 
article “Process of Protein Transport by the Type III Secretion System” (2004). Microbiology 


















The T3S needle  
Specific to Pa, the T3S needle is 60-120 nm in length, 7-10 nm in width, 2 nm in internal 
diameter, and facilitates the transfer of bacterial effectors into the host cell (Fig. 4) (229, 298). 
The needle is composed of 9 kDa PscF subunits and contains 57% sequence similarity with 
YscF, the major protein component of the Yersinia-T3S needle (Table I) (229). Despite 
sequence similarity, functional complementation studies of a pscF deletion by yscF indicate that 
the PscF and YscF needle proteins are species-specific (229). The role of the needle in effector 
translocation is supported by studies showing that deletion of pscF results in the loss of needle 
formation and effector translocation (229).   
Needle biogenesis is regulated by a PscE-PscF-PscG complex within the bacterial cytoplasm.  
Binding of PscF to its two cytosolic chaperones keeps it in a secretion efficient conformation 
and prevents oligomerization while inside the bacteria (241, 248). T3S needle length is highly 
regulated and is postulated to be controlled by PscP, a homologous protein to YscP, the 
“molecular ruler” in Yersinia-T3S needle formation (Table I) (3, 153, 214). It is hypothesized that 
the two ends of YscP act as an anchor, where one end is tethered to the basal body and the 
other tethered to the growing needle. Upon completion of needle synthesis, and when the 
needle equals the length of the YscP protein, a signal is believed to be transmitted to the basal 
body, thereby terminating YscF secretion and initiating secretion of other proteins (153). 
Electron microscopy and crystal structure analysis of Yersinia needles have revealed a distinct 






Figure 4. The Pa-T3S structural apparatus. The Pa-T3S injectisome spans the bacterial inner 
membrane (IM), periplasmic space, and outer membrane (OM). The needle projects from the 
bacterial outer membrane and is comprised of PscF subunits. PcrV or the V-antigen is located 
at the tip of the needle structure and serves as an assembly platform for the translocon channel 
that forms in the host cell membrane (PopB and PopD).  
The image appears by permission of Elsevier Limited. The figure is part (a) of a four part figure 
and was originally published in the article “Structural Characterization and Membrane 
Localization of ExsB from the Type III Secretion System (T3SS) of Pseudomonas aeruginosa” 




LcrV, the needle tip protein in Yersinia, was identified in 1956 as the V-antigen because it 
induced protection against plague in a mouse model of infection (39). In Pa, the needle tip 
protein is PcrV, also termed a V-antigen (Fig. 4). While LcrV and PcrV share the highest 
sequence similarity between needle tip proteins, structural similarity exists with IpaD, BipD, and 
SipD, the needle tip proteins of Shigella, Burkholderia, and Salmonella, respectively (Table I) 
(31, 216). Needle tip proteins are hydrophilic, and contain two alpha-helices, which can form a 
coiled-coil, and two globular domains (67). The globular domains of LcrV are larger than those 
of IpaD, BipD, SipD, and PcrV (reviewed in (215)). In comparison, the needle tip proteins of E. 
coli and Bordetella form filamentous structures at the end of their T3S needles, but these 
filamentous proteins appear to function in a manner similar to IpaD, BipD, SipD, and PcrV 
(reviewed in (279). Unlike Yersinia and Pa, the needle tip proteins from Salmonella and 
Shigella cannot be functionally complemented with each other despite their similarities (238). 
Together with the needle, needle tip complexes have been implicated in triggering T3S (63, 
198, 321).  
Pa PcrV is a 295 amino acid protein that oligomerizes into a ring-like structure at the needle tip 
(36, 63, 111, 119, 215, 216). PcrV is encoded by the pcrGVHpopBD operon which in addition to 
PcrV, encodes for two translocon proteins, PopB and PopD; the chaperone for the translocon 
proteins, PcrH; and a chaperone/regulatory protein for PcrV, PcrG (Table I) (92, 101, 346). 
While PcrV has not been isolated from membranes, it is believed to serve as an assembly 
platform for translocon channel insertion and function in host cell membranes (28, 111, 118, 
119, 216, 283). In vitro studies have shown that deregulation of effector secretion occurs with 
deletion of pcrV, whereby effector proteins are secreted into the extracellular environment in an 
uncontrolled manner (119, 280, 282, 303, 304). This is in contrast to lcrV mutants where Yop 
secretion is down-regulated (22, 220). The functionality of PcrV is tied to the α12 helix in the C-
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terminal domain which is important for intramolecular coiled-coil formation (111). Deletion of the 
α12 helix, or mutation of residues within this helix, results in normal effector secretion; but 
functional pore formation and host cell cytotoxicity are prevented (56, 111, 119, 194). Linker-
scanning mutagenesis used to further dissect the mechanism underlying the role of PcrV in 
translocon formation and effector translocation identified: (1) that residues located at the end of 
the globular N-terminal domain and at the base of the anti-parallel coiled-coil are responsible 
for assembly and positioning of PcrV on the needle tip; (2) that the region between residues 44 
and 64 within the N-terminal globular domain are responsible for secretory control of both 
translocon and effector proteins; and (3) that the two leucine motifs within PcrV may be 
responsible for the timing of translocon and effector secretion (280).  
Due to the flexibility that has been found in PcrV, it has been proposed that it may undergo a 
conformational shift which controls effector secretion but not translocon protein secretion (181, 
280). In addition, PcrV was shown to regulate effector secretion in combination with its 
chaperone PcrG in a binding-independent manner (181). In support of these observations, in 
vitro studies found that ExoS secretion was up-regulated in Pa strains with an in-frame pcrG 
deletion (303). Taken together, these studies indicate that PcrV is not only important for 
translocon insertion and function in host cell membranes, but in combination with PcrG, can 
also regulate effector translocation into host cells.  
Translocon channel 
Effector translocation across the host cell plasma membrane requires two additional proteins, 
termed translocases. In Pa-T3S, the translocon proteins are PopB and PopD (Fig. 4) (56, 282, 
304). PopB and PopD are hydrophobic proteins which form an approximate 2.8-3.5 nm 
diameter translocon channel in the host cell membrane (56, 119). PopB is a 45 kDa, 392 amino 
acid protein that contains two alpha-helical transmembrane domains and two coiled-coil 
domains. PopD is a 31 kDa, 296 amino acid protein with one central transmembrane domain, 
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and the C-terminus has the potential to form an amphipathic alpha-helix (283). PcrH, the 
chaperone for PopB and PopD, is an 18.5 kDa protein that is responsible for the stabilization of 
both proteins inside the bacterial cytoplasm (9, 35, 283). Despite PcrH sharing 59% similarity 
with LcrH, the chaperone for the Yersinia translocon proteins, YopB and YopD, PcrH has not 
been shown to be coupled to regulation of Pa-T3S (Table I) (35, 346).  
Co-immunoprecipitation (CoIP) studies have shown that PopB directly interacts with PopD 
within red blood cell membranes (119). PcrV serves as an assembly platform for translocon 
function, by binding to PopD but not PopB. Therefore, the stability of the translocon channel 
relies on PopB’s interaction with PopD in the host cell membrane in conjunction with PopD’s 
interaction with PcrV located on the needle tip. Despite the interaction between PcrV and PopD, 
PcrV has not been isolated from cell membrane fractions (119).  
Deane et al. proposed that upon completion of translocon formation in the host cell membrane, 
a signal is initiated by a conformational change in the needle tip protein that is propagated 
down the needle to the bacteria, initiating effector secretion (63). Chaperones, along with N-
terminal secretory signals, were identified as key components in preventing premature protein 
translocation through the T3S needle and translocon channel prior to the bacteria receiving the 
secretory signal from the needle. Immediately following translation of translocon and effector 
proteins, chaperones bind to and prevent their target from completing tertiary folding and from 
being immediately degraded (103, 301). Chaperones are also thought to target their proteins to 
the T3S injectisome, thus preventing T3S proteins from being nonspecifically secreted through 
the flagellar apparatus (182). Interestingly, another level of secretion regulation by chaperones 
was recently identified in Salmonella (179). In this new model, chaperones have an essential 
role in targeting both translocon and effector proteins to a bacterial sorting platform located 
near the T3S injectisome. Together, the sorting platform and chaperones ensure that the 
translocon channel proteins are secreted prior to the effector proteins (179). Once the target 
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protein is delivered to the sorting platform, the chaperone is removed. It is believed that the T3S 
proteins travel through the needle and the translocon channel in a partially unfolded state due 
to the small inner diameter of the needle, and that this process depends on the ATPase located 
at the cytosolic base of the secretion apparatus (6, 110).  
While much is known about T3S regulation and structural apparatus assembly, including the 
size of the translocon channel, what remains unknown is the stoichiometric ratio of PopB to 
PopD within the channel or what serves as their eukaryotic cell membrane receptor. Another 
important unknown concept in the translocation process is what is the host cell factor that 
allows for translocon insertion and function in host cell membranes, as eukaryotic membranes 
are structured to resist channel formation. By understanding how the eukaryotic cell is involved 
in translocon formation it may be possible to target these steps to prevent Pa-T3S and the 
establishment of Pa infection.   
Effectors 
Following assembly of the T3S structural apparatus, Pa modulates host cell function through 
the secretion of four known effectors: ExoS, ExoT, ExoU, and ExoY (Table I and Fig. 5). ExoS 
and ExoT are bi-functional toxins that share 75% amino acid identity, and contain Rho-GTPase 
activating protein (GAP) and adenosine-diphosphate (ADP)-ribosyltranserferase (ADPRT) 
activities (116, 147, 166, 341). ExoU contains phospholipase A2 activity that results in a rapid 
loss of host cell plasma membrane integrity (85, 278). ExoY is an adenylate cyclase that 
contributes to systemic spread of Pa (320).  
Acute Pa infections are phenotypically characterized as invasive or cytotoxic due to the 
mutually exclusive presence of either the exoS or exoU genes (82, 85, 88, 285). ExoS 
characterizes infections as invasive, is expressed by 58-72% of clinical Pa isolates, and is 
known to function in pathogenesis (reviewed in (129))(2, 297, 320). ExoU is expressed by 28-
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42% of isolates and characterizes infections as cytotoxic (reviewed in (129))(82, 88, 285). While 
ExoT is expressed by 92-100% of Pa isolates, its contribution to the establishment of Pa 
infection remains minor (82, 183, 290, 320). ExoY is found in 89% of Pa clinical isolates 





















Figure 5. Pa-T3S effector proteins.  ExoS and ExoT are bi-functional proteins which contain 
Rho-GAP (GAP) and ADP-ribosyltransferase (ADPRT) activities. ExoU contains phospholipase 
activity (PLA2) and ExoY is an adenylate cyclase. Each protein contains an N-terminal secretory 
signal (S). Proteins S, T, and U contain a chaperone binding domain (CBD) and a membrane 
localization domain (MLD). The ADPRT activity of ExoS and ExoT requires binding of the host 
cell co-factor (CF) 14-3-3 for activation once translocated into the host cell. The key catalytic 
amino acid residues for each protein are indicated. The presence of exoS or exoU is mutually 
exclusive in Pa strains, while exoY is found in 70-95% of strains and exoT is found in 92-100% 
of Pa strains.   
This image appears by permission of the Nature Publishing Group. The figure was originally 
published in the article “The type III secretion system of Pseudomonas aeruginosa: infection by 




ExoS was identified in 1978 in the culture supernatant of Pa strain 388 as an ADP-
ribosyltranserferase, which catalyzes the transfer of ADP-ribose from NAD to eukaryotic host 
cell proteins (25, 147). Skin extracts and sera from burned mice infected with strain 388 
contained ExoS highlighting its importance in virulence (25). ExoS is a 453 amino acid, 49 kDa 
protein and was recognized to be distinct from Pa ToxA in that it did not ADP-ribosylate 
elongation factor-2 (147, 219). Additional differences between the two ADPRT toxins is that: (1) 
ToxA is internalized into host cells via receptor mediated endocytosis, and is cleaved by furin 
once in the host cell cytosol, while ExoS requires the T3S apparatus for delivery into host cells 
and the host cell protein 14-3-3 for activation; (2) ExoS is heat stable relative to ToxA; and (3) 
conditions which potentiate ToxA activity partially inactivate ExoS (46, 137, 146-148, 165, 342).  
Following the identification of 49 kDa ExoS, a 53 kDa form of the ExoS protein was also 
identified (219). The 53 kDa protein was initially thought to be a pro-enzyme form of ExoS that 
would then be cleaved to the 49 kDa enzymatically active form (172, 219). This hypothesis was 
supported by evidence that the 53 kDa form was found to contain 0.2% of the ADPRT activity of 
the 49 kDa protein (341, 346). Through genetic analysis, it was later recognized that the 53 kDa 
protein contained 75% amino acid similarity to the 49 kDa protein, and was encoded by a 
different gene, termed exoT (341, 346). Thus, the 53 kDa protein initially believed to be a less 
active pro-enzyme form of ExoS was recognized to be a distinctly different protein, ExoT. Like 
ExoS, ExoT was further characterized as a bi-functional toxin possessing both Rho-GAP and 
ADPRT activity. ExoS was subsequently discovered to be secreted by a T3S system when 
genetic analysis showed similarity of Pa genes with genes from the Yersinia Ysc T3S system 





The ExoS protein contains several domains, including two catalytic domains. The amino 
terminal of ExoS contains a secretory signal followed by a chaperone binding domain (Fig. 5) 
(20). A membrane localization domain (MLD) is located between residues 51-72, and targets 
ExoS to the eukaryotic plasma membrane where it is essential for ADP-ribosylation of host cell 
substrates, such as Ras (Fig. 5) (232, 351). The MLD is also important for Rho-GAP activity, 
where, as studies have shown, mutation of the MLD abolishes ExoS GAP activity in vivo (353).     
The ExoS GAP domain spans residues 96-233 and contains an arginine finger at residue 146 
that is responsible for down-regulation of host cell Rho-family proteins (Fig. 5) (116, 167). The 
GAP domain of ExoS is alpha-helical, and while there does not appear to be any structural 
similarity between ExoS GAP and eukaryotic Rho-GAPs, a low level of similarity is shared with 
GAP domains found at the amino terminals of Yersinia YopE and Pa ExoT (154, 166, 339, 
345). Within eukaryotic cells, ExoS GAP activity towards Rac1 and Cdc42 results in actin 
reorganization, while inactivation of Rho stimulates actin stress fiber formation (116, 136, 167, 
233). Interestingly, kinetic analysis has shown that ExoS contains higher catalytic activity 
towards Rho-family proteins than the eukaryotic p50RhoGAP protein (186). In terms of ExoS 
catalytic activity towards individual Rho-family proteins, ExoS exhibits highest activity towards 
Rac1 and Cdc42, followed by RhoA (186). Modulation of host cell actin dynamics by ExoS GAP 
activity serves as an anti-internalization factor to prevent bacterial uptake and Pa death (52, 
100, 108, 116, 263).  
ExoS ADPRT activity targets the Ras family of low molecular weight G (LMWG) proteins where 
ADP-ribosylation prevents their interaction with downstream targets. This results in cell 
rounding and inhibition of DNA synthesis (95, 96, 106, 135, 205, 326). Cyclophilin A and the 
ezrin/radixin/moesin (ERM) family of proteins have also been identified as additional ExoS 
ADPRT substrates (69, 195, 196). The ExoS ADPRT domain spans residues 234-453 and 
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requires the host cell factor 14-3-3 for catalytic activity (Fig. 5) (46, 102, 137, 163). Following 
translocation into the host cell, ExoS binds to 14-3-3 between residues 420 and 429 located 
within the ADPRT domain. Additionally, ExoS binding to 14-3-3 depends on leucine residues 
422, 423, 426, and 428 that are located within an amphipathic groove of 14-3-3 (134, 226). 
Contrary to other 14-3-3 binding motifs, crystal structure analysis has shown that ExoS binds to 
14-3-3 in a phosphorylation independent manner, with reversed orientation via hydrophobic 
interactions (226).  
ADP-ribosylation of host cell proteins by ExoS depends on catalytic glutamic acid residues 379 
and 381. In vitro, E379 participates in the transfer of ADP-ribose to target substrates and E381 
contributes to catalytic activity of ExoS (188, 249). Through cell line analysis, a hierarchy of 
eukaryotic substrate modification by ExoS ADPRT activity has been identified. In human cell 
lines, Ras and RalA were identified as early substrates followed by Rab5, Rab8, Rab11, and 
Rab7. Rac1 and Cdc42 were found to be late substrates (97). However, in rodent cell lines 
Rac1, Rab5, and Rab8 are not ExoS ADPRT substrates (270). These results indicate that the 
host cell type influences the differences in ExoS toxicity.  
Role of ExoS in infection 
ExoU is currently believed to be the most virulent of the Pa-T3S effectors because it is 100 
times more cytotoxic than ExoS (73, 183, 290, 322). The mutually exclusive presence of either 
ExoU or ExoS in Pa strains, taken together with results from clinical studies, has shown that 
ExoS may still have a prominent role in infection. Early clinical studies of Pa isolates from 
tracheal, urinary tract, or wound infections identified significantly higher levels of ExoS from 
wound and urinary tract sites, and that isolates producing increased ExoS could be isolated 
from both colonizing and infection sites (124, 272). Together, these studies led to the 
hypothesis that in vivo wound or urinary tract conditions may allow for increased ExoS 
production, and that this could be enhanced by prolonged infection (124).    
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The majority of studies investigating the role of both ExoS and the Pa-T3S system in Pa 
infection have been conducted in patients with respiratory disease. In studies of patients with 
various lower respiratory infections, 30 of 108 (28%) Pa isolates were found to express ExoS 
(269). The mortality rate for patients infected with a PcrV negative Pa isolate was 3%, which 
increased to 25% when the Pa isolate also expressed ExoS or ExoU, thus highlighting the role 
of both ExoS and ExoU in disease severity (269). Studies of Pa isolates from patients with VAP 
found that 23 of 35 isolates (66%) contained the exoS gene, 16 of which produced detectable 
amounts of ExoS when analyzed in vitro (130). Twelve of the 16 ExoS secreting strains were 
isolated from patients with severe disease, further suggesting that ExoS contributes to disease 
severity (130). Finally, studies by Zhuo et al. found the presence of the type III proteins ExoS, 
ExoU, and PcrV in: (1) 16 of 24 (66.7%) Pa isolates from patients with respiratory infections 
with low Pa burden; (2) 13 of 17 (76.5%) patients with high Pa burden without VAP; and (3) 17 
of 28 (60.7%) patients with high Pa burden who developed VAP (356). Specifically, ExoS has 
been found in 63% of isolates from patients with low Pa burden, 54% in isolates from patients 
with high Pa burden without VAP, and in 47% of isolates with high Pa burden and VAP (282). 
From these studies it was suggested that Pa are more likely to be planktonic and not contained 
within biofilm in patients with a high Pa burden, and that these Pa isolates are more virulent due 
to the high percentage that express components of the T3S (356).  
The identification of ExoT by Yahr et al. lends support to an increased pathogenicity of Pa 
infections associated with co-expression of ExoS or ExoU with ExoT (73, 269, 341). A recently 
published study by El-Solh et al. highlights the importance of Pa-T3S and the effectors ExoS, 
ExoU, and ExoT in Pa bloodstream infections (73). Of 85 patients diagnosed with a Pa 
bloodstream infection, 37 (44%) patients had an isolate that expressed at least one of the type 
III secretory proteins. The ExoU/ExoT phenotype was identified as the most prevalent in 18 of 
37 (49%) isolates, while the ExoS/ExoT phenotype was identified in eight of 37 (22%) isolates. 
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Two (5%) isolates were found to express ExoS alone, and nine (24%) expressed ExoT alone 
(73). Previous antimicrobial treatment was found in 48 patients, 65% of which had a T3S 
positive phenotype. Of these, ExoS was identified in five (23%) isolates resistant to 
ciprofloxacin and in one (7%) isolate resistant to gentamicin (73). Together these studies 
suggest that despite antimicrobial treatment, patients who had T3S positive bloodstream 
isolates had a poorer clinical prognosis. The question from these studies is why is expression of 
ExoT with ExoS or ExoU important to infection? ExoT, like ExoS, contains Rho-GAP activity 
that functions in preventing internalization (52, 108, 166). In strains producing ExoS alone, a 
low percentage of Pa can be internalized (76, 88, 243). ExoU does not contain any known anti-
internalization properties. Therefore, it may be possible that the role of ExoT expression in 
conjunction with ExoS or ExoU is to enhance the anti-internalization capabilities of Pa, 
especially since ExoT is expressed by nearly all strains (183, 290, 320).  
The role of T3S in acute Pa infections is supported by clinical results showing that mortality 
rates are increased in patients with Pa isolates expressing T3S proteins and that antibodies 
against T3S components confer protection from Pa-T3S infection. Additionally, the role of ExoS 
in infections is supported by clinical results showing that mortality is increased in patients 
colonized with ExoS or ExoU expressing Pa isolates compared to PcrV only expressing 
isolates.  
The current model for the role of T3S in establishment of Pa infection is shown in Figure 6. In 
this model, Pa expressing flagella and pili bind to the host cell surface, potentially through 
asialo-GM1, an asialylated glycolipid located within epithelial cell membranes or through 
adhesion to the CFTR (81, 113, 122). Disruption of epithelial integrity from components of the 
T3S system, such as ExoS or ExoU, followed by disruption of the ECM by Pa factors such as 
elastase and proteases, allows for transversal of Pa to the blood stream to facilitate bacterial 
dissemination to other sites of the body (129, 218, 231, 297). In the establishment of a chronic 
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infection, following bacterial binding and initiation of T3S, Pa will form a biofilm on the epithelial 
surface (reviewed in (334)). Production of alginate in conjunction with down-regulation of 
flagella, pili, LPS, and T3S by Pa reduces immune recognition of Pa and contributes to 
persistence of the bacteria (40, 125, 192). The step which remains the least understood in this 
model of Pa infection is what is the host cell factor that allows for T3S translocon insertion and 











Figure 6. Model of Pa-T3S in the establishment of Pa infection. Pa binds to the host 
epithelial layer via flagella and pili. Toxin production, presumably due to the T3S system, results 
in the damage to the epithelial barrier which allows traversal of the bacteria to the blood stream. 
Bacteria that remain at the initial site of infection may go on to produce a biofilm. 
The image appears by permission of John Wiley and Sons. This figure was part (a) of a two 
part figure originally published in the review “Pseudomonas aeruginosa: Host defence in the 
lung diseases” (2010). Respirology. 15(7):1037-1056 authored by Williams et al. 
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Host Cell Influences in Pseudomonas-T3S 
Unlike obligate pathogens which target specific cell types, Pa is able to cause disease in a wide 
variety of cell and tissue types. While it is: (1) hypothesized that host cell factors at the site of 
infection may influence the severity of disease, as indicated by increased ExoS production in 
wound and UTI Pa isolates; (2) known that T3S is involved in the establishment of infection; 
and (3) known that establishment of acute cellular Pa infections parallels cellular sensitivity to 
Pa-T3S; it is unknown what the host cell factor is that allows for the establishment of infection in 
so many tissue and cell types (reviewed in(129))(33, 124, 206, 271). Asialo-GM1, a receptor for 
flagella, pili, and LPS, the CFTR, and epithelial cell polarity were factors implicated in Pa-T3S, 
but no clear role of the host cell had been elucidated (62, 87, 156, 243). 
The first sets of studies developed in this area aimed to identify the host cell factors responsible 
for the insertion and function of Pa-T3S translocon proteins in host cell membranes. Initially, 
purified Pa translocon proteins, PopB and PopD, were found to bind to liposomes in a 
cholesterol-independent manner, but oligomerized and induced channel formation in the 
liposome in a cholesterol-dependent manner (283). In 2005, Hayward et al. showed that 
translocon proteins, SipB and IpaB, from Salmonella and Shigella respectively, bound to 
cholesterol in vitro with high affinity and that depletion of eukaryotic cell membranes of 
cholesterol blocked T3S (132). However, Faudry et al. subsequently showed that channel 
formation in liposomes was cholesterol independent and that both PopB and PopD bound to 
phosphotidylserine (80). Together, the role of cholesterol in Pa-T3S remained unclear due to 
differences in the experimental systems used. At the same time, studies evaluating over 40 cell 
lines including epithelial, endothelial, fibroblasts, macrophages, and T cells showed that only 
two types of cells were resistant to Pa-T3S, confluent polarized epithelial cells and 
promyelocytic HL-60 cells (206, 271). Both cell culture models could be induced to become 
sensitive to Pa-T3S through disruption of apical-basal lateral polarity for confluent monolayers 
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or differentiation of HL-60 cells with phorbol esters (206, 271). Studies have also found that 
translocon channel formation in host cell membranes can be influenced by translocated 
effectors. Studies in Yersinia have shown that the effectors YopE, YopT, and YopK can inhibit 
T3S channel formation in host cell membranes, which contributes to a dampening of host 
inflammatory response towards the bacteria (34, 68, 324). Additionally, studies where Pa-T3S 
effectors were expressed in Yersinia have indicated that Pa may have the ability to regulate 
translocon formation and effector translocation via its effectors, but it remains to be determined 
if other T3S systems have this capability (4).   
Present Studies 
Knowing that a cellular or immunocompromise is needed for the establishment of Pa infection 
and Pa-T3S, the purpose of the first set of studies presented in this dissertation was to identify 
the host cell factors that allow for the establishment of Pa-T3S infection. Two cell models were 
utilized to determine what would induce resistance to Pa-T3S in a sensitive line (HT-29 cell 
model) and what would induce sensitivity in a resistant cell line (HL-60 cell model). In using the 
T3S effector ExoS to monitor sensitivity or resistance to Pa-T3S infection, these studies 
identified that sensitivity to Pa-T3S was induced with acquisition of cell migration, while 
resistance was induced when eukaryotic cells lost cell migration capabilities. Specifically, it was 
identified that Rac1/Cdc42-mediated focal complexes, which are located at the leading edge in 
migrating cells, were important in T3S sensitivity. From these studies, we developed the 
hypothesis that as cells migrate, actin-induced changes in the host cell alters the membrane in 
a manner that allows for translocon insertion and effector translocation, and that this process is 
mediated by Rac1 and Cdc42.  
The second set of studies was designed to further investigate the hypothesis that the leading 
edge in migrating cells is the host cell factor required for Pa-T3S induction. A T24 cell model 
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was used for these studies because they exhibit a highly migratory phenotype where the 
leading edge can be differentiated from the trailing edge. In order to understand how ExoS 
might be regulating translocation at the leading edge, we utilized Pa strains expressing ExoS 
with mutations that abolished its GAP (R146A) and/or ADPRT (E379A, E381A, or 
E379A/E381A) activities. These studies found: (1) Pa expressing WT ExoS localized to the 
leading edge in migrating T24 cells. This localization was significantly increased compared to 
T24 cells treated with Pa expressing a pUCP empty vector or translocon mutant (ΔPopB). (2) 
Increases in ExoS translocation by Pa expressing ExoS deficient in GAP activity were attributed 
to continued effector translocation by internalized Pa. (3) Increases in ExoS translocation by Pa 
expressing ExoS deficient in ADPRT activity related to maintenance of leading edge properties. 
(4) Increases in ExoS translocation by ExoS deficient in both GAP and ADPRT activities related 
to increased bacterial binding, Pa internalization, continued effector translocation within host 
cells, and maintenance of the T24 leading edge actin structure. (5)  Lastly, both Pa and ExoS 
were observed to align along actin filaments. From these studies the hypothesis evolved into 
actin induced changes in membrane dynamics at the leading edge of migrating cells allows for 
translocon insertion. ExoS translocation into the host cell is facilitated by actin filament linkage 
to the membrane via ERM proteins. As ExoS tracts along actin and reaches its targets within 
the host cell, it subsequently down-regulates effector translocation through disruption of the 
actin linkage to the membrane by interfering with ERM proteins, and preventing Pa 
internalization via inactivation of Rho-family GTPases.  
The final set of studies presented in this dissertation utilized cell models which are known to 
differ in regulation of leading edge dynamics. MTC and MTLn3 cells are closely related cell 
lines used to study differences in host cell metastasis. MTC cells were isolated from a 
mammary tumor and are a non-metastatic epithelial cell line. MTLn3 cells are from the same 
mammary tumor, but had metastasized to the lung, where they were isolated. Previous studies 
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have shown that MTC cells regulate leading edge dynamics via Rac1 while MTLn3 cells 
regulate leading edge dynamics via Rho (71, 72). Studies presented in this chapter found that 
increased sensitivity of MTLn3 cells, compared to MTC cells, was attributed to increased Pa 
internalization by MTLn3 cells. Treatment of MTLn3 cells with the ROCK inhibitor Y-27632 was 
found to decrease sensitivity to Pa-T3S to levels comparable to MTC cells, while treatment of 
MTC cells with the Rac1 inhibitor, NSC23766, was found to increase MTC cell sensitivity to Pa-
T3S. From these studies the hypothesis developed that increased MTLn3 sensitivity to Pa-T3S 
occurs because these cells are resistant to ExoS GAP activity due to high levels of Rho at the 
leading edge, while MTC cells are sensitive to ExoS GAP activity due to high levels of Rac1 at 
the leading edge. Studies using a third cell line, Madin-Darby canine kidney (MDCK) cells, to 
analyze wounded monolayer sensitivity to Pa-T3S found that wounds were most sensitive to 
Pa-T3S 4-6 hr post-wounding. In addition, sensitivity was due to Pa internalization, which can 
potentially be attributed to the increased presence of Rho at the leading edge in the cells 
migrating to close the wound.  
Together, the studies presented in this dissertation highlight the mechanism underlying the 
opportunistic nature of Pa infections, which are known to target wounded epithelial barriers and 
support the hypothesis that host cell migration properties are contributing factors in Pa-T3S 
translocation and in the establishment of Pa infection. Specifically, at the leading edge, Rac1 
and Cdc42-mediated actin polymerization induces changes in membrane dynamics which 
allows for translocon insertion. Pa then utilizes actin linked to the plasma membrane via 
phosphorylated ERMs to translocate ExoS into the host cell. In turn, ExoS regulates Pa-T3S by 
targeting Rho-family GTPases to prevent Pa internalization, and by potentially targeting ERM 
proteins to interrupt the actin-plasma membrane linkage, which prevents further translocation. 
Increased T3S sensitivity of certain cancer cell lines, as well as cell lines which migrate via 
Rho-mediated amoeboid migration can be attributed to the cells being resistant to ExoS GAP 
 
 43
activity, whereby Pa can be internalized and continue to translocate effectors within the host 
cell (Fig. 7).        
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Figure 7. Model of the role of the host cell in the establishment of Pa-T3S infection. A) In 
Rac1-mediated cell migration, eukaryotic cells migrate via a mesenchymal phenotype. Pa 
preferentially targets the leading edge of these migrating cells due to active actin polymerization 
and changes in membrane viscosity, which allow for translocon insertion. ExoS is translocated 
into the host cell via actin at the leading edge. Once inside the cell, ExoS GAP activity targets 
GTP-bound Rac1 and causes hydrolysis to GDP-bound Rac1 to prevent Pa internalization by 
the host cell. ExoS ADPRT activity interrupts actin-plasma membrane linkage through 
disruption of ERM proteins, which regulates T3S by inhibiting further ExoS translocation. B) In 
Rho-mediated cell migration, eukaryotic cells migrate via an amoeboid phenotype. GTP-bound 
Rho is more resistant to the effects of ExoS GAP activity and as a result, Pa can use actin to 
become internalized in membrane vesicles and continue T3S translocation within the host cell. 
ExoS ADPRT has limited inhibitory effects on pERM mediated actin-plasma membrane linkage 


















Chapter 2: Role of Host Cell Polarity and Leading Edge Properties in 
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Type III secretion (T3S) functions in establishing infections in a large number of Gram-negative 
bacteria, yet little is known about how host cell properties might function in this process. We 
used the opportunistic pathogen, Pseudomonas aeruginosa, and the ability to alter host cell 
sensitivity to Pseudomonas T3S to explore this problem. HT-29 epithelial cells were used to 
study cellular changes associated with loss of T3S sensitivity, which could be induced by 
treatment with methyl-beta-cyclodextrin or perfringolysin O. HL-60 promyelocytic cells are 
innately resistant to Pseudomonas T3S and were used to study cellular changes occurring in 
response to induction of T3S sensitivity, which occurred following treatment with phorbol esters. 
Using both cell models, a positive correlation was observed between eukaryotic cell adherence 
to tissue culture wells and T3S sensitivity. In examining the type of adhesion process linked to 
T3S sensitivity in HT-29 cells, a hierarchal order of protein involvement was identified that 
paralleled the architecture of leading edge (LE) focal complexes. Conversely, in HL-60 cells 
induction of T3S sensitivity coincided with the onset of LE properties and the development of 
actin-rich projections associated with polarized cell migration. When LE architecture was 
examined by immunofluorescent staining for actin, Rac1, IQ-motif-containing GTPase-activating 
protein 1 (IQGAP1) and phosphatidylinositol 3 kinase (PI3 kinase), intact LE structure was 
found to closely correlate with host cell sensitivity to P. aeruginosa T3S. Our model for host cell 
involvement in Pseudomonas T3S proposes that cortical actin polymerization at the LE alters 
membrane properties to favor T3S translocon function and the establishment of infections, 
which is consistent with Pseudomonas infections targeting wounded epithelial barriers 




Originally identified because of its role in Yersinia virulence (50), type III secretion (T3S) is now 
recognized to contribute to the pathogenesis of a large number of Gram-negative bacteria. T3S 
allows the direct translocation of ‘effectors’ from the bacterial cytosol into eukaryotic cells, 
enabling bacteria to manipulate host cells to establish infections while evading immune 
responses. The T3S system includes a bacterially formed ‘injectisome’ needle-like 
nanostructure that serves as a conduit for transferring bacterial effectors to eukaryotic cells. A 
bacterially formed ‘translocon’ channel is then believed to mediate effector translocation across 
host cell membranes. The mechanism underlying T3S translocon channel formation and host 
involvement in this process remains the least understood events in T3S. We have used the 
opportunistic pathogen, Pseudomonas aeruginosa, and insights into T3S provided by it to study 
this problem. 
P. aeruginosa is a ubiquitous environmental bacterium that is capable of causing infections of 
high morbidity and mortality in individuals compromised by wounds, immune defects, or cystic 
fibrosis. While the cellular alteration predisposing individuals to P. aeruginosa infections is not 
known, factors that have been implicated include: alterations in expression of putative P. 
aeruginosa receptors, such as asialo-GM1, alterations in the cystic fibrosis transmembrane 
conductance regulator, and cellular changes affecting epithelial cell polarity (62, 91, 156, 243). 
Studies have also drawn attention to the role of T3S during initial phases of P. aeruginosa 
infections (56, 117, 151). Consistent with this notion, cellular properties influencing P. 
aeruginosa infections, such as apical-basolateral polarity (91, 156, 243), also influence 
sensitivity to P. aeruginosa T3S (Pa-T3S) (206). The integral role of T3S in the establishment of 
P. aeruginosa infections is evident in the ability of the T3S translocon protein, PcrV, to induce 
adaptive immune protection against P. aeruginosa infections (282). P. aeruginosa offers an 
advantage in studying mechanisms underlying T3S translocon function and host cell 
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involvement in this process for, as an opportunistic pathogen, eukaryotic cells sensitive or 
resistant to Pa-T3S have been identified and are available for mechanistic comparisons (206).  
Current studies support the suggestion that in Pa-T3S translocon formation, the needle tip 
protein, PcrV oligomerizes into a ring-like structure in association with the T3S needle complex 
and serves as an assembly platform for membrane insertion and pore formation by hydrophobic 
translocator proteins, PopB and PopD (111, 119, 216). Consistent with this model, PcrV is 
required for T3S pore formation in red blood cells and for translocation of effectors into 
nucleated cells (118). Also consistent with this model, PopB and PopD maintain intrinsic pore 
forming properties, and PopB and PopD, but not PcrV, can penetrate into and be detected in 
eukaryotic cell membrane fractions (80, 283). A precise understanding of the mechanism of 
T3S translocon formation and function, however, has been hampered by an inability to detect 
the direct interaction of PcrV with either PopD or PopB (9, 119, 283). A role of host cell 
membrane properties in Pa-T3S translocon function has been revealed by studies that found 
PcrV to be required for T3S pore formation in eukaryotic cells, whereas PcrV was not required 
for pore formation in lipid vesicles (119, 216, 283). 
The limited understanding of host cell involvement in T3S translocon function attests to 
experimental difficulties in identifying bacterial-host cell interactions during T3S. Current studies 
have implicated host cell lipid rafts and their cholesterol component in T3S translocon 
formation, but the mechanism underlying their role in T3S is unclear (132, 175, 176, 259, 318). 
In our analyses of over 40 cell lines (including epithelial, fibroblasts, endothelial, macrophage, 
and T-cells), two cell types were identified to be resistant to T3S: confluent polarized epithelial 
cells and promyelocytic HL-60 cells (206, 271). We also found host cell sensitivity to Pa-T3S to 
be an alterable property. Polarized epithelial cells can become T3S sensitive by disruption of 
tight junctions and loss of apical-basolateral polarity (206). HL-60 cells can be converted to Pa-
T3S-sensitive by treatment with the differentiating phorbol ester, 12-O-tetradeconylphorbol-13-
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acetate (TPA) (271). In studies of HL-60 cells, resistance to Pa-T3S has been found to occur at 
the level of membrane translocation. 
The questions being asked in this study are: (1) how do eukaryotic cells change in conjunction 
with alterations in Pa-T3S sensitivity; and (2) how can this be applied to understanding the role 
of host cell properties in T3S translocon function? Two basic approaches were used to answer 
these questions. First, Pa-T3S-sensitive HT-29 epithelial cells were used as a model to 
examine alterations in cellular properties occurring in conjunction with loss of host cell 
sensitivity to Pa-T3S. Second, Pa-T3S-resistant HL-60 cells were used to examine alterations 
in cellular properties that occur upon induction of Pa-T3S sensitivity. Both approaches led to the 
recognition of a relationship between host cell polarity, directional migration, and leading edge 
(LE) properties with Pa-T3S sensitivity. These findings have led us to hypothesize that as an 
opportunistic pathogen P. aeruginosa relies on alterations in membrane properties at the LE for 




Bacterial strains - P. aeruginosa strain PA103exoUexoT::Tc (PA103ΔUT) (314) and 
PA103ΔPopB, a T3S translocon mutant strain, were provided by Dara Frank (Medical College 
of Wisconsin, Milwaukee, WI, USA). Hemagglutinin (HA)-tagged ExoS (ExoS-HA) (232) was 
provided by Joseph Barbieri (Medical College of Wisconsin). PA103ΔUT expressing plasmid-
encoded ExoS-HA (Pa-ExoS-HA) was the primary strain used in this study to assay for host cell 
sensitivity to Pa-T3S. PA103ΔUT expressing a plasmid encoded enzymatically inactive ExoS-
GAP/ADPRT mutant (having R146A-GTPase activating protein and E379A/E381A-ADP-
ribosyltransferase mutations) was used as a control to evaluate the role of ExoS enzymatic 
function in our analyses and was constructed as previously described (95).  
Eukaryotic cell culture - HT-29, T24, and HL-60 cells were obtained from American Type Cell 
Culture Collection (ATCC, Manassas, VA) and were cultured according to ATCC specifications 
in media supplemented with 10% fetal bovine serum, 100 U penicillin ml-1, and 100 g 
streptomycin ml-1 (Hyclone). 
Bacterial-eukaryotic cell co-culture studies and drug treatments - In co-culture studies of 
T3S-sensitive cells, HT-29 or T24 cells were seeded at 2.5 x 105 or 1.0 x 105 cells ml-1, 
respectively, unless otherwise specified, and grown to 70-90% confluency. Both HT-29 and T24 
cells were examined using the drug treatments listed in Supplementary Table S1 to confirm that 
drug effects were not cell line specific. Prior to drug treatment, cells were washed twice with 
Dulbecco’s PBS (DPBS; HyClone), and drugs were added in cell line specific medium 
containing 0.6% BSA (bovine serum albumin, Sigma-Aldrich). Cells were treated with drugs as 
specified and then co-cultured with 107 c.f.u. ml-1 of the indicated P. aeruginosa strain or no 
bacteria for 4-5 h, as previously described (224). In studies using perfringolysin-O (PFO, 
C459A; (291)), PFO was activated with 5 mM DTT. Monomer locked PFO (ssPFO, 
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T319C/V334C; (250)) and prepore locked PFO (dsPFO, S190C/G57C; (144)) were dialyzed 
against HEPES buffered saline prior to addition to cells. All PFO constructs were provided by 
Rodney Tweten (University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA). 
In co-culture studies of T3S resistant cells, HL-60 cells were seeded at a density of 1 x 105 cells 
ml-1, 12 h prior to TPA differentiation or co-culture with P. aeruginosa. Terminal differentiation 
was induced with 20 nM TPA, (Calbiochem) (47, 184) for the indicated times. Prior to co-culture, 
non-adherent HL-60 cells were collected, centrifuged, and reseeded with the corresponding 
adherent fractions (when present) in medium containing 0.6% BSA. Cells were co-cultured for 
4-5 h with Pa-ExoS-HA (m.o.i. 30:1).  
Analysis of eukaryotic cell cytotoxicity, adherence, and Pa-T3S sensitivity - Following co-
culture of HT-29 cells with P. aeruginosa strains, bacteria were removed, cells detached, and 
extracellular proteins degraded with 0.25% trypsin-1mM EDTA (Hyclone). Cells were washed 
two times in medium containing 200 g ciprofloxacin ml-1, and an aliquot of cells was examined 
for cell viability, adherent cells, and total cell number using trypan blue staining. The percentage 
of adherent HT-29 cells was calculated relative to non-drug treated control adherent cells 
remaining in tissue culture wells following co-culture studies. A second aliquot of cells was 
examined for total protein (BCA Protein Assay; Pierce). The remainder of cells was processed 
for either cell extract or membrane fractionation analysis. For cell extract analysis, cells were 
resuspended and lysed in 4X Laemmli sample buffer (174). For cell membrane analysis, cells 
were resuspended in digitonin fractionation buffer and fractionated as previously described 
(264). RalA localization to the membrane fraction was used to confirm the specificity of the 
fractionation procedure. 
Following studies of co-culture of HL-60 cells with P. aeruginosa strains, cells were collected 
and washed with medium containing ciprofloxacin, extracellular proteins were degraded with 
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trypsin and cell membrane fractionation was performed as described for HT-29 cells. To 
quantify HL-60 cell adherence to tissue culture wells relative to Pa-T3S sensitivity, HL-60 cells 
were seeded in duplicate, treated with TPA for increasing times, and then co-cultured with Pa-
ExoS-HA. One sample was assayed for T3S effector translocation, as described below. The 
other sample was assayed for the percentage of adherent cells by enumerating cells adherent 
and non-adherent to tissue culture wells in each sample using trypan blue staining; the 
percentage of adherent cells was calculated relative to total cells.  
Eukaryotic cell sensitivity to Pa-T3S was assayed based on the translocation of ExoS-HA, ExoS 
ADP ribosylation of RalA, or membrane insertion of translocon proteins, PopB and PopD, as 
determined by SDS-PAGE and immunoblot analysis (95, 96, 271). Comparisons of host cell 
T3S sensitivity were based on equal protein loading, and detection antibodies included: 
monoclonal anti-HA to detect ExoS-HA (Covance Research Products); monoclonal anti-RalA to 
detect ExoS effector function (BD-Transduction Laboratories); and polyclonal anti-PopB and 
anti-PopD to detect translocon membrane insertion (provided by Joseph Barbieri and Dara 
Frank). Monoclonal anti-glyceraldehyde 3-phosphate dehydrogenase (GAPDH; Chemicon 
International) was used as a protein expression/loading control. Immunoblots were developed 
using horseradish peroxidase (HRP)-conjugated anti-mouse or anti-rabbit IgG (Sigma-Aldrich) 
and detected by enhanced chemiluminescence (GE Healthcare Bio-Sciences Corp). 
Percentage RalA ADP ribosylation was quantified relative to total RalA based on densitometry 
analyses using ImageJ 1.40g software (Wayne Rasband, NIH), averaging a minimum of three 
independent experiments.  
Analysis of effects of drug treatments on bacteria - Effects of drug treatments on P. 
aeruginosa growth were determined following co-culture experiments by diluting and plating co-
culture supernatants on Luria broth agar plates, using a micro-dilution plating technique (237). 
P. aeruginosa adherence to HT-29 cells was determined following a 3 h co-culture period by 
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scraping cells into DPBS containing 0.6% BSA (DPBS-BSA), washing three times with DPBS-
BSA, lysing cells on ice in 0.25% Triton X-100, then diluting and plating the lysate. Number of 
bacteria per eukaryotic cell was calculated. The efficiency of T3S effector production and 
secretion in the presence of drugs was determined by harvesting co-culture supernatants and 
detecting ExoS-HA and PopB by SDS-PAGE and immunoblot analysis. 
Immunofluorescence (IF) analyses - HT-29 cells were seeded at 1.5 x 105 cells ml-1 in 
chamber slides (Nalge Nunc International) 48 h prior to drug treatment and co-cultured with Pa-
ExoS-HA or enzymatically inactive ExoS for 3 h. This shorter co-culture period allowed for 
bacterial-host cell interaction with limited bacterial effects on eukaryotic cell morphology. Cells 
were then fixed with 3% paraformaldehyde in actin stabilization buffer (ASB; (115), 
permeabilized with 0.2% Triton X-100 in ASB, blocked, and stained using monoclonal 
antibodies to: IQ-motif-containing GTPase-activating protein 1 (IQGAP1) (Invitrogen), α-tubulin 
(Invitrogen), Rac1 (BD Transduction Laboratories) or phosphatidylinositol 3-kinase (PI3K) (BD 
Transduction Laboratories) coupled with anti-mouse Alexa Fluor 488 conjugate (Invitrogen). 
Actin was stained using phalloidin conjugated to tetramethylrhodamine B isothiocyanate 
(Phalloidin-TRITC, Sigma-Aldrich). Lipid rafts were stained with Alexa Fluor 488-labeled cholera 
toxin B subunit (CTB, Invitrogen). P. aeruginosa was stained with a polyclonal guinea pig 
antibody against P. aeruginosa (Biogenesis) or a polyclonal rabbit antibody against P. 
aeruginosa LPS (provided by Joseph Lam, University of Guelph, Canada), followed by an 
appropriate Alexa Fluor conjugate (Invitrogen). Cells were mounted using Fluoromount-G 
(Southern Biotechnology Associates) and visualized using a Plan-Neofluar x100/1.3 oil objective 
on a Zeiss LSM 510 confocal microscope (Jena, Germany), or a Plan-Apochromat x63/1.40 oil 
objective on a Zeiss Imager.Z1 LSM 510 confocal microscope. Images were captured and 
exported as 8-bit TIF files into Adobe Photoshop CS2 (Adobe Systems Incorporated, San Jose, 
CA) and cropped. 
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For IF staining of TPA-differentiated HL-60 (dHL-60) cells, cells were seeded on glass cover 
slips, differentiated with 20 nM TPA for the indicated time, and then co-cultured for 3 h with Pa-
ExoS-HA. Samples were prepared for IF analysis and stained for the indicated proteins, as 
described above. For IF staining of undifferentiated, non-adherent T3S resistant HL-60 (rHL-60) 
cells or T3S sensitive (sHL-60) cells, cells were seeded in tubes, collected by centrifugation and 
prepared for IF analysis as above, with the exception that cells were centrifuged between 
washes and fixed to glass slides using a cytospin. 
IQGAP1 siRNA knockdown - ON-TARGETplus SMARTpool RNA oligomers against human 
IQGAP1 (Dharmacon) were transfected into HT-29 cells using TransIT-TKO Transfection 
Reagent (Mirus Bio Corporation), according to the manufacturer’s specifications. siRNA 
sequences targeting multiple IQGAP1 mRNA sequences included: (1) 
GAACGUGGCUUAUGAGUAC, (2) GCAGGUGGAUUACUAUAAA, (3) 
CGAACCAUCUUACUGAAUA, and (4) CAAUUGAGCAGUUCAGUUA. siCONTROL Non-
Targeting siRNA #1 (Dharmacon) was used as a control. Cells were co-cultured with Pa-ExoS-
HA 48 or 72 h post-transfection. IQGAP1 expression was examined by Western blot analysis 
and quantified by densitometry using ImageJ, and percentage IQGAP1 expression was 
determined relative to quantified levels of IQGAP1 in non-drug treated cells that were co-
cultured with Pa-ExoS-HA.  
Focal complex, focal adhesion, and LE functional analyses - To assess the role of focal 
complexes and focal adhesions in Pa-T3S sensitivity of adherent HT-29 cells, cells were seeded 
24-48 h prior to treatment with the following inhibitors: (1) Rac1 inhibitor, NSC23766 (EMD 
Chemicals), added to cells 16 h prior to co-culture; (2) Rho-kinase (ROCK) inhibitor, Y-27632 
(Alexis Biochemicals), added to cells 1 h prior to co-culture; (3) Src kinase inhibitor, PP2 
(Calbiochem), added to cells 1 h prior to co-culture; or (4) Cdc42 inhibitor, secramine A 
(C35H39BrN2O5S; provided by Thomas Kirchhausen, Harvard Medical School, MA, USA and 
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Gerald B. Hammond, University of Louisville, KY, USA), added to cells in medium containing 
0.5% BSA and 1% DMSO 1 h prior to co-culture. In examining the effects of inhibitors on non-
adherent HT-29 cells, cells were seeded at 5.0 x 105 cells ml-1, followed by the immediate 
addition of drugs as described above. To assess the role of LE associated actin, microtubules 
(MTs) and PI3K in Pa-TS3, HT-29 cells were seeded as described above for pre- and post-
adherence drug treatment studies and treated with the following inhibitors for 1 h: latrunculin B 
(LatB; BIOMOL International), nocodazole (Sigma-Aldrich), AS605240, or LY294002 (Cayman 
Chemicals). To disrupt existing MTs, cells were placed at 4oC for 3 h prior to drug treatment. 
Cells were co-cultured with Pa-ExoS-HA in the presence of drug, and drug toxicity and Pa-T3S 
sensitivity were examined as previously described.  
Statistical analysis - Statistical significance was calculated based on a Student’s t test, using 
JMP, Version 7 Software (SAS Institute). The relationship between eukaryotic cell adherence to 
tissue culture wells and Pa-T3S effector translocation was computed using a Pearson’s 
correlation coefficient based on comparisons of percentage adherence with percentage RalA 





Inhibition of host cell Pa-T3S sensitivity. The finding that most cultured cells are sensitive to 
Pa-T3S underscores the conserved nature of host cell properties conferring T3S sensitivity. To 
help characterize these properties, cell lines were treated with agents that alter membrane 
properties, cytoskeletal structure, or cell signaling pathways, and their effects on host cell Pa-
T3S sensitivity were determined. Pa-T3S sensitivity was monitored based on effector 
internalization following co-culture with P. aeruginosa strains expressing the T3S effector, ExoS. 
Of the many agents tested (summarized Supplementary Table, S1), two membrane modulating 
agents, MCD and PFO were identified to inhibit host cell Pa-T3S-sensitivity. Similar results 
were obtained with HT-29, T24, and other tested Pa-T3S sensitive cell lines. The finding that 
agents modulating membrane structure, but not those altering cytoskeletal structure or common 
cell signaling pathways, affected T3S sensitivity provided an initial indication that host cell 
sensitivity to Pa-T3S was linked to membrane properties.  
With the identification of MCD and PFO as Pa-T3S inhibitory agents, these agents were then 
used as tools to characterize alterations in host cell properties associated with loss of Pa-T3S 
sensitivity. MCD depletes membrane cholesterol, and in dose-response studies, treatment of 
HT-29 epithelial cells with 2-3 mM MCD, prior to co-culture with Pa-ExoS-HA, caused a 
decrease in T3S effector ExoS translocation (Fig. 8a, indicated by asterisks). The decrease in 
ExoS translocation corresponded with a decreased shift in the apparent molecular mass of 
RalA, reflecting the decreased internalization and functional ADP ribosylation of host cell RalA 
by ExoS. As shown in Fig. 8(a), RalA exhibits variable shifts in molecular mass upon ADP 
ribosylation by ExoS. This relates to RalA having primary (Arg52) and secondary (Arg135 and 
Arg161) sites of ExoS ADP ribosylation, which results in one or two shifts in RalA as assayed by 
SDS-PAGE and Western blot analysis (96, 270). Quantification of the shift in molecular mass of 
RalA (determined by densitometry) can in turn be used as a read-out of the efficiency of ExoS 
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effector translocation (96, 270). MCD also caused a dose-dependent decrease in the 
translocation of enzymatically inactive ExoS (a GAP/ADPRT mutant), but inhibition required a 
slightly higher, 4-5 mM, concentration of MCD (data not shown). This finding suggests that the 
mechanism underlying the inhibitory effects of MCD on Pa-T3S is somehow augmented by 
ExoS.  
Inhibition of Pa-T3S by MCD occurred in the absence of major effects on HT-29 cell viability as 
determined by trypan blue exclusion assays. However, a decrease in HT-29 cell adherence to 
tissue culture wells (a 29-34% loss of adherence) occurred in conjunction with a decrease in 
T3S sensitivity (initial decrease in adherence indicated by an asterisk in Fig. 8a). Membrane 
fractionation studies confirmed that inhibition of Pa-T3S by MCD occurred at the level of Pa-
T3S translocon insertion and effector translocation, as apparent in the decrease in PopB and 
ExoS in membrane fractions of MCD treated cells (Fig. 8b). Effects of MCD were also 
targeted to host cells, as evident by the lack of effect of MCD on T3S effector/translocator 
production (Fig. 8c), or on P. aeruginosa growth or adherence to host cells (Fig. 8d), at 3 mM 
inhibitory concentrations. Inhibitory effects of MCD on Pa-T3S were consistent with the 
findings of other Gram-negative bacteria that support the role of cholesterol-rich membrane rafts 
in T3S (132, 259, 318). CTB binds GM1 gangliosides that partition to lipid rafts, and when 
coupled to Alexa Fluor 488 can be used to monitor alterations in lipid rafts relative to increasing 
concentrations of MCD (337). Previous studies using CTB to track lipid rafts found increasing 
concentrations of MCD to disrupt lipid raft organization (180). When CTB was used to monitor 
lipid rafts in HT-29 cells relative to increasing concentrations of MCD and inhibition of T3S, 
CTB staining changed from a diffuse punctate pattern to an aggregated pattern at 0.5 mM 
MCD, a concentration of MCD lower than that required to inhibit T3S. These results indicated 
that lipid raft reorganization preceded inhibition of Pa-T3S. Our conclusions from studies using 
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MCD to identify host cell properties involved in T3S sensitivity were that: (1) membrane 
cholesterol influences Pa-T3S translocon insertion, and (2) membrane alterations more severe 




















Figure 8. Effect of MβCD treatment on Pa-T3S sensitivity. HT-29 cells were treated with the 
indicated concentration of MβCD for 30 min, prior to and during co-culture with strain Pa-ExoS-
HA. (a) To assay for Pa-T3S sensitivity, HT-29 cell extracts were immunoblotted for 
translocation of T3S effector, ExoS and for internalized effector function based on ExoS ADP 
ribosylation of RalA (as recognized by a shift in molecular mass of RalA). GAPDH served as a 
protein expression/loading control. Percent viable and adherent cells were enumerated using 
trypan blue staining. Asterisks mark initial decreases in Pa-T3S sensitivity and loss of HT-29 cell 
adherence. (b) Effects of MβCD on Pa-T3S translocon insertion were assessed by 
immunoblotting HT-29 cell membrane fractions for PopB and ExoS. Inhibition of Pa-T3S 
coincided with interference of PopB translocon and ExoS membrane insertion. PA103 PopB 
served as a translocon mutant control in these studies. sn, T3S induced P. aeruginosa culture 
supernatant used as a molecular mass marker for ExoS and PopB. (c) Effects of MβCD on P. 
aeruginosa induction and production of T3S effectors were determined by harvesting and 
assaying co-culture supernatants for PopB and ExoS by immunoblot analysis. (d) Effects of 
MβCD on P. aeruginosa growth were determined by quantifying P. aeruginosa c.f.u. in co-
culture supernatants at the end of the culture period. Results are expressed as the ratio (mean 
± SD) of c.f.u. of MβCD-treated vs. non-drug treated cells, co-cultured with Pa-ExoS-HA. Effects 
of MβCD on P. aeruginosa-adherence to HT-29 cells were determined following the co-culture 
period by harvesting and plating HT-29 cell lysates to quantify c.f.u. Results are expressed as 
number (mean ± SEM x10-3) of P. aeruginosa adhering per HT-29 cell. (e) The relationship 
between the effects of MβCD on Pa-T3S sensitivity and host cell lipid raft structure was 
determined following co-culture with Pa-ExoS-HA and using Alexa Fluor 488-labeled CTB to 
stain GM1 gangliosides that partition to lipid rafts. Results of all studies are representative of 














PFO affects membrane properties differently than MCD causing oligomerization of membrane 
cholesterol in conjunction with pore formation (310). PFO was found to inhibit HT-29 cell 
sensitivity to Pa-T3S in a dose-dependent range of 0.04-0.2 g PFO ml-1 (Fig. 9a) and was used 
to further examine host cell properties linked to Pa-T3S sensitivity. As observed with MCD, 
inhibition of Pa-T3S by PFO occurred in the absence of major effects on HT-29 cell viability but 
in conjunction with loss of HT-29 cell adherence to tissue culture wells (a 26-52% loss of 
adherence), which was greater than that observed for MCD (Fig. 9a). PFO also caused a 
dose-dependent decrease in the translocation of enzymatically inactive ExoS, but inhibition 
required a slightly higher, 0.3-0.4 g ml-1, concentration of PFO (results not shown). The 
increased toxic effects of PFO on HT-29 cell adherence limited the co-culture time, which was 
reflected in decreased detection of ExoS in cell extracts. In membrane fractionation studies, 
increasing concentrations of PFO caused translocator protein PopB and effector ExoS to 
accumulate in membranes rather than to decrease, as was observed with MCD (Fig. 9b). PFO 
was also confirmed to target host cell properties based on its lack of effect on T3S 
effector/translocator production (Fig. 9c) or on P. aeruginosa growth or adherence to host cells 
(Fig. 9d). Comparisons of effects of MCD and PFO on T3S thus found depletion of membrane 
cholesterol by MCD to interfere with T3S translocon insertion, while oligomerization of 
membrane cholesterol by PFO allowed translocon insertion but not effector translocation. 
Cholesterol-dependent cytolysins, such as PFO, have been reported to bind and serve as 
probes for cholesterol-rich lipid rafts (223, 293, 330). When CTB was used to track how PFO 
altered lipid rafts in relation to inhibition of Pa-T3S, lipid raft reorganization occurred at sub-T3S 
inhibitory concentrations (0.02 g ml-1) of PFO (Fig. 9e). More severe aggregation and eventual 
loss of lipid raft staining occurred at T3S inhibitory concentrations (0.1-0.2 g ml-1) of PFO. 
These findings are consistent with studies of the cholesterol-dependent cytolysin, listeriolysin O, 
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which was found to be a potent aggregator of lipid rafts (112). The fact that alterations in lipid 
rafts by both PFO and MCD preceded inhibition of T3S sensitivity provided evidence that lipid 
raft organization was indirectly related to host cell Pa-T3S sensitivity.  
PFO pore formation has been dissected into distinct steps: (1) binding of PFO monomers to the 
eukaryotic cell receptor, cholesterol; (2) oligomerization of PFO monomers in association with 
membrane cholesterol to form a pre-pore complex; and (3) pore formation, associated with the 
extension of amphipathic transmembrane hairpins (310). We were able to clarify the stage in 
PFO function inhibiting Pa-T3S through the use of PFO mutants locked at either the cholesterol 
monomer-binding step (ssPFO) (250) or at the cholesterol oligomerization pre-pore complex 
step (dsPFO) (144). Treatment of HT-29 cells with ssPFO or dsPFO, prior to exposure to Pa-
ExoS-HA, caused no inhibition of T3S, even at concentrations 1000-fold higher than that of wild 
type PFO (Fig. 9f). Collectively, our conclusions from using PFO as a T3S inhibitory tool were 
that: (1) PFO interrupted T3S effector translocon function but not membrane insertion, differing 
from the effects of MCD; and (2) neither binding to nor oligomerization of membrane 
cholesterol, or the redistribution of lipid rafts by PFO appeared to be sufficient to interfere with 
Pa-T3S. Rather, alterations in membrane properties associated with intact PFO were required 
to inhibit Pa-T3S in HT-29 cells.  
To summarize, studies of T3S sensitive cells provided evidence that cellular properties linked to 
membrane structure were involved in host cell Pa-T3S sensitivity, and that membrane 
cholesterol influenced T3S translocon insertion and function. What remained unclear was the 
mechanism underlying the role of membrane structure in Pa-T3S sensitivity, although MCD or 
PFO treatment found cholesterol or lipid raft reorganization to be insufficient to interrupt host cell 




Figure 9. Effect of PFO treatment on Pa-T3S sensitivity. HT-29 cells were treated with the 
indicated concentration of PFO 1 h prior to and during co-culture with strain Pa-ExoS-HA. 
Effects of PFO on: (a) inhibition of Pa-T3S, (b) Pa-T3S translocon insertion, (c) P. aeruginosa 
induction and production of T3S effectors, (d) P. aeruginosa growth and P. aeruginosa-
adherence to HT-29 cells, and (e) lipid raft structure were determined as described in Fig. 8. In 
membrane fractionation studies, an increase in PopB and ExoS membrane association 
occurred relative to increasing concentrations of PFO, indicating that PFO inhibited ExoS 
translocation and translocon function after membrane insertion. (f) To examine the stage in PFO 
function inhibiting Pa-T3S, HT-29 cells were treated with wild type PFO, ssPFO or dsPFO for 1 
h prior to and during co-culture with strain Pa-ExoS-HA. Pa-T3S was assayed based on ExoS 
ADP ribosylation of RalA, and asterisks indicate initial decreases in RalA ADP ribosylation and 
loss of HT-29 cell adherence to tissue culture wells. Results of all studies are representative of 




















Induction of Pa-T3S sensitivity in HL-60 cells. Promyelocytic HL-60 cells are innately 
resistant to Pa-T3S (rHL-60 cells) but can be induced to become T3S-sensitive by treatment 
with the differentiation agent, TPA (dHL-60 cells) (271). It was also observed that HL-60 cells 
acquire sensitivity to Pa-T3S in culture after multiple passages (sHL-60 cells). We therefore 
used HL-60 cells as an alternative model system to study host cell properties involved in Pa-
T3S by monitoring cellular alterations in rHL-60, sHL-60, and dHL-60 cells. Although the 
stimulus that induces sHL-60 cell Pa-T3S sensitivity is unknown, TPA differentiation of HL-60 
cells has been well studied and causes HL-60 cells to differentiate from round, non-adherent 
promyelocytes to adherent macrophages that exhibit properties of polarized migrating cells (47, 
184). TPA differentiation of HL-60 cells is known to involve activation of protein kinase C (PKC) 
signaling pathways, which induce early (after 15 min), intermediate (2-3 h) and late (12-24 h) 
patterns of gene expression (295, 307, 355). Relating temporal patterns of TPA-induced gene 
expression to induction of T3S sensitivity in turn provided another means of gaining insight into 
host cell properties involved in Pa-T3S sensitivity. 
When HL-60 cells were exposed to 20 nM TPA and then co-cultured with Pa-ExoS-HA, 
induction of T3S sensitivity occurred after a 12-24 h exposure to TPA, as assayed based on 
ExoS translocation and ADP ribosylation of RalA (Fig. 10a). In examining the relationship 
between induction of T3S sensitivity and T3S translocon function, ExoS membrane 
translocation was found to coincide first with PopB and then with PopD translocon protein 
membrane insertion (Fig. 10a). This finding indicated that HL-60 cell resistance to Pa-T3S 
related to membrane properties that affected T3S translocon insertion, which similar to HT-29 
cells, identified a role for membrane properties in T3S translocon insertion and function. The 
requirement for a 12-24 h exposure to TPA for induction of T3S sensitivity indicated that 
expression of late TPA response genes, which includes actin binding and adherence-related 
proteins, were involved in cellular alterations affecting T3S sensitivity.  
 
 67
To further understand host cell properties involved in Pa-T3S sensitivity, we monitored 
alterations in HL-60 cell architecture relative to induction of T3S sensitivity by staining for the 
cytoskeletal proteins actin and tubulin. Pa-T3S-resistant rHL-60 cells were characterized by 
dense cortical actin staining and weak tubulin staining that lacked pronounced MT radiations 
(Fig. 10b). sHL-60 cells maintained a round, non-adherent morphology, indistinguishable from 
that of rHL-60 cells by phase-contrast microscopy. However, upon staining for actin and tubulin, 
sHL-60 cells exhibited pronounced MT radiations, which identifies an early stage in the 
induction of directional migration in HL-60 cells. MT radiations were also evident in a small 
population of HL-60 cells exposed to TPA for 12 h, but the frequency of this phenotype was not 
sufficient to detect effector translocation by immunoblot analysis. After 18 and 24 h exposure to 
TPA, dHL-60 cells exhibited extensive tubulin radiations and actin-enriched projections that 
defined a mature migratory phenotype. At this stage in TPA differentiation, dHL-60 cells were 
highly sensitive to Pa-T3S as documented by immunoblot analyses at 24 h (Fig. 10a). To 
summarize, in studies of HL-60 cell architecture it became evident that MT radiations and actin-
rich projections, characteristic of polarized migrating cells, occurred in conjunction with induction 









Figure 10. Examining the induction of Pa-T3S sensitivity in HL-60 cells.  (a) Pa-T3S-
resistant rHL-60 cells were treated with 20 nM TPA for the indicated time, prior to co-culture with 
Pa-ExoS-HA. Cells were lysed and fractionated, and the membrane fraction was resolved by 
SDS-PAGE and immunoblotted for ExoS and RalA to assay T3S effector translocation and 
function, and for PopB and PopD to assess T3S translocon membrane insertion. sn, P. 
aeruginosa culture supernatant used as molecular mass markers for ExoS, PopB, and PopD. 
(b) The morphology of rHL-60 cells, T3S-sensitive sHL-60 cells, and TPA differentiated dHL-60 
cells (differentiated for 12, 18, or 24 h) was examined by IF staining for tubulin (green) and actin 
(red). Microtubule radiations developed during early stages of Pa-T3S sensitivity and continued 
to develop in dHL-60 cells in association with actin enriched projections and induction of Pa-T3S 
sensitivity. Images are representative of common phenotypes observed under the indicated 


















Association of eukaryotic cell adhesion processes with Pa-T3S sensitivity. The complex 
nature of bacterial-host cell interactions during T3S has made it experimentally difficult to 
determine how eukaryotic cell properties contribute to T3S translocon function. The 
serendipitous finding in studies of P. aeruginosa that helped bridge this understanding was that 
eukaryotic cells acquire or lose adherence to tissue culture wells in conjunction with the gain or 
loss Pa-T3S sensitivity. TPA induces HL-60 cells to differentiate from non-adherent 
promyelocytes to adherent macrophages (47, 184). In relating HL-60 cell adherence to Pa-T3S 
sensitivity, approximately 70% of HL-60 cells became adherent to tissue culture wells following 
a 24 h exposure to TPA. To further examine this relationship, TPA induction of HL-60 cell T3S 
sensitivity was directly compared with induction of HL-60 cell adherence in samples run in 
parallel, using ExoS translocation and ADP ribosylation RalA to quantify the efficiency of T3S. In 
these studies, a positive correlation (r=0.8146; determined using Pearson’s correlation 
coefficient) was detected between the percentage of adherent HL-60 cells and the efficiency of 
T3S effector translocation (shown in Supplementary Fig. S1a). Studies of TPA differentiated HL-
60 cells thus provided an initial indication that the relationship between eukaryotic cell 
adherence mechanisms and Pa-T3S was statistically relevant. 
We also observed that HT-29 epithelial cells lost adherence to tissue culture wells in association 
with inhibitory effects of MCD and PFO on Pa-T3S (Figs. 8a and 9a). To determine whether a 
reverse correlation between inhibition of Pa-T3S directly and loss of adherence was evident, we 
used a similar approach to examine adherence and T3S sensitivity in HT-29 cells. In these 
studies, a positive correlation was observed between the loss of HT-29 cell adherence to tissue 
culture wells and the inhibitory effects of MCD (r=0.8651) and PFO (r =0.7836) on Pa-T3S 
sensitivity (Supplementary Figs. S1b, c). The finding that inhibition of HT-29 cell Pa-T3S 
sensitivity correlated with loss of adherence to tissue culture wells, and conversely that 
induction of HL-60 cell T3S sensitivity correlated with acquisition of adherence, provided 
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evidence that eukaryotic cell adherence mechanisms and Pa-T3S sensitivity might somehow be 
functionally linked. The importance of this finding to our studies was that it directed our attention 
to the use of eukaryotic cell adherence mechanisms in further analyses of host cell involvement 
in Pa-T3S. 
Examining the type of adhesion mechanism involved in host cell Pa-T3S sensitivity. 
Wounded epithelial barriers, which are sensitive to P. aeruginosa infections and Pa-T3S, 
undergo cell migration in response to the wound healing process. Fig. 11(a) diagrams the 
organizational structure of LE proteins that drive cell movement. Rac1 mediates adherence at 
the LE through the formation of dynamic, focal complexes (222). Focal complexes can mature 
into more stable Rho-mediated focal adhesions (as shown in Supplementary Fig. S2a), that 
form behind focal complexes and at the rear of cells, where they serve as traction points in cell 
migration (256). Based on evidence that host cell adherence to tissue culture wells correlated 
with Pa-T3S sensitivity, we next used inhibitors that target proteins within focal complexes or 
focal adhesions to examine whether these adhesion mechanisms were involved in Pa-T3S. 
Inhibitors that were used to test the involvement of focal complexes in Pa-T3S included: (1) 
NSC23766, which inhibits Rac1 function by blocking Rac1 interaction with its GEF (107); or (2) 
secramine A, which interferes with Cdc42 binding to membranes in a RhoGDI-dependent 
manner (234, 340). When HT-29 cells were treated with Rac1 or Cdc42 inhibitors, prior to co-
culture with Pa-ExoS-HA, dose-dependent decreases in effector translocation were observed 
(Fig. 11a, black bars), with significant decreases in T3S (P<0.05-0.025) occurring at higher drug 
concentrations. Treatment with both Rac1 and Cdc42 inhibitors together did not augment 
inhibitory effects on Pa-T3S (results not shown). Inhibitors used to test the role of focal 
adhesions in Pa-T3S included: (1) Y-27632, an ATP-competitive inhibitor of p160ROCK (61); or 
(2) PP2, a Src kinase inhibitor. Unlike treatments that affect focal complexes, ROCK inhibitor at 
4 times its inhibitory concentration, and Src kinase inhibitor at concentrations as high as 80 m, 
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caused no dose-dependent or significant inhibition of Pa-T3S (Supplementary Fig. S2b, black 
bars). None of the inhibitors affected P. aeruginosa growth or secretion of T3S proteins. 
The correlation between cell adherence and Pa-T3S sensitivity led us to examine whether 
eukaryotic cell adherence processes stabilize T3S translocon function. To test this possibility, 
HT-29 cells were treated with Rac1, Cdc42, ROCK, or Src kinase inhibitors, as described 
above, but inhibitors were added at the time of HT-29 cell seeding, prior to establishment of 
adherence. When treated with inhibitors before adherence, HT-29 cells remained non- or 
loosely adherent during co-culture with Pa-ExoS-HA. As shown in Fig. 11(a) (gray bars), both 
Rac1 and Cdc42 inhibitors caused a greater inhibition of T3S effector translocation when 
applied to non-adherent as compared to adherent HT-29 cells. In contrast, no significant or 
dose-dependent inhibition of T3S effector translocation was detected when ROCK or Src kinase 
inhibitors were applied prior to establishment of adherence (Supplementary Fig. S2b, gray 
bars). Additional evidence supporting the lack of involvement of focal adhesions in Pa-T3S 
included: (1) the inability of antibodies that block integrin signaling to interfere with Pa-T3S 
(results not shown), and (2) the finding that SYF fibroblastic cells that are deficient for all three 
Src kinases, Src, Fyn, and Yes (162) were sensitive to Pa-T3S (results not shown). Together 
these studies favored a role of LE focal complexes, over that of focal adhesions, in host cell Pa-
T3S sensitivity, and also provided evidence that host cell adherence processes stabilize Pa-T3S 
secretion. 
Examining the relationship between host cell LE properties and Pa-T3S. If LE focal 
complexes contribute to host cell Pa-T3S sensitivity, other LE associated proteins, as shown in 
Fig. 11(a), might be predicted to influence T3S effector translocation. To allow for a stabilizing 
effect of cell adherence on Pa-T3S, HT-29 cells were treated at the time of seeding, prior to 
establishment of adherence, or 48 h after adherence with: (1) LatB to inhibit actin 
polymerization; (2) nocodazole, combined with incubation at 4oC, to destabilize and inhibit MT 
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formation; (3) LY294002 to inhibit all PI3K isoforms; or (4) AS605240 to inhibit the -isoform of 
PI3K involved in cell motility (19, 41). Following drug treatment cells were co-cultured with Pa-
ExoS-HA, and host cell T3S sensitivity was quantified based on the efficiency of ExoS 
translocation and ADP ribosylation RalA. As shown in Fig. 11(b) (black bars), and consistent 
with the data in Supplementary Table S1, most of these treatments caused no significant 
decrease in T3S effector translocation when applied to adherent HT-29 cells. The one exception 
was 100 M LatB, which caused a significant (P<0.02) decrease in T3S effector translocation. 
When applied to non-adherent HT-29 cells, both 10 and 100 M LatB caused a significant 
decrease (P<0.002) in T3S effector translocation (Fig. 11b, gray bars), as did 10 M nocodazole 
(P<0.02), implicating a role of MTs in Pa-T3S. The role of PI3K in Pa-T3S was less evident with 
200 M LY294002 causing a decrease in effector translocation, but this did not attain statistical 
significance. The finding that the roles of actin, MTs, and PI3K in T3S effector translocation 
paralleled their organizational structure at the LE provided further validation of the role of LE 
properties in Pa-T3S. Also, the increased effectiveness of inhibitors when applied to non-
adherent HT-29 cells was again supportive of LE adherence exerting a stabilizing role in Pa-
T3S translocation. 
IQGAP1 localizes to the LE, where it functions as a scaffolding protein during cell migration, 
binding directly to F-actin, Cdc42, and Rac1, and indirectly capturing MT plus ends during cell 
migration (21, 104, 127). The role of LE IQGAP1 in cell motility was confirmed in IQGAP1 
knockdown (siRNA), which led to suppressed cell migration (199). To further examine whether 
LE properties associated with cell migration contributed to host cell Pa-T3S sensitivity, transient 
IQGAP1 siRNA knockdown studies were performed in HT-29 cells, and IQGAP1 expression 
was related to the efficiency of Pa-T3S effector translocation following co-culture with Pa-ExoS-
HA. When IQGAP1 expression was quantified by densitometry in siRNA dose-response studies, 
a significant decrease in IQGAP1 was detected at 5 nM IQGAP1 siRNA (P<0.001), with non-
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targeting siRNA studies requiring 20-fold higher concentrations to decrease IQGAP1 expression 
(see Supplementary Fig. S3). Significant decreases (P<0.001) in T3S effector translocation 
relative to non-targeting siRNA occurred at 100 nM IQGAP1 siRNA. The fact that transient 
siRNA expression studies were performed on adherent HT-29 cells, yet still a significant 
reduction in Pa-T3S was detected, is supportive of IQGAP1 playing a role in Pa-T3S.  
Collectively, the model developing for host cell involvement in Pa-T3S was that membrane 
properties linked to eukaryotic cell adhesion mechanisms played a stabilizing role in T3S 
effector translocation. In studies examining the type of adhesion mechanism involved, a 
hierarchal order of protein involvement reflecting the architecture of the LE was observed with: 
(1) actin, Rac1 and Cdc42 playing a more direct role in Pa-T3S, (2) MTs and IQGAP1 playing 












Figure 11. Examining adherence mechanisms and LE properties involved in host cell Pa-
T3S sensitivity. (a) Diagram of major eukaryotic cell proteins mediating LE focal complex 
adherence. Proteins enclosed in solid lined boxes were found to mediate Pa-T3S sensitivity 
based on inhibition studies. To examine the role of focal complexes in Pa-T3S, HT-29 cells were 
seeded and allowed to adhere for 48 h (black bars), before treatment with Rac1 inhibitor 
(NSC23766) or Cdc42 inhibitor (secramine A), or were treated with inhibitors in the same 
manner immediately following seeding prior to establishment of adherence (gray bars). Cells 
were then co-cultured with Pa-ExoS-HA in the presence of inhibitors, and Pa-T3S sensitivity 
was quantified in cell lysates based on the efficiency of ExoS ADP ribosylation of RalA. The 
mean ± SEM of three independent experiments is graphed. Significant decreases relative to 
non-drug treated controls are indicated by *(P<0.05) or **(P<0.025). (b) To examine the role of 
LE properties in Pa-T3S sensitivity, HT-29 cells were treated with the indicated inhibitors, either 
48 h after (black bars) or immediately following seeding (gray bars) and co-cultured with Pa-
ExoS-HA and assayed for Pa-T3S sensitivity as in (a). Inhibitor treatments included: LatB, to 
disrupt actin; nocodazole, combined with incubation at 4oC for 3 h to destabilize/disrupt MTs; 
AS605240, to inhibit PI3K; and LY294002, to inhibit all PI3K isoforms. Drug concentration 
relative to the efficiency of Pa-T3S effector translocation is graphed as in (a), and the mean ± 
SEM of five-seven independent experiments are represented. Significant decreases in RalA 

















Examining host cell architecture associated with Pa-T3S sensitivity. The LE is a functional 
assemblage of proteins that leads to cortical actin polymerization, which exerts a force on the 
plasma membrane to drive cell movement. Because of its dependence on assembly for 
function, the preferred method for examining LE function is through IF microscopy of LE 
architecture. The ability to alter Pa-T3S sensitivity in both HL-60 cells and HT-29 cells provided 
systems to monitor alterations in LE architecture relative to induction or inhibition of host cell 
T3S sensitivity. 
 HL-60 cell model - HL-60 cells allow LE architecture to be examined relative to stages 
in induction of Pa-T3S sensitivity, as defined by rHL-60, sHL-60, and dHL-60 cells. Host cell 
proteins that were visualized by IF staining for their cellular localization relative to alterations in 
Pa-T3S sensitivity included: (1) LE-associated Rac, IQGAP1, and PI3K, (2) focal adhesion-
associated, Rho, and (3) actin. Supplementary Fig. S4(a) shows representative images from 
T3S-resistant rHL-60 cells, which consistent with their undifferentiated state, exhibited limited 
motility and LE properties, and lacked actin-enriched membrane structures, such as lamellipodia 
or filopodia. Rac distribution was cytosolic and did not co-localize with actin. IQGAP1 localized 
to the cell periphery, and as a scaffolding protein, co-localized with cortical actin (represented by 
yellow staining in the merged image). Localization of PI3K, which serves as a marker for 
polarization, resembled that of Rac1. Rho exhibited a polarized cytosolic staining pattern and 
did not co-localize with actin. In comparing staining patterns of rHL-60 with sHL-60 cells, the 
major differences observed in sHL-60 cells were that: (1) Rac1 staining became co-localized 
with actin, and (2) PI3K staining became more polarized (Supplementary Fig. S4a, b, indicated 
by arrows). Co-localization of Rac1 with actin and the polarized localization of PI3K serve as 
markers for the induction of functional LE properties. The finding that Rho localization was not 
altered in sHL-60 cells indicated that focal adhesion properties were not being modulated in 
conjunction with induction of Pa-T3S sensitivity.  
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Binding of P. aeruginosa to LE associated Rac, IQGAP1 and actin in T3S-sensitive dHL-60 cells 
is shown in Fig. 12. HL-60 cells treated with TPA for 18h developed mature LE structures, as 
evident in Rac and IQGAP1 staining patterns, which co-localize with actin in association with 
lamellipodia and cell motility projections. P. aeruginosa was found to bind to actin-rich LE 
projections at a 44.8 % frequency and at sites of high-intensity Rac staining at a 78.5 % 
frequency, when compared with P. aeruginosa association with dHL-60 cells in general. 
(Frequencies of P. aeruginosa association with LE regions were derived from 13 co-culture 
experiments and observation of 289 bacterial-eukaryotic cell associations.) Our conclusions 
from studies of LE architecture in HL-60 cells were that: (1) induction and development of Rac1, 
IQGAP1 and actin LE structures coincided with induction of T3S sensitivity, and (2) LE cell 













Figure 12. P. aeruginosa binding to LE of T3S-sensitive dHL-60 cells. HL-60 cells were 
differentiated with TPA for 18 h, then co-cultured with P. aeruginosa and stained for P. 
aeruginosa (blue) relative to LE-associated Rac or IQGAP1 (both green) and actin (red). Images 
show LE properties underlying P. aeruginosa binding and are representative of staining patterns 





HT-29 cell model - HT-29 cells provided a means of monitoring alterations in LE architecture in 
relation to loss of Pa-T3S sensitivity following treatments with MCD or PFO. To relate LE 
architecture to previous Pa-T3S sensitivity studies, HT-29 cells were treated with increasing 
concentrations of MCD or PFO, then co-cultured with Pa-ExoS-HA, and stained for Rac1 or 
PI3K in relation to cortical actin. Similar studies were performed using P. aeruginosa expressing 
an ExoS-GAP/ADPRT mutant to assess how ExoS activity influenced these studies. 
HT-29 cells maintain properties of normal epithelial cells, including the ability to undergo 
collective migration as occurs during wound healing (145). Consistent with these properties, LE 
migration of HT-29 cells occurred at the periphery of cell clusters (Supplementary Fig. S5, 0 
MβCD or PFO). In monitoring the effects of MCD or PFO on LE properties in the presence of 
Pa-ExoS-HA, intact LE properties were evident at sub-T3S inhibitory concentrations of MCD 
(0.5 mM) or PFO (0.02 g ml-1), as observed by the close underlying association of Rac1 or 
PI3K with cortical actin in the direction of cell migration (Fig. S5, marked by arrowheads). 
Alterations in LE architecture became apparent in some cells at 1.0 mM MCD or 0.1 g PFO 
ml-1 by the disruption or loss of actin staining relative to Rac1 or PI3K (Supplementary Fig. S5, 
marked by arrows). Extensive loss of LE actin became apparent at T3S inhibitory 
concentrations of MCD (3mM) or PFO (0.2 g ml-1). To summarize, studies using MCD or 
PFO to inhibit T3S sensitivity found disruption of LE actin to closely coincide with interference of 
Pa-T3S. 
Inhibitory effects of MCD or PFO on Pa-T3S also coincided with alterations in LE properties 
when cells were co-cultured with P. aeruginosa expressing enzymatically inactive ExoS. 
However, consistent with ExoS targeting LE associated Rac1 and Cdc42 (95, 233, 264), 
phenotypic alterations occurring in association with enzymatically inactive ExoS were different. 
Rather than observing severe disruption or loss of LE actin upon inhibition of Pa-T3S, LE 
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protein architecture underlying actin was not disrupted in MCD or PFO treated HT-29 cells in 
association with P. aeruginosa expression of an ExoS-GAP/ADPRT mutant (results not shown). 
These results are of interest because they highlight the potential for T3S effectors, such as 
ExoS, to target host cell properties predicted to facilitate T3S translocon function. The effect of 
ExoS on LE actin also provides an explanation for why inhibitory effects of MCD and PFO on 
Pa-T3S were augmented by ExoS.  
In examining P. aeruginosa association with LE properties in HT-29 cells, LE architecture was 
found to underlie P. aeruginosa binding in 54% of bacterial-HT-29 cell associations under 
conditions of T3S sensitivity. (Frequencies of P. aeruginosa binding to HT-29 cells were 
determined based on eight independent co-culture experiments and greater than 500 P. 
aeruginosa-HT-29 cell enumerated associations.) This association is represented in Fig. 13 
(T3S-sensitive panels), where IQGAP1, actin, and P. aeruginosa staining were used to visualize 
P. aeruginosa binding to the LE of HT-29 cells. P. aeruginosa did not preferentially associate 
with the LE of HT-29 cells after inhibition of T3S by treatment with 0.2 g PFO ml -1, but rather 

















Figure 13. P. aeruginosa binding to LE of HT-29 cells. P. aeruginosa binding to T3S 
sensitive or T3S resistant HT-29 cells was assessed following co-culture with Pa-ExoS-HA and 
staining for IQGAP1 (green), actin (red), and P. aeruginosa (blue). Left panel (lower 
magnification) shows the frequency of P. aeruginosa association with the LE of clusters of T3S-
sensitive HT-29 cells. Bar, 20 µM. Middle panel (higher magnification) shows P. aeruginosa 
association with LE lamellipodia. Right image shows the more random and intercellular 
association of P. aeruginosa with HT-29 cells treated with 0.2 g PFO ml-1 to cause loss of T3S 
sensitivity. Results are representative images obtained in two-three independent experiments. 
Bars, 10 µm. 
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To summarize, studies examining the relationship between LE architecture and Pa-T3S 
sensitivity found that acquisition of LE architecture coincided with induction of Pa-T3S sensitivity 
in HL-60 cells. Conversely, disruption of LE architecture coincided with loss of Pa-T3S 
sensitivity in HT-29 cells. LE architecture was also found to underlie P. aeruginosa binding in 
both HL-60 and HT-29 cells under conditions of Pa-T3S sensitivity. As bacterial binding to host 
cells is integral to T3S translocon function, the preferential binding of P. aeruginosa to the LE of 
HL-60 and HT-29 cells under conditions of T3S sensitivity is consistent with the notion that the 
LE region serves as the host cell site of P. aeruginosa binding during T3S translocon insertion 
and function. Together these findings provide evidence of a close relationship or a role of 




Studies support the suggestion that T3S effectors are translocated into eukaryotic cells through 
a bacterially produced pore or channel in host cell membranes. Once internalized T3S effectors 
manipulate eukaryotic cell function in a manner that contributes to the establishment of 
infections. The purpose of our studies was to gain insight into the possible role of host cell 
properties in T3S translocon function and effector translocation. We chose P. aeruginosa as a 
model system to study this problem, because as an opportunistic pathogen, eukaryotic cell lines 
that are sensitive (HT-29 cells) or resistant (HL-60 cells) to Pa-T3S were available for 
mechanistic comparisons (206, 271). Addressing how host cells function in Pa-T3S required a 
series of progressive studies, but eventually studies of HT-29 and HL-60 cells converged to 
reveal a relationship between host cell LE properties and Pa-T3S translocon function.  
When T3S-sensitive HT-29 cells were used to study host cell properties involved in Pa-T3S, it 
proved experimentally difficult to inhibit Pa-T3S. Of the many agents tested, only MCD and 
PFO were found to inhibit Pa-T3S sensitivity in the absence of effects on P. aeruginosa. MCD 
and PFO have the common property of modulating membrane properties in a cholesterol-
dependent manner. However, in examining the mechanism underlying their inhibition of T3S, 
neither modulation of membrane cholesterol or lipid rafts appeared sufficient to inhibit Pa-T3S 
sensitivity. Rather, the eukaryotic cell property found to most closely correlate with loss of Pa-
T3S sensitivity was loss of HT-29 cell adherence to tissue culture wells.  
Promyelocytic HL-60 cells are non-adherent and lack directional polarity and, along with 
polarized epithelial monolayers, were the only other cell line identified to be resistant to Pa-T3S 
(271). HL-60 cells can be experimentally induced to become Pa-T3S sensitive by treatment with 
the differentiating agent, TPA (271). TPA differentiated HL-60 cells also serve as a model 
system to study neutrophil migration in response to chemoattractants (128, 289). In using HL-60 
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cells to study alterations in cellular properties that occur upon induction of Pa-T3S sensitivity, 
again a direct correlation was observed between HL-60 cell adherence to tissue culture wells 
and Pa-T3S sensitivity. It was further recognized in HL-60 cells that resistance to Pa-T3S 
related to the lack of PopB and PopD translocon protein insertion into the cellular membrane.  
Recognition of a direct correlation between eukaryotic cell adherence mechanisms and Pa-T3S 
translocon function provided an important missing link in understanding host cell involvement in 
Pa-T3S, and led us to explore the functional relationship between eukaryotic cell adhesion 
mechanisms and Pa-T3S. Focal complexes form dynamic cell adherence structures at the LE 
and can be distinguished from more stable focal adhesions based on Rac/Cdc42, rather than 
Rho, mediating their adherence mechanisms. In using Rac1 or Cdc42 inhibitors to examine the 
role of LE focal complexes in T3S, both agents were found to inhibit T3S effector translocation. 
This was in contrast with ROCK or Src kinase inhibitors that target focal adhesions, which 
caused no significant inhibition of Pa-T3S. Notably, Rac1 and Cdc42 inhibitors were more 
efficient in inhibiting Pa-T3S if added prior to adherence of HT-29 cells to tissue culture wells. 
Together these studies provided evidence that LE adherence properties were facilitating and 
stabilizing Pa-T3S effector translocation. 
The relationship between eukaryotic cell LE properties and Pa-T3S sensitivity was corroborated 
in studies of HL-60 cells. sHL-60 cells gained sensitivity to Pa-T3S in culture after multiple 
passages but remained phenotypically indistinguishable from rHL-60 cells relative to a round, 
non-adherent morphology. In comparing LE properties of rHL-60 and sHL-60 cells, differences 
observed in sHL-60 cells included enhanced MT projections, Rac co-localization with actin, and 
the polarized localization of PI3K. These observations are consistent with sHL-60 cells acquiring 
LE architecture in conjunction with induction of Pa-T3S sensitivity.  
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As an opportunistic pathogen, P. aeruginosa infects disrupted epithelial barriers, whereas intact 
epithelial barriers that maintain apical-basolateral polarity are resistant to P. aeruginosa 
infections (91, 156, 243). Evidence that host cell LE properties that direct cell migration function 
in Pa-T3S sensitivity is highly consistent with P. aeruginosa infections, which target disrupted 
epithelial barriers undergoing wound-healing cell migration. In migrating epithelial cells, polarity 
is mediated by interlinked feedback loops that involve Rac, Cdc42, Rho, PI3K, integrins, and 
MTs. In examining host cell proteins contributing to Pa-T3S sensitivity, a hierarchal order of 
protein function was recognized with first, actin, Rac1, and Cdc42, then MTs and IQGAP1, and 
to a lesser degree PI3K functioning in Pa-T3S. Notably the hierarchal order of proteins affecting 
Pa-T3S sensitivity paralleled the functional assembly of cellular proteins at the LE. Because of 
the dependence of the LE on protein assembly, LE function was examined by IF staining and 
microscopic analysis of LE architecture. In using both HL-60 and HT-29 cell models to examine 
the relationship between LE cell architecture and Pa-T3S, the integrity of LE architecture closely 
coincided with Pa-T3S sensitivity. Collectively, identification of: (1) a relationship between host 
cell adherence mechanisms and Pa-T3S sensitivity; (2) evidence for a role of focal complexes 
but not focal adhesions in Pa-T3S; (3) a hierarchal order of protein involvement in Pa-T3S 
function that reflected LE structure; and (4) the close correlation between LE cell architecture 
and Pa-T3S sensitivity all point to eukaryotic cell LE properties playing a role in sensitivity to Pa-
T3S. 
Eukaryotic membranes are structured to resist channel formation as occurs during T3S but can 
be modulated through localized alterations in membrane composition or mechanical forces to 
favor channel formation. Pa-T3S translocon formation in eukaryotic membranes requires 
translocator proteins, PopB, PopD, and PcrV. Beyond this, a role of host cell properties in Pa-
T3S became apparent from the identification of Pa-T3S-resistant cells (206, 271). Studies 
presented here provide evidence and lead us to hypothesize that LE properties are the host cell 
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factor required for Pa-T3S translocon insertion and effector translocation. Mechanistically, the 
role of LE properties in facilitating T3S translocon membrane insertion can be explained by 
alterations in membrane properties that occur at the LE. As shown in the model of host cell 
involvement in Pa-T3S in Fig. 14, activated Rac1/Cdc42-mediated actin polymerization at the 
LE drives cell membrane lamellipodia or filopodia protrusions, which introduce forces on plasma 
membranes that could facilitate PopB/PopD membrane insertion. Actin filaments must be 
tethered to the cell membrane to exert forces that drive membrane protrusions, and LE 
adherence mechanisms secure and stabilize these actin-membrane associations. The 
relationship between host cell adherence and Pa-T3S can be explained by the stabilizing role 
that LE adherence processes have on actin-membrane associations predicted to facilitate 
translocon insertion. The subtlety of alterations in cell architecture required for Pa-T3S 
sensitivity became evident in sHL-60 cells, in which induction of MT radiations and polarized co-
localization of Rac with actin were observed to coincide with induction of Pa-T3S sensitivity. 
Once T3S is established, host cell properties involved in Pa-T3S translocon function appear 
quite stable as evidenced by the requirement of agents, such as MCD and PFO, which disrupt 
cell polarity and LE architecture to inhibit Pa-T3S sensitivity. Retrospectively, the inability of 
most agents in Supplementary Table SI to inhibit Pa-T3S can be explained by their inability to 
cause severe alterations in cell polarity. The notion that MCD and PFO interfere with Pa-T3S 
by disrupting cell polarity and LE architecture is consistent with recent studies which found 
MCD to alter the polarized redistribution of cellular factors mediating cell migration (267). 
Cholesterol is known to accumulate at the LE of migrating cells, where it has been hypothesized 
to alter plasma membrane viscosity to allow the dynamic actin network to push the membrane 
forward (193). The correlation between inhibition of Pa-T3S sensitivity by MCD and PFO with 
loss of LE structure attests to the possibility that the function of membrane cholesterol in Pa-
T3S relates to its polarization to the LE and its facilitation of actin-induced membrane 
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protrusions. Important to an understanding of host cell involvement in Pa-T3S is that loss or 
gain of LE architecture in HT-29 or HL-60 cells provides an explanation for alterations in Pa-T3S 














Figure 14. Model for the role of eukaryotic cell properties in Pa-T3S. Our model predicts 
that alterations in membrane properties associated with F-actin polymerization at the LE induce 
forces on membranes that are required for PopB (B) and PopD (D) translocon insertion and 
function. V, PcrV, (PscF) T3S needle protein. The role of specific leading edge proteins in Pa-
T3S is described in the text. Pa, P. aeruginosa. 
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The opportunistic nature of P. aeruginosa infections and reliance on a predisposing host cell 
factor were essential to our identifying host cell properties involved Pa-T3S. However, the 
opportunistic nature of P. aeruginosa infections likely adds a dimension to T3S translocon 
function not apparent in obligate Gram-negative pathogens. For example, our model predicts 
that cortical actin polymerization at the LE is required for Pa-T3S translocon function, which 
closely aligns with recent studies in Yersinia that have found T3S translocon function to also rely 
on actin polymerization (207). Yersinia is known to engage host cell integrin receptors in 
association with T3S effector translocation, and this leads to Rho activation and actin 
polymerization, which are proposed to trigger YopB/YopD translocon function. P. aeruginosa as 
an opportunistic pathogen is unable to engage integrin or other actin polymerization 
mechanisms, and as a result is dependent on LE properties that trigger actin polymerization for 
the PopB/PopD translocon function. The role of actin polymerization in Yersinia T3S, and our 
studies which identify a role of actin polymerization in Pa-T3S, draw attention to a potential 
central role of host cell cortical actin in T3S translocon function.  
To summarize, the complexity of bacterial-eukaryotic cell interactions during T3S has made it 
difficult to understand how eukaryotic cell properties might contribute to T3S translocon function. 
By using cell culture models that are sensitive or resistant to Pa-T3S we were able to identify a 
relationship between LE properties and host cell Pa-T3S sensitivity, and this has led us to 
hypothesize that cortical actin-induced alterations in membrane properties at the LE facilitate 
T3S translocon insertion and function. The integral and complex role of LE properties in 
eukaryotic cell survival attests to the highly co-evolved nature of Pa-T3S relative to eukaryotic 
cell function. The use of the LE in Pa-T3S is highly consistent with the opportunistic lifestyle of 
P. aeruginosa, which targets wounded epithelial barriers undergoing cell migration. The 
requirement of LE properties for Pa-T3S is predicted to differ from that of obligate pathogens, 
such as Yersinia, which are able to engage integrin to induce actin polymerization required for 
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translocon function. The ability of cortical actin dynamics to alter membrane properties to favor 
T3S translocon insertion or function has the potential to be a common theme for host cell 
involvement in T3S. The precise characterization of host involvement in T3S is anticipated to 
provide insight into the design and development of novel therapeutic approaches to inhibit this 
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Supplementary Figure S1. Examining the relationship between eukaryotic cell adherence 
mechanisms and Pa-T3S sensitivity. Graphs showing the relationship between adherence to 
tissue culture wells and Pa-T3S sensitivity of individual samples for: (a) HL-60 cells, following 
TPA induction of T3S sensitivity, or for HT-29 cells upon loss of T3S sensitivity by treatment 
with (b) MβCD or (c) PFO. Percentage adherence was calculated using trypan blue staining to 
enumerate adherent cells, which was related to adherent cells in control samples. Percentage 
effector translocation was calculated based on the efficiency of ExoS ADP ribosylation of host 
cell RalA, as determined by densitometry analysis of immunoblots comparing modified RalA to 
total RalA for individual samples. r, Pearson’s correlation coefficient. Results from two or three 








Supplementary Figure S2. Examining the role of focal adhesions in host cell Pa-T3S 
sensitivity. (a) Diagram of major eukaryotic cell proteins mediating focal adhesions. Proteins 
enclosed in dashed boxes were not found to mediate Pa-T3S sensitivity. (b) To examine the 
role of focal adhesions in Pa-T3S, HT-29 cells were treated with a ROCK inhibitor (Y-27632) or 
Src kinase inhibitor (PP2), either 48 h after adherence (black bars) or immediately following 
seeding prior to adherence (grey bars), and then co-cultured with Pa-ExoS-HA in the presence 
of drugs. T3S sensitivity was quantified in cell lysates based on the efficiency of ExoS 
translocation and ADP ribosylation of RalA. Drug concentration relative to efficiency of Pa-T3S 











Supplementary Figure S3. Examining the role of leading edge IQGAP1 in host cell Pa-T3S 
sensitivity. HT-29 cells were transfected with IQGAP1 or random non-targeting siRNA. After a 
72 h transfection period, adherent HT-29 cells were co-cultured with Pa-ExoS-HA. Cell lysates 
were assayed for IQGAP1 expression, using densitometry to quantify IQGAP1 immunoblots, 
and Pa-T3S effector translocation was quantified based on ExoS ADP ribosylation of RalA. The 
mean ± SEM of percentage IQGAP1 or T3S effector translocation, when compared with non-
transfected cells co-cultured with Pa-ExoS-HA, is shown relative to increasing concentrations of 
siRNA. Results of three independent experiments are represented. Significant decreases 







Supplementary Figure S4. Relationship between HL-60 cell LE architecture and Pa-T3S 
sensitivity. LE architecture of: (a) T3S-resistant rHL-60 cells, and (b) T3S-sensitive sHL-60 
cells was compared by immunofluorescent staining for Rac, IQGAP1, and PI3K, with Rho 
serving as a focal adhesion marker. Proteins were visualized using Alexa Fluor-488 conjugated 
anti-mouse antibody (each stained green). Actin was stained in each panel with phalloidin–
TRITC (red). Co-localization with actin is indicated by yellow staining in merged images. Arrows 
point to the major differences in rHL-60 and sHL-60 cells, which are the co-localization of Rac1 
with actin and increased polarization of PI3K in sHL-60 cells. Images are representative of the 
most frequent staining patterns, as observed in two independent experiments. 
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Supplementary Figure S5. Relationship between HT-29 cell LE architecture and Pa-T3S 
sensitivity. HT-29 cells were treated with increasing concentrations of Pa-T3S inhibitors (a,c) 
MβCD or (b,d) PFO, as described in the text, then co-cultured with Pa-ExoS-HA. Alterations in 
the localization of LE-associated Rac1 (a,b) or PI3K (c,d) (both stained green) were assessed 
relative to actin (red). P. aeruginosa were present in these studies but not stained. Arrowheads 
point to intact LE structures at 0 and sub-T3S inhibitory concentrations of MβCD (0.5 mM) and 
PFO (0.02 μg ml−1). Arrows point to disrupted leading edge structures, as evident from the 
interruption or loss of cortical actin in cells treated with 1 or 3 mM MβCD or 0.1 or 0.2 μg ml−1 























Chapter 3: Gaining Insight into the Opportunistic Nature of Pseudomonas 













Contents of this chapter have been submitted to Infection and Immunity and are 
currently under review 
The authors on the manuscript are: 
 Dacie R. Bridge, Karen H. Martin, Elizabeth R. Moore, Wendy M. Lee,  





Opportunistic Pseudomonas aeruginosa (Pa) infections target wounded epithelial barriers, but 
the property of wounded cells that increases susceptibility to Pa infections remains unclear. This 
study further explored the hypothesis that initiation of Pa infections is linked to cell migration 
properties induced during wound repair using: (1) highly migratory T24 epithelial cells as a cell 
culture model, (2) mutations in ExoS to manipulate type III secretion (T3S) involved in initiating 
Pa infections, and (3) visualization of ExoS and PopB translocation to monitor the Pa infectious 
process. In these analyses Pa expressing wild type ExoS bound preferentially to the leading 
edge of T24 cells, where translocation of ExoS GTPase activating protein (GAP) and ADP-
ribosyltransferase (ADPRT) activities rapidly shutdown leading edge properties involved in cell 
migration in conjunction with inhibition of T3S. ExoS GAP inhibits Pa internalization, and an 
ExoS GAP- mutant increased T3S translocation in association with Pa internalization and 
secretion of ExoS within T24 cells. ExoS ADPRT activity disrupted actin anchoring to the 
plasma membrane and constricted leading edge architecture. Mutations in ExoS ADPRT activity 
in turn led to increased T3S translocation consistent with it targeting cellular proteins that inhibit 
T3S. An ExoS GAP-/ADPRT- mutant enhanced both Pa internalization and T3S translocation, 
and this occurred in conjunction with maintenance of leading edge architecture and the entry 
and guidance of Pa along actin filaments. ExoS was also found to track actin within T24 cells, 
providing a mechanism for the facilitated translocation of ExoS at the leading edge. Collectively, 
this study demonstrated the ability of: (1) Pa to secret ExoS intracellularly when ExoS GAP 
activity is mutated, introducing in novel means of ‘translocating’ ExoS into host cells; (2) ExoS 
ADPRT activity to target a cellular substrate(s) that disrupts actin-plasma membrane 
associations and leading edge architecture in conjunction with inhibition of ExoS translocation, 
and (3) both ExoS and Pa to interact or align with actin during the Pa infectious process. In 
conclusion, ExoS was found to contribute to the opportunistic nature of Pa infections through its 




Pseudomonas aeruginosa (Pa) is a ubiquitous environmental bacterium capable of causing 
infections of high morbidity and mortality in individuals who have damaged epithelial barriers, 
are immunocompromised, or have cystic fibrosis. While the cellular property that allows the 
establishment of Pa infections remains unknown, healthy epithelial monolayers with apical 
basolateral polarity are recognized to be resistant to Pa infections (87, 156, 243). Pa maintains 
a broad range of virulence factors that facilitate its survival in nature and its pathogenicity in 
hosts. Of these, the type III secretion (T3S) system is conserved in both environmental and 
clinical Pa isolates (82) and contributes to the severity of acute Pa infections (129). T3S 
provides bacteria with a means of directly translocating effectors into eukaryotic cells via a 
bacterially formed needle-like conduit nanostructure and translocon channel in host cell 
membranes. Translocated effectors then allow bacteria to manipulate host cell processes in a 
manner specific to the lifestyle of the bacteria. In Pa, the integral role of T3S in initiating Pa 
infections is supported by the finding that cellular susceptibility to Pa infections parallels cellular 
sensitivity to T3S (33, 206, 271). Consistent with T3S being integral to Pa infections, this study 
used manipulations of the T3S effector ExoS to help dissect the cellular mechanism underlying 
the Pa infectious process.  
Pa utilizes T3S to modulate host cell function through four identified effectors, ExoS, ExoT, 
ExoU, and ExoY. ExoS and ExoT are homologous, bifunctional proteins that include Rho 
GTPase activating protein (GAP) (116, 166) and ADP-ribosyltransferase (ADPRT) activities 
(147, 341). ExoS functions in Pa pathogenesis (130, 297, 320) and is expressed by 58-72% of 
clinical isolates (129). The contribution of ExoT to disease appears limited (183, 290, 320), but 
its expression by 92-100% of isolates (129) implies its importance to Pa survival. ExoU has 
phospholipase A2 activity and causes rapid loss of plasma membrane integrity and cell death 
(278). The mutually exclusive presence of exoS or exoU genes dictates whether Pa invades or 
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lyses cells, respectively, and expression of ExoU is associated with more virulent Pa infections 
(90, 285, 290). ExoY is an adenylate cyclase found in 70-95% of clinical isolates (82, 347) and 
may contribute to Pa systemic spread (320). The least understood stage in T3S is the 
translocation of effectors across host cell membranes. In Pa this requires three proteins, 
membrane channel forming PopB and PopD, and channel assembling PcrV (215). 
Polarized epithelial monolayers and undifferentiated HL-60 promyelocytic cells have the 
common property of being resistant to Pa infections and T3S effector translocation (206, 271). 
Both cell culture models also have the potential to become sensitive to Pa infections and T3S: in 
epithelial monolayers this occurs in conjunction with disruption of apical-basolateral polarity, and 
in HL-60 cells this is induced by differentiation with phorbol esters (206, 271). Previous studies 
in our laboratory characterizing host cell properties that influence the establishment of Pa 
infections identified a relationship between host cell leading edge properties involved in cell 
migration and cellular sensitivity to T3S translocated ExoS (33). The epithelium is structured to 
resist pore formation as occurs during T3S translocation, and the observed relationship between 
leading edge properties and T3S translocation led us to hypothesize that actin-plasma 
membrane associations at the leading edge alter membrane properties to facilitate T3S and the 
establishment of Pa infections.  
The small size of the T3S translocon pore currently precludes direct examination of translocon 
channel formation in relation to leading edge properties of migrating epithelial cells. As an 
alternative approach for assessing the role of cell migration in T3S translocation, this study used 
ExoS with mutations in its GAP or ADPRT activities to manipulate T3S, and then examined how 
these manipulations influenced the Pa infectious process in highly migratory T24 epithelial cells. 
Our studies found that Pa expressing wild type (WT) ExoS preferentially bound to the actin-rich 
leading edge region of T24 cells, where T3S translocated ExoS gained access to actin filaments 
that facilitated its internalization. T3S translocated ExoS ADPRT activity then interrupted T3S in 
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conjunction with targeting cellular proteins that disrupt actin-plasma membrane association and 
leading edge architecture. No alterations in leading edge architecture were observed when 
mutations in both ExoS GAP and ADPRT activities were introduced, and this led to enhanced 
T3S translocation and Pa internalization, and Pa aligned with actin filaments as it migrated to 
the perinuclear region of T24 cells. Collectively, our studies found that ExoS plays a paradoxical 
role in Pa infections by contributing to Pa toxicity, but its toxic effects also interrupt T3S 


















MATERIALS AND METHODS 
Bacterial strains and culture conditions. Pa strain PA103ΔexoUexoT::TC (PA103ΔUT) (315) 
that lacks known T3S effectors, and strain PA103ΔPopB, a T3S translocon mutant, were 
provided by Dara Frank (Medical College of Wisconsin, Milwaukee, WI). Wild type ExoS with a 
hemagglutinin tag (ExoS-HA) and Pa expressing plasmid encoded ExoS-R146K/E379D/E381D-
3XFLAG (ExoS-KDD-3XFLAG) were provided by Joseph Barbieri (Medical College of 
Wisconsin). PA103ΔUT was used to express plasmid encoded ExoS enzymatic mutants, 
described in Table II. The ExoS-E379A-ADPRT- mutant and ExoS-R146A-GAP-/E379A 
ADPRT- mutant were constructed for this study using the Quick Change PCR-based site 
directed mutagenesis (Strategene, La Jolla CA), as previously described (20). The E379A 
mutation was introduced into the PstI-BamHI fragment of the exoS gene cloned into the pUCP 
vector (65) using the following primers: forward, 5’-
GGATATCGAACTACAAGAATGCAAAAGAGATTCTCTATAAC-3’ and reverse, 5’-
GTTATAGAGAATCTCTTTTGCATTCTTGTAGTTCGATATCC-3’. The R146A/E379A double 
mutant was constructed using the E379A primers and pUCP encoded ExoS-R146A mutant as 
template. All bacterial strains were grown in ExoS induction medium (TSBD-N) (147) for 14-16 
hr prior to co-culture with eukaryotic cells. 
Eukaryotic cell culture and bacterial-eukaryotic cell co-culture conditions. T24 cells were 
obtained from American Type Cell Culture Collection (ATCC, Manassas VA) and cultured in 
McCoy’s 5A medium containing 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 
μg/ml streptomycin (Hyclone, Logan UT). For Pa-T24 cell co-culture studies, T24 cells were 
seeded at 0.5-0.75x105 cells/ml, grown for 24 or 48 hr and washed twice in medium containing 
0.6% bovine serum albumin (BSA; Sigma-Aldrich, St. Louis MO), prior to addition of 107 CFU/ml 
Pa (MOI: 10-15 Pa per T24 cell). T24 cells were infected with Pa for 1.5-4.5 hr, as indicated, 
depending on the type of analysis. 
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Analysis and quantification of T3S translocation. Cells were seeded for 48 hr and co-
cultured with Pa for 3.5-4 hr, which is the time required to detect T3S translocation in T24 cells 
by immunoblot analysis. Pa were removed, cells were washed twice in medium containing 200 
μg/ml ciprofloxacin, and cells were detached and extracellular proteins degraded with 0.05% 
trypsin-1 mM EDTA (Hyclone). An aliquot of cells was assayed for viability based on trypan blue 
exclusion, and viable and total cell numbers were enumerated using a hemacytometer. A 
second aliquot of cells was examined for total protein using the BCA Protein Assay (Pierce, 
Rockford IL). Remaining cells were resuspended in digitonin fractionation buffer and 
fractionated as previously described (264). 
Membrane and cytosolic fractions were assayed for ExoS and PopB translocation by SDS-
PAGE and immunoblot analysis based on equal protein loading. RalA served as a membrane 
fraction loading control, and ADP-ribosylation of RalA provided a functional assay of T3S 
translocated ExoS ADPRT activity (96). ExoS and PopB translocation into membrane fractions 
was quantified by densitometry using ImageJ 1.40g software (http://rsbweb.nih.gov/ij/) and 
normalized with RalA density for each sample. Glyceraldehyde 3-phosphate dehydrogenase 
(GAPDH) served as a cytosolic fraction loading control, and ExoS translocation into cytosolic 
fractions was quantified and normalized with GAPDH density for each sample. Antibodies used 
in immunoblot analyses included: anti-HA (Covance Research, Princeton NJ), anti-PopB 
(provided by Joseph Barbieri), anti-RalA and anti-ezrin (BD-Transduction, San Jose CA), anti-
GAPDH (Millipore, Temecula CA), and anti-phospho-ERM (pERM, Cell Signaling, Danvers MA). 
Analysis of T24 cell adherence and morphology. To assay effects of ExoS mutants on T24 
cell adherence, cells were seeded 48 hr prior to co-culture with Pa for 4 hr, a co-culture time 
that allowed detection of toxic effects of ExoS on T24 cell adherence to tissue culture wells. 
Cells were washed, detached, and stained with trypan blue as in immunoblot analyses, and 
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adherent cells were enumerated using a hemacytometer. Percent T24 cell adherence to tissue 
culture wells was calculated relative to total cells in uninfected control wells.  
T24 cell rounding was visually estimated following a 3, 3.5, 3.75, and 4 hr co-culture period. 
Differences in the efficiency of cell rounding were most evident following a 3-3.5 hr co-culture 
period, which are reported in Table 1. Cell rounding progressed to 85-95% following a 4 hr co-
culture period with Pa expressing ExoS with active GAP and / or ADPRT activities. 
 
Immunofluorescence analysis. T24 cells were seeded in chamber slides (Nalge Nunc 
International, Rochester NY) 24 hr prior to co-culture with Pa for the indicated times, then 
washed twice in Dulbecco's Phosphate-Buffered Saline (DPBS; Hyclone). The site of Pa binding 
to T24 cells was determined after a 1.5 hr co-culture period and examined by fixing cells in 3% 
paraformaldehyde in actin stabilization buffer (ASB) (33, 115), permeabilizing with 0.2% Triton-
X100 in ABS, and blocking with 0.8% BSA, 0.1% fish gelatin, and 10 μg/ml goat IgG. Cells were 
stained for: F-actin using TRITC-phalloidin (Sigma-Aldrich), Pa using anti-Pa LPS (Joseph Lam, 
University of Guelph, Guelph, Ontario); and trailing edge using anti-caveolin-1 (N-20; Santa 
Cruz Biotechnology, Santa Cruz CA). Pa and caveolin-1 were visualized using an anti-rabbit 
Alexa Fluor 647 conjugate (Invitrogen, Carlsbad CA). Bacterial localization to the leading edge, 
lamellipodium, perinuclear, and trailing edge of T24 cells was visually enumerated. 
To assay ExoS translocation and Pa internalization, cells were co-cultured with Pa for 1.25 to 3 
hr as indicated, fixed, and blocked as above. External Pa were stained using anti-Pa LPS, 
followed by blocking with 6% BSA in DPBS and visualized using a Qdot 655 goat anti-rabbit 
conjugate (Invitrogen). Cells were fixed again, permeabilized, blocked, and all Pa were stained 
with anti-Pa LPS followed by an Alexa Fluor 647 conjugate (Invitrogen). Internal Pa were 
differentiated by absence of Qdot 655 staining. ExoS was detected using anti-HA and an anti-
mouse Alexa Fluor 488 conjugate. Detection of pERM following infection with Pa strains 
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required fixation with 10% trichloroacetic acid on ice for 10 min. Cells were then stained for 
external Pa and total Pa, as previously described, and pERM and total ezrin were detected 
using specific antibodies, indicated above. Total Pa and pERM were visualized using an anti-
rabbit Alexa Fluor 647 conjugate. 
Following staining procedures cells were mounted using Fluoromount-G (Southern 
Biotechnology Associates, Birmingham AL) and examined using a Plan-Apochromat 63x/1.40 
oil objective on a Zeiss Imager.Z1 LSM 510 confocal microscope (Jena, Germany). Images 
were exported to Adobe Photoshop CS4 Extended (Adobe Systems Incorporated, San Jose, 
CA) as 8 bit TIFF files, where immunofluorescence intensity levels were adjusted equivalently. 
Co-immunoprecipitation of actin with ExoS. To examine actin association with T3S 
translocated ExoS, T24 cells were seeded in 100 mm dishes, grown to 90% confluency and co-
cultured for 4.5 hr with PA103∆UT expressing ExoS-KDD-3XFLAG. Cells were washed twice 
with DPBS and detached with 0.25% trypsin (Hyclone). Trypsin was neutralized with FBS, and 
cells were pelleted by low-speed centrifugation and resuspended in HB2 buffer (3 mM 
imidazole, pH 7.4, 250 mM sucrose, containing PIC protease inhibitor cocktail; Sigma) (352), 
and kept on ice. Cells were lysed by passage through a 27 gauge needle, unbroken cells and 
nuclei were pelleted by centrifugation (16,000 g for 5 min), and proteins were precipitated with 
anti-FLAG M2-Agarose affinity resin (Sigma), as previously described (352). Proteins were 
eluted with 300 ng of 3XFLAG peptide, resolved by SDS-PAGE, and silver stained. 
To identify ExoS interacting proteins, bands from two gels were excised, and silver ions were 
removed by adding fresh destaining solution (15 mM potassium ferricyanide, 50 mM thiosulfate 
in distilled water) (Invitrogen). Samples were rinsed twice with distilled water, equilibrated with 
100 mM ammonium bicarbonate (Fisher Scientific, Pittsburgh PA), rinsed three times in 50% 
acetonitrile (ACN, Fisher Scientific) in 100 mM ammonium bicarbonate (23°C, 15 min), and 
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dehydrated in 100% ACN. Dehydrated gel samples were trypsinized in situ with 200-300 ng 
trypsin (Proteomics Grade, Sigma) for 14 hr, and peptides were extracted twice with 50% ACN, 
2.5% trifluoroacetic acid (Fisher Scientific) in distilled water and dried using a CentriVap Speed 
Vacuum. Peptides were then mixed with 5 µl alpha-Cyano-4-hydroxycinnamic acid (Applied 
Biosystems, Carlsbad CA), and 0.5 µl was spotted onto the target for MALDI-TOF analysis. 
MALDI-TOF was performed using the 4700 Proteomics Analyzer (Applied Biosystems), which 
was calibrated using CalMix (Applied Biosystems) with the following instrument settings: (i) 
minimum signal to noise of 10, (ii) mass tolerance of ±2 m/z, (iii) minimum peaks to a match of 
6, (iv) maximum outlier error of 5 ppm, and (v) a laser intensity of 3900. Mass spectra were 
individually calibrated using internal trypsin peaks with Data Explorer software (Applied 
Biosystems). Proteins were identified using ProteinProspector (http://prospector.ucsf.edu/ 
prospector/mshome.htm), set to a mass accuracy of ±150 ppm to compare unknown mass 
fingerprints to those of known proteins in the NCBI database using a species-specific filter for 
Homo sapiens or Pseudomonas aeruginosa. 
Statistical analysis. JMP Version 9 Software (SAS Institute, Cary, NC) was used for statistical 
analyses, and significance was determined by a two-sided alpha level set at P<0.05. A one-way 
ANOVA was used to evaluate differences among Pa strains relative to ExoS/RalA and 
PopB/RalA concentrations in membrane fractions and the site of Pa localization on T24 cells. 
The number of internal or external Pa per T24 cell was evaluated by a least squared means. 
Relative intensity of pERM was analyzed by a randomized complete block. For all data, multiple 
comparisons were analyzed with a Tukey’s HSD test. Pearson’s correlation coefficient was used 






Table II. ExoS mutant activity and cellular toxicity 
1 ExoS constructs are listed from highest to lowest cytotoxicity, ranked based on additive toxic effects of  
the construct on T24 cell rounding, viability and adherence. 
2 Mean T24 cell rounding, determined after a 3-3.5 hr co-culture period. 
3 Mean T24 cell viability, determined based on trypan blue exclusion analyses after a 3.5-4 hr co-culture  
period. 
4 Mean percent T24 cells adherent to tissue culture wells after a 4 hr co-culture period. 










 Enzyme activity Effect on T24 cells  










R146A-HA - + 32.5 51.2 32.5 (95) 
WT ExoS-HA + + 22.5 51.3 28.4 (171) 
E381A-HA + Reduced 35 96.9 48.5 (188) 
E379A/E381A-HA + - 34 97.7 78.0 (95) 
R146A/E381A-HA - Reduced 0 80.9 62.7 (95) 
E379A-HA + - 11.3 98.6 68.1 This study 
R146A/E379A-HA - - 0 87.2 80.6 This study 
R146A/E379A/E381A-HA - - 0 88.6 80.3 (95) 




Characterizing the influence of ExoS enzyme activity on T3S translocation in T24 cells. 
ExoS GAP and ADPRT activities have been found to alter ExoS translocation into eukaryotic 
cells, but the alteration varies with the cell culture system, and the mechanism underlying the 
alteration is unclear (4, 45, 95). To evaluate how ExoS GAP and ADPRT activities influence 
T3S in T24 cells, cells were co-cultured for 3.5-4 hr with strain PA103ΔUT (which lacks T3S 
effectors but retains an intact T3S system (314)), expressing plasmid-encoded WT ExoS or 
ExoS with mutations in GAP (R146A), ADPRT (E379A, E381A, or E379A/E381A), or 
GAP/ADPRT (R146A/E379A, R146A/E381A, or R146A/E379A/E381A) activities (Fig. 15A). 
Cellular toxicity of Pa ExoS mutants, ranked based on T24 cell rounding, viability, and 
adherence to tissue culture wells is shown in Table 1, and ExoS-R146A was identified as the 
most cytotoxic and ExoS-R146A/E379A/E381A as the least cytotoxic form of ExoS. ExoS 
translocation into membrane fractions was quantified based on immunoblot analysis, and a 
progressive increase in translocation was observed with WT < GAP- < ADPRT- < GAP-
/ADPRT- mutants (Fig. 15B). Quantification of ExoS translocation confirmed significant 
differences between group A (WT and GAP- mutant) and group C (GAP-/ADPRT- mutants) 
(P<0.001), and between group B (ADPRT- mutants) and group C (GAP-/ADPRT- mutants) 
(P<0.05) (Fig. 15C). Translocation of WT ExoS was also significantly less (P<0.05) than that of 
ExoS ADPRT- mutants. Differences in ExoS translocation observed by ExoS GAP- or ADPRT- 
mutants provided evidence that the two activities exerted different influences on T3S. 
PopB membrane insertion was used as a measure of general T3S translocation and differed 
slightly from ExoS translocation in that mutations in ExoS ADPRT activity were less effective in 
enhancing PopB translocation. However, overall comparisons of PopB and ExoS membrane 
translocation identified a positive correlation (r = 0.829, P<0.001) between the two. A significant 
increase (P<0.05) in PopB translocation was also observed by Pa expressing an ExoS  
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R146A/E379A/E381A GAP-/ADPRT- mutant as compared to Pa expressing WT ExoS, ExoS 
GAP-, or ExoS ADPRT- mutants, indicating that ExoS GAP and ADPRT activities caused a 
general decrease in T3S translocation (Fig. 15C). 
RalA ADP-ribosylation, recognized by a shift in mobility by SDS-PAGE analysis, provides a 
functional read-out of T3S translocated ExoS ADPRT activity (96), and Pa expressing ExoS with 
E381A mutations, but retaining an active E379 catalytic residue, showed a low level of ADPRT 
activity, as recognized by a slight shift in RalA mobility (Fig. 15B). This activity coincided with 
increased cellular toxicity, as shown by decreased adherence and/or increased cell rounding by 
E381A and R146A/E381A mutants, as compared to respective E379A and R146A/E379A 
mutants (Table II). Alterations in T3S translocation did not appear to relate to a negative 
feedback effect on ExoS expression by infected T24 cells, as determined by the relatively equal 
concentrations of ExoS mutants and PopB in co-culture supernatants (Fig. 15D). The ability of 
mutations in ExoS GAP and ADPRT activities to enhance ExoS and PopB translocation 
indicated that ExoS was targeting cellular processes that affect T3S translocation, which if 











Figure 15. Influence of ExoS activity on Pa-T3S translocation. A) Linear model of ExoS 
GAP and ADPRT domains showing key functional residues (20). B) T24 cells were co-cultured 
for 3.5-4 hr with strain PA103∆UT expressing plasmid encoded WT ExoS or ExoS with 
mutations in GAP (R146A), ADPRT (E379A, E381A, E379A/E381A), or GAP/ADPRT 
(R146A/E379A, R146A/E381A, R146A/E379A/E381A) activities. pUCP is a vector control, and 
ΔPopB is a translocon mutant control. Cells were harvested, fractionated and T3S translocation 
of ExoS and PopB into membrane fractions was assayed by immunoblot analysis. RalA 
modification is a functional read-out of translocated ExoS ADPRT activity, and asterisks mark 
ADP-ribosylated RalA. Total RalA served as a membrane fraction loading control. C) T3S 
translocated ExoS and PopB were quantified by densitometry and normalized with RalA density 
for each sample. Results are expressed as the mean ExoS/RalA or PopB/RalA ratio ± SEM. 
Asterisks mark significant differences in ExoS translocation (**P<0.001, A vs. C; or *P<0.05, B 
vs. C). PopB translocation by groups A and B are also significantly different (P<0.05) from that 
of Pa expressing an ExoS-R146A/E379A/E381A GAP-/ADPRT- mutant (not indicated on 
graph). D) Co-culture supernatants were harvested and compared for ExoS and PopB 
expression by Pa in the presence of T24 cells based on immunoblot analysis. Results are 
















Examining Pa binding to T24 cells in relation to T3S translocation. T3S translocation 
requires Pa binding to eukaryotic cells, and another means of evaluating the role of leading 
edge properties and cell migration in Pa-T3S is to relate the site of Pa binding to T24 cells to 
ExoS translocation efficiency. T24 cells exhibit a highly migratory mesenchymal pattern 
characterized by an expansive lamellipodium with dense actin staining and membrane ruffling, 
and caveolin-1 staining that localizes to the trailing edge can be used to further define the 
direction of migration polarity (149) (Fig. 16A). Pa binding to T24 cells was examined using 
immunofluorescence staining and confocal microscopy (IF). After a 1.5 hr co-culture, which 
allows Pa binding but causes minimal effects on cell morphology, Pa expressing WT ExoS and 
having the least efficient T3S translocation bound preferentially to the leading edge (Fig. 16B). 
In comparison, Pa expressing GAP-, ADPRT-, or GAP-/ADPRT- mutants and having more 
efficient T3S translocation bound primarily within the lamellipodium (Figs. 16C-E), as did the Pa 
pUCP vector control (Fig. 16F) and Pa ΔPopB mutant (not shown). Statistical analysis 
confirmed significantly more (P<0.05) Pa expressing WT ExoS bound to the leading edge of 
T24 cells than Pa pUCP or Pa ΔPopB, indicating that ExoS GAP and ADPRT activities 
increased Pa binding to the leading edge.  
To summarize, expression of WT ExoS correlated with Pa binding to the leading edge of T24 
cells, but more efficient T3S translocation by ExoS ADPRT- or GAP-/ADPRT- mutants was 
associated with Pa binding within the lamellipodium. This finding was contradictory to our 
hypothesis that actin-plasma membrane associations at the leading edge facilitated T3S 
translocation, making it important to understand the mechanism underlying the increased T3S 





Figure 16. Site of binding of Pa expressing ExoS constructs to T24 cells. A) Diagram of 
T24 cell regions in relation to mesenchymal migration. Leading edge architecture, indicated by 
dense actin staining (white) and membrane ruffling was differentiated from the trailing edge by 
caveolin-1 staining (light blue). B-F) T24 cells were co-cultured for 1.5 hr with Pa expressing the 
indicated ExoS construct. Left panels show representative images of the Pa binding site to T24 
cells by Pa expressing the indicated ExoS construct. Pa (blue) binding is indicated by yellow 
arrows. Scale bar is 10 µm. Right panels show quantification of the percent of the respective 
Pa strain binding to the leading edge, lamellipodium, perinuclear, or trailing edge. Pa binding 
was enumerated based on visualizing the binding of each strain to an average of 74 T24 cells. 
The graph shows Pa binding to the indicated regions of the cell. Asterisks denote a significant 








Examining T3S translocation by Pa expressing ExoS enzymatic mutants. To further 
explore the relationship between Pa binding to the leading edge or lamellipodium of T24 cells 
and the efficiency of T3S translocation, HA-tagged ExoS mutant constructs were used to 
monitor T3S translocation by IF following co-culture with Pa for 2.2 to 3 hr. T24 cells are less 
adherent to glass slides than to tissue culture wells, and a 2.2-3 hr co-culture period allowed 
assessment of Pa binding in relation to ExoS translocation, while the majority of T24 cells 
remained adherent. As ExoS GAP activity is known to have an anti-internalization function (52, 
64, 100, 263), to differentiate ExoS translocation by external or internal Pa, a double Pa IF 
staining protocol was developed, staining extracellular Pa with Qdot 655 and total Pa with Alexa 
Fluor 647, while also staining for ExoS using an anti-HA antibody. Visualization of external Pa, 
internal Pa, and ExoS using this protocol is shown in Supplementary Figure S6. 
As previously indicated (Fig. 16B), when T24 cells were co-cultured with Pa expressing WT 
ExoS for 1.5 hr, the leading edge remained intact and extracellular Pa bound primarily to the 
leading edge. Increasing the co-culture time with WT ExoS beyond 1.5 hr led to a rapid decline 
in leading edge architecture, as recognized by the loss of dense actin staining in the direction of 
cell migration (Fig. 17B) in comparison to cells co-cultured with the Pa pUCP vector control (Fig. 
17A). Consistent with immunoblot analyses, translocation of WT ExoS into T24 cells was 
difficult to detect by IF but was apparent based on T24 cell rounding and loss of migration 
polarity. WT ExoS also disrupted actin linkage to the plasma membrane as evident in the loose 
wavy actin filaments extending from T24 cells (Fig. 17B, indicated by blue arrows). Preferential 
binding of Pa expressing WT ExoS to the leading edge could in turn be related to the leading 
edge being an early site of Pa contact, but upon ExoS translocation and loss of cell architecture, 
Pa binding to other regions of T24 cells became less distinguishable.  
As with WT ExoS, co-culture of T24 cells with Pa expressing an ExoS-R146A GAP- mutant led 
to loss of actin linkage to the plasma membrane (Fig. 17C, blue arrows), which was attributed to 
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ExoS ADPRT activity shared by both WT ExoS and the ExoS GAP- mutant. As anticipated, Pa 
internalization was detected when ExoS GAP was mutated, and ExoS staining was found to co-
localize with internalized Pa (Fig. 17C, marked by yellow arrow in panel 1). This finding 
indicated that ExoS was being expressed by internalized Pa and identified an alternative 
mechanism of translocating ExoS into T24 cells. This mode of translocation will be referred to 
as T3S translocation by internalized Pa in our studies to distinguish it from conventional T3S 
translocation by external Pa. The binding of a Pa ExoS GAP- mutant within the lamellipodium of 
T24 cells, as shown in Figure 16C, can now also be related to internalized Pa localizing within 
the lamellipodium.  
IF studies revealed further increases in T3S translocation by Pa expressing an ExoS-
E379A/E381A ADPRT- mutant, as compared to WT ExoS and an ExoS GAP- mutant. Pa ExoS 
ADPRT- mutants remained extracellular and bound predominantly within the lamellipodium, and 
both diffuse and punctate ExoS staining patterns were observed (Fig. 17D). Punctate ExoS 
staining in close association with extracellular Pa may reflect sites of T3S membrane 
translocation (Fig. 17D, panel 2), and if so, this was detected by Pa within the lamellipodium, 
perinuclear, and leading edge regions of T24 cells. ExoS ADPRT- mutants maintain GAP 
activity, which altered T24 cell morphology causing cellular projections that had high intensity 
ExoS staining. Our interpretation of these results was that Pa expressing an ExoS ADPRT- 
mutant translocated ExoS at sites other than the leading edge, but that increased ExoS staining 
in projections that extended from the leading edge related to this being an early site of T3S 
translocation. 
Even higher levels of T3S translocation were evident in IF studies by Pa expressing an ExoS-
R146A/E379A/E381A GAP-/ADPRT- mutant, and this related to T3S translocation by 
internalized Pa (Fig. 17E). ExoS GAP-/ADPRT- staining was initially detected in close 
association with internalized Pa (Fig. 17E, panel 1), and then became more diffuse as Pa 
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migrated to the perinuclear region of T24 cells (Fig. 17E, panels 2 and 3). Diffuse ExoS staining 
is interpreted to relate to the translocation and diffusion of ExoS within the cytosol by 
internalized Pa. Intense ExoS staining co-localizing with Pa is interpreted to reflect localized 
induction or secretion of ExoS. Intense ExoS staining surrounding Pa is presumed to relate to 
ExoS secretion by Pa contained within a membrane vesicle (Fig. 17E, particularly evident in 
panel 3). If these interpretations are correct, ExoS induction can occur when Pa are localized 
within the lamellipodium and perinuclear regions of T24 cells, indicating that ExoS is being 
differentially induced as Pa migrate to the perinuclear region of T24 cells. Consistent with this 
possibility, time course studies detected a progression in ExoS GAP-/ADPRT- mutant staining 
(shown in Fig. 17F): (1) at early co-culture times (1 hr 15 min) ExoS was detected in association 
with extracellular Pa; (2) with increasing time (1 hr 45 min) Pa entered T24 cells and ExoS was 
detected in close association with internalized Pa; (3) by 2 hr 15 min, ExoS was detected in 
close association with Pa migrating to the perinuclear region; and (4) by 3 hr, dense ExoS 
staining was localized to the perinuclear region of T24 cells where a large number of Pa 
resided. Subsequent T24 cell lysis and plating studies found that internalized Pa ExoS GAP-
/ADPRT- mutants remained viable within T24 cells in numbers consistent with that observed in 
IF studies (data not shown). 
To summarize, in examining the role of ExoS GAP and ADPRT activity in T3S translocation in 
T24 cells it was found that: (1) WT ExoS facilitates Pa binding to the leading edge, but ExoS 
GAP and ADPRT activity rapidly disrupt leading edge properties to inhibit T3S translocation by 
external Pa; (2) mutations in ExoS GAP activity enhance T3S translocation, and this relates Pa 
internalization and translocation of ExoS within cells; (3) mutations in ExoS ADPRT activity 
enhance T3S translocation by external Pa, and this occurs in conjunction with T3S translocation 
remaining engaged as Pa move from the cell periphery to within the lamellipodium; and (4) 
mutations in both ExoS GAP and ADPRT activity further enhance T3S translocation, and this 
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relates to Pa internalization and continued T3S translocation as Pa migrate to the perinuclear 






















Figure 17. Visualizing the effects of ExoS enzymatic activity on T3S translocation in 
relation to Pa internalization. A-E) T24 cells were co-cultured for 2.2-3 hr with Pa expressing 
a: A) pUCP vector control, or HA-tagged B) WT ExoS C) ExoS GAP-, D) ExoS ADPRT-, or E) 
ExoS GAP-/ADPRT- mutant. ExoS was visualized relative to Pa internalization and alterations 
in cell morphology. Cells were stained for external Pa (yellow + pink), internal Pa (pink), ExoS 
(green), and actin (white). Yellow arrows indicate internalized Pa. Blue arrows indicate loose 
actin. White arrows indicate direction of migration polarity. Images are representative of 
observations from six independent studies. Scale bar is 10 µm. F) A time course study was 
performed examining ExoS and Pa internalization following co-culture of T24 cells with Pa 
expressing an HA-tagged ExoS GAP-/ADPRT- mutant for 1 hr 15 min, 1 hr 45 min, 2 hr 15 min, 
or 3 hr. Cells were stained as above and examined for ExoS and Pa internalization relative to 
increasing co-culture time. Bottom panels show an enlarged view of the respective upper image. 
Red arrows in the 1 hr 15 min images mark ExoS GAP-/ADPRT- mutant staining by external Pa. 




















Examining T3S translocation by internalized Pa. We attributed enhanced T3S translocation 
by a Pa ExoS GAP- mutant to ExoS translocation by internalized Pa, but the mechanism 
underlying the greater levels of translocation of an ExoS GAP-/ADPRT- mutant remained 
unclear. When Pa internalization by ExoS mutant strains was quantified, Pa ExoS GAP-
/ADPRT- mutants (R146A/E379A, R146A/E381A, or R146A/E379A/E381A) were found to be 
internalized at a significantly higher frequency (P<0.001) than the other Pa strains, including the 
Pa ExoS-R146A GAP- mutant (Fig. 18A). In comparing Pa internalization to Pa binding to the 
external surface of T24 cells, a significant decrease (P<0.05) in Pa binding was detected by Pa 
expressing WT ExoS and the ExoS GAP- mutant, as compared the other ExoS mutant strains 
(Fig. 18A). These results demonstrated that ExoS ADPRT activity affected T3S translocation in 
two ways: 1) its presence induced toxic effects on T24 cells that decreased Pa binding; and 2) 
its absence in combination with a GAP- mutation increased Pa internalization. 
Increased Pa internalization by Pa expressing ExoS GAP-/ADPRT- mutants was also reflected 
in higher levels of cytosolic ExoS, as determined in cell fractionation and immunoblot analyses 
(Fig. 18B). This finding indicated that the primary mechanism of translocation of ExoS into the 
cytosol of T24 cells was through secretion by internalized Pa. A shift in the mobility of cytosolic 
ExoS was observed by SDS-PAGE analysis following co-culture with Pa expressing ExoS-
R146A, E381A, or R146A/E381A mutants. This shift related to ExoS auto-ADPRT activity (257) 
attributed to residual ADPRT activity of the active E379 residue retained by these mutants. The 
functional significance of this activity remains unclear. 
To understand how mutations in ExoS ADPRT activity when combined with an ExoS GAP- 
mutation further enhanced Pa internalization, IF analyses were performed comparing Pa 
internalization by ExoS GAP- and ExoS GAP-/ADPRT- mutants. These analyses revealed that 
Pa expressing ExoS GAP-/ADPRT- mutants entered and migrated within T24 cells along actin 
filaments that guided their perinuclear migration (Fig. 18C, indicated by yellow arrows). In 
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comparison, Pa expressing an ExoS GAP- mutant entered T24 cells, but Pa intracellular 
migration did not align with actin, nor was it generally directed to the perinuclear region (Fig. 
18C R146A panels, indicated by blue arrows). The inability of Pa expressing an ExoS GAP- 
mutant, which retained active E379 and/or E381 ADPRT residues, to align with actin filaments 
in T24 cells is consistent with ExoS ADPRT activity disrupting actin-plasma membrane 
associations required for Pa-actin alignment. Enhanced Pa internalization by ExoS GAP-
/ADPRT- mutants can in turn be related to their ability to align with actin in T24 cells, which 
secondarily allows increased ExoS translocation by internalized Pa. 
To summarize these results, ExoS translocation into cytosol of T24 cells related to secretion of 
ExoS by internalized Pa, and enhanced Pa internalization and ExoS translocation by Pa 
expressing ExoS GAP-/ADPRT- mutants related to the ability of Pa to align with actin filaments 












Figure 18. Examining T3S translocation by internalized Pa. A) T24 cells were co-cultured for 
2.2-2.5 hr with Pa expressing WT ExoS, or ExoS with the indicated GAP- and/or ADPRT- 
mutations, or a pUCP vector control. Cells were stained for external or internal Pa as in Figure 
17, and internalized Pa (bar graph) or externally bound Pa (line graph) were enumerated based 
on Pa association with an average of 124 T24 cells per strain. Results are expressed as the 
mean ± SEM of the number of Pa internalized or externally bound per T24 cell. Asterisks mark 
significant differences in Pa internalization (**P<0.001, A vs. B). A significant difference 
(P<0.05) in external Pa binding was also detected by Pa expressing WT ExoS or an ExoS-
R146A GAP- mutant, as compared to all other Pa ExoS mutant strains (not indicated on graph). 
Results are representative of six independent experiments. B) T24 cells were co-cultured for 
3.5-4 hr with the indicated Pa strains, cells were harvested, fractionated, and ExoS translocation 
into cytosolic fractions was assayed by immunoblot analysis. RalA, which localizes to the 
membrane, and GAPDH, which localizes to the cytosol were used as cell fractionation controls. 
Asterisks mark auto-ADP-ribosylated ExoS attributed to an active E379 ADPRT catalytic 
residue retained by the respective strains. C) T24 cells were co-cultured from 2.2-3 hr with Pa 
expressing the indicated ExoS mutant, and cells were stained for internal or external Pa, ExoS, 
and actin, as described in Figure 17. Pa expressing ExoS GAP-/ADPRT- mutants aligned along 
actin filaments (indicated by yellow arrows) consistent with an actin-based motor directing Pa 
internalization and migration to the perinuclear region of T24 cells. Pa expressing an ExoS-
R146A GAP- mutant entered T24 cells but did not align along actin filaments (blue arrows mark 








Examining the role of actin in ExoS internalization. Although we were able to establish the 
mechanism for the negative effects of ExoS GAP and ADPRT activity on T3S translocation, the 
actual role of the leading edge in T3S translocation remained unclear. Insight into how the 
leading edge facilitated T3S translocation was obtained during Pa internalization studies, where 
it was observed in IF analyses that ExoS was tracking actin filaments. The tracking of actin by 
ExoS is visualized in Figure 18C in all R146A/E379A mutant panels, the first and second 
R146A/E381A mutant panel, all R146A/E379A/E381A mutant panels, and the third R146A 
GAP- mutant panel (this is not specifically marked in Fig. 18C). In fact the tracking of actin by 
ExoS facilitated detection of internalized Pa alignment with actin. When ExoS-actin tracking was 
related to mutations in ExoS enzyme activity, WT ExoS, ExoS GAP-, and/or ExoS ADPRT- 
were all able to track actin, indicating that actin tracking by ExoS was independent of its enzyme 
activity (Fig. 19A). However, it should be noted that ExoS-actin tracking was observed more 
frequently when ExoS ADPRT mutations were introduced. 
To further assess ExoS interaction with actin within T24 cells, Pa expressing an ExoS-KDD-
3XFLAG ExoS GAP-/ADPRT- mutant was used in co-immunoprecipitation (CoIP) studies to 
identify proteins that interact with T3S translocated ExoS. Four major ExoS interactive protein 
bands were identified by SDS-PAGE in CoIP analyses (Fig. 19B). When these bands were 
excised and analyzed by MALDI-MS, band 1, 45 kDa, was identified to contain peptides from 
lysosomal associated protein 1 (LAMP1); band 2, 40 kDa, was identified to include peptides 
from beta-actin; band 3, 30 kDa, was identified as the epsilon isoform of 14-3-3 protein; and 
band 4 was identified to include 14-3-3 proteins of mixed isoforms. The finding that 14-3-3 
proteins interact with ExoS is consistent with previous studies (352) and with 14-3-3 proteins 
being a co-factor of ExoS ADPRT activity (102). Bands 1 and 2 were not homogenous proteins, 
and the identification of LAMP1 as an ExoS interactive protein in band 1 is consistent with Pa 
expressing an ExoS GAP-/ADPRT- mutant being internalized within endocytic vesicles where 
 
 133
ExoS would have access to lysosomal proteins. Importantly for our studies the co-localization of 
actin with ExoS in band 2 confirms the ability of T3S translocated ExoS to interact with actin in 
T24 cells. In turn, ExoS translocation at the leading edge can be explained by this being a site 
of close actin-plasma membrane association, which would allow T3S translocated ExoS access 




Figure 19. ExoS aligns with actin filaments in T24 cells. A) Pa expressing the indicated 
ExoS constructs were co-cultured with T24 cells and stained for external Pa, internal Pa, ExoS, 
and actin as in Figure 17. Yellow arrows point to the tracking of ExoS along actin filaments. 
Scale bar is 10 µm. B) T24 cells were co-cultured for 4.5 hr with PA103∆UT expressing ExoS-
KDD-3XFLAG, an ExoS GAP-/ADPRT- inactive mutant (ExoSi) or the pUCP vector control. Co-
immunoprecipitation eluates were resolved by SDS-PAGE, silver stained and the indicated 
bands (*) were excised and analyzed by MALDI-MS. A lysis buffer negative control is also 
shown. *1: included lysosomal-associated membrane protein-1 (LAMP1), *2: included beta 
actin, *3: identified as 14-3-3 epsilon, and *4: included 14-3-3 proteins of different isotypes. 












Examining the role of ExoS ADPRT activity in T3S translocation. The finding that mutations 
in ExoS ADPRT activity enhance ExoS translocation in T24 cells provided evidence that ExoS 
ADPRT activity targets and inactivates a cellular protein(s) required for T3S translocation. ERM 
proteins (ezrin, radixin, and moesin) mediate the regulated linkage of actin to the plasma 
membrane at the leading edge (32, 309) and are high affinity substrates of ExoS ADPRT activity 
(195). Consistent with ERMs being a target of ExoS ADPRT activity that interrupts T3S 
translocation: 1) ADP-ribosylation of ERMs by ExoS was found to interfere with ERM 
phosphorylation (pERM) (195, 297), which is required for ERM binding to F-actin, and 2) we 
found ExoS ADPRT activity to disrupt actin anchorage to plasma membrane in conjunction with 
inhibition of Pa-T3S (Figs. 17B and C, blue arrows) and the alignment of internalized Pa with 
actin (Fig. 18C, R146A panels, blue arrows) 
When Pa expressing ExoS mutants were examined for interference of ERM phosphorylation in 
T24 cells, pERM in membrane fractions was significantly reduced (P<0.001), based on 
quantification of immunoblot analysis, following co-culture with Pa expressing ADPRT active 
ExoS (WT ExoS or an ExoS GAP- mutant), as compared with other ExoS mutant strains (Fig. 
20A). Interestingly neither an E379A nor E381A mutation alone caused a decrease in ERM 
phosphorylation, indicating that mutations in both ADPRT residues were required to interrupt 
pERM-actin linkage. When pERM and ezrin localization was examined by IF and related to T3S 
translocation by ExoS mutants, co-localization of pERM and ezrin within leading edge 
architecture was observed in untreated (0) or pUCP vector control treated T24 cells, confirming 
localization of pERM to the leading edge in T24 cells (Fig. 20B). This leading edge architecture 
was lost following co-culture with Pa expressing WT ExoS, where pERM and ezrin were 
observed to diffuse away from the leading edge but remain at the cell periphery, sometimes co-
localizing to constricted patches. Single ExoS-E379A or E381A ADPRT mutations allowed the 
effect of each residue on leading edge-pERM architecture to be evaluated. Co-culture with a Pa 
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ExoS-E379A mutant (having an active E381 residue) led to diffuse pERM-ezrin staining along 
the leading edge, but leading edge architecture remained intact. An ExoS-E381A mutant 
(having an active E379 residue) led to a loss of leading edge architecture, but ezrin and pERM 
remained co-localized along the cell periphery. When both ADPRT residues were mutated (Fig. 
20B, E379A/E381A panels), leading edge properties and pERM-ezrin staining closely 
resembled that of uninfected or Pa pUCP treated control cells. The coordinated effects of ExoS 
E379 and E381 residues on leading edge architecture can be related to ExoS E379 having a 
more pronounced influence on pERM-ezrin localization to the leading edge, while ExoS E381 
had a more pronounced influence on underlying leading edge architecture.  
In comparing effects of ExoS ADPRT activity on ERM phosphorylation and Pa-T3S 
translocation, it was recognized that mutations in both ExoS-E379A and E381A were required to 
inhibit ERM phosphorylation, while individual ExoS-E379A or E381A mutations were able to 
enhance T3S translocation. This outcome can be related to the ability of ExoS E379 or E381 to 
disrupt pERM-ezrin leading edge architecture to interfere with T3S translocation, yet neither 
residue alone is able to inhibit ERM phosphorylation and disrupt actin-plasma membrane 
linkages predicted to be required for T3S translocation, thus providing a mechanistic 
explanation for the coordinated roles of ExoS E379 and E381 in inhibiting T3S translocation. 
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Figure 20. Effect of ExoS ADPRT activity on ERM phosphorylation and localization within 
T24 cells. A) T24 cells were co-cultured for 3.5-4 hr with no bacteria (0), Pa expressing the 
indicated ExoS construct or the pUCP vector control. Cells were fractionated and membrane 
fractions were assayed by immunoblot analysis for pERM (ezrin-Thr567, radixin-Thr564, and 
moesin-Thr558) and total ezrin. Densitometry analysis detected a significant decrease 
(P<0.001) in pERM following co-culture with Pa expressing WT ExoS or ExoS-R146A GAP- 
mutant, as compared to the other Pa ExoS mutant strains. B) T24 cells were untreated (0) or 
were co-cultured for 2 hr with Pa expressing the pUCP vector control or indicated ExoS 
construct and examined by IF, staining for pERM (pink), ezrin (green), or cell associated Pa 
(pink or pink + yellow, indicated by yellow arrows). White arrows indicate direction of migration 







This study addressed the cellular mechanism underlying the establishment of opportunistic Pa 
infections by using mutations of ExoS enzyme activity to modulate T3S translocation and the 
ability of Pa to infect cells. The study was directed by the hypothesis that actin-plasma 
membrane associations at the leading edge are required for T3S translocation and evolved by: 
first, identifying the effects of ExoS GAP and ADPRT activities on T3S in migrating T24 
epithelial cells; second, demonstrating that Pa expressing WT ExoS preferentially bound to the 
leading edge of T24 cells; third, showing that ExoS ADPRT activity disrupted actin-plasma 
membrane anchoring in conjunction with interruption of T3S translocation; and fourth, 
demonstrating that both Pa and ExoS internalization were facilitated by their ability to align with 
or track actin. Interestingly, through manipulations of ExoS GAP and ADPRT activities we were 
also able to unveil the innate infectious potential of Pa in T24 cells and constraints introduced by 
ExoS that influence the opportunistic nature of Pa infections.  
The importance of T3S to Pa infections is shown by the ability of ExoS or ExoU to define the 
invasive or cytotoxic phenotype of Pa during infections (82, 88, 285), and by the ability of the 
translocon protein, PcrV, to induce protective immunity against Pa infections (282). Pa is 
regarded as an extracellular pathogen, but a small percentage of Pa are internalized into 
epithelial cells, a percentage that varies with Pa strain and with epithelial cell line confluency 
and polarity (76, 88, 243). ExoS GAP activity has an anti-internalization function (15, 64, 100, 
263), but we found that ExoS ADPRT activity can further enhance the anti-internalization activity 
ExoS GAP activity in T24 cells. Pa expressing WT ExoS was internalized at a low frequency of 
an average of one Pa per three T24 cells. This frequency increased 4-fold upon introduction of 
an ExoS GAP- mutation and 15-fold when both ExoS GAP- and ADPRT- mutations were 
introduced. IF studies revealed that increased internalization a Pa ExoS GAP-/ADPRT- mutant 
related to Pa entering T24 cells and aligning with actin filaments that directed perinuclear 
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migration of Pa. The lower level of internalization by a Pa ExoS GAP- mutant coincided with an 
inability to align with actin after entry into T24 cells; an activity that was lost due to ExoS ADPRT 
activity retained in this strain. Previous transmission electron microscopy (TEM) studies 
revealed that Pa enter cells in tightly enclosed membrane vesicles, which increase in size and 
eventually lyse as Pa traverse inward (76, 89, 244). We did not examine Pa vesicle association 
within T24 cells, but we observed Pa expressing an ExoS GAP- mutant to be internalized within 
a membrane vesicle in TEM analysis of J774A.1 macrophages, indicating that this is a common 
mechanism of internalization, even when an ExoS GAP- mutation is introduced (Supplementary 
Fig. S7). Also, in IF analysis of T24 cells we were able to visualize intense ExoS staining closely 
surrounding internalized Pa, which is a staining pattern consistent with Pa secreting ExoS while 
contained within a membrane vesicle. Interestingly, this staining pattern was detected by Pa at 
the periphery of the lamellipodium, within the lamellipodium, and in the perinuclear regions of 
T24 cells indicating that ExoS expression was being induced at different stages in Pa 
intracellular migration process. ExoS translocation by internalized Pa was confirmed in cytosolic 
fractionation and immunoblot analyses. The notion that ExoS is induced after Pa internalization 
adds a new level of unknowns to T3S induction mechanisms but is consistent with a recent 
report describing the translocation of Yops into the host cell cytosol by the Yersinia Ysc T3S 
system (354).  
ExoS GAP and ADPRT activities influenced ExoS T3S translocation in T24 cells at a relative 
efficiency of WT ExoS < ExoS GAP- < ExoS ADPRT- < ExoS GAP-/ADPRT-, as assessed 
based on cell population (immunoblot) and single cell (IF) approaches. Subsequent studies 
allowed characterization of the eukaryotic cell basis for this hierarchy of T3S translocation 
efficiency. The slight increase in T3S translocation detected by Pa expressing an ExoS-R146A 
GAP- mutation was attributed to the translocation and sequestering of ExoS within the T24 cells 
by internalized Pa. Yersinia T3S effector, YopE, functions similarly to ExoS GAP in its ability to 
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down-regulate Rho-GTPases, interfere with phagocytosis, and decrease effector translocation 
(4, 26, 207, 328). However, the mechanism of YopE interference of T3S translocation appears 
to differ from that of ExoS GAP in being linked to regulatory influences on actin polymerization 
that affect pore formation, and to the down-regulation of Yop synthesis (4, 5, 207, 324). We 
were unable to detect an influence of ExoS GAP activity on pore formation in T24 cells, based 
on trypan blue exclusion assays that compared membrane integrity of Pa expressing WT ExoS 
and an ExoS GAP- mutant (Table II). We were also unable to detect a negative impact of ExoS 
GAP activity on T3S protein expression, based on levels of ExoS and PopB in T24 cell co-
culture supernatants following infection with Pa ExoS mutants (Fig. 15D). In this regard, 
previous studies using A549 epithelial cells and an exoS-GFP reporter construct were able to 
detect a negative feedback effect of ExoS enzymatic activity on Pa induction of T3S (45). 
Differences observed between our studies and those of Cisz et al., may relate to our use of a Pa 
population based ExoS expression assay and their use of single cell Pa-T3S induction assay. 
However, in our system, potential negative feedback effects of ExoS enzyme activity on T24 cell 
mediated induction of Pa-T3S appear to be secondary to effects of ExoS on host cell properties 
that influence Pa binding and T3S translocation. Apparent differences in the mechanism of 
interruption of T3S translocation by ExoS GAP and YopE relate to some extent to bacterial 
properties, as demonstrated by the ability of ExoS GAP to complement a YopE mutant in 
suppressing T3S translocation when expressed in Yersinia (4). It is also possible that influences 
of ExoS ADPRT activity, which are lacking in Yersinia, may impact the role of ExoS GAP activity 
on Pa-T3S translocation.  
More fundamental to understanding the mechanism underlying T3S translocation was the 
pronounced inhibition on ExoS translocation caused by ExoS ADPRT activity. This finding 
supports the novel notion that eukaryotic protein(s) targeted by ExoS ADPRT activity inhibit T3S 
translocation. ERM proteins link actin to the plasma membrane at the leading edge (32, 309) 
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and are high affinity substrates of ExoS ADPRT activity (195). Consistent with ERM proteins 
being targets of ExoS ADPRT activity that interrupt T3S translocation, ExoS ADPRT activity was 
found to: 1) disrupt actin-plasma membrane linkages hypothesized to be involved in Pa-T3S 
translocation, and 2) alter leading edge pERM-ezrin architecture in conjunction with decreased 
T3S translocation. Further evidence for the role of ERMs in Pa-T3S was provided by individual 
ExoS-E379A or E381A ADPRT mutations, which enhanced Pa-T3S translocation but were 
individually ineffective in inhibiting ERM phosphorylation. Enhanced T3S translocation can be 
related to loss of the toxic effects of the individual ExoS E379 or E381 residues on leading edge 
architecture. Continued T3S translocation in the presence of the remaining active ADPRT 
residue can also be explained by the inability of either residue alone to inhibit ERM 
phosphorylation and disrupt actin-plasma membrane linkages predicted to be required to Pa-
T3S translocation. The importance of this finding is that it provides a mechanistic explanation for 
the coordinated roles of ExoS E379 and E381 in inhibiting T3S translocation, which is consistent 
with the hypothesis that actin-plasma membrane associations at the leading edge underlie Pa-
T3S translocation. While further studies are required to confirm the role of ERM proteins in Pa-
T3S translocation, the prospect of identifying a host cell protein that mediates T3S translocation 
offers the potential of being applied to the development of novel anti-Pa therapeutic strategies 
that are resilient to normal antibiotic resistance mechanisms.  
In direct comparisons of ExoS and PopB membrane translocation it was also recognized that 
mutations in ExoS ADPRT activity caused a more pronounced increase in ExoS than PopB 
translocation (Figs. 15B and C). The bias in the interference of ExoS translocation by ExoS 
ADPRT was subsequently related to the ability of ExoS to interact with actin filaments within 
T24 cells, an interaction that would be compromised by toxic effects of ExoS ADPRT activity on 
actin-plasma membrane linkage. PopB membrane insertion presumably is not dependent on an 
interaction with actin, and hence its translocation would not be as directly affected by the 
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disruption of actin-plasma membrane linkage. The mechanism underlying increased 
translocation by Pa ExoS ADPRT- mutants can in turn be related to actin-plasma membrane 
anchorage at the leading edge and within the lamellipodium that is retained in the absence of 
ExoS ADPRT activity and allows continued ExoS translocation. The ability of ExoS to bind actin 
provides a new perspective on adaptations acquired by T3S effectors to facilitate their 
internalization. Collectively, studies of ExoS ADPRT activity introduced four novel findings to 
Pa-T3S by: 1) differentiating the mechanism of PopB membrane insertion from that of ExoS 
translocation; 2) identifying the potential of actin to facilitate ExoS internalization, and 3) 
recognizing that a target of ExoS ADPRT activity was involved in T3S membrane translocation, 
and 4) providing a mechanistic explanation consistent with this target being ERM proteins based 
on studies of individual ADPRT catalytic residues.  
The highest levels of ExoS and PopB translocation occurred in association with mutations in 
both ExoS GAP and ADPRT activities, which can be explained by the different and additive 
influences of ExoS GAP and ADPRT activities on T3S translocation. In relating our findings of 
ExoS mutants to the Pa infectious process, the scenario that evolved was that translocation of 
WT ExoS into T24 cells occurred initially at the leading edge, where actin is in close association 
with the plasma membrane and accessible to interaction and tracking by ExoS. Upon 
translocation, ExoS GAP activity interferes with Pa internalization, and ExoS ADPRT activity 
interrupts actin-plasma membrane associations. Therefore, both activities serve to limit T3S 
translocation but through different mechanisms. Interestingly, mutation of ExoS GAP and 
ADPRT activities allowed recognition of the innate ability of Pa to be internalized, to align along 
actin filaments, and to continue T3S translocation within cells; a fate that might be encountered 
by the low percentage of WT Pa that are normally internalized in T24 cells. Our studies also 
draw attention to the paradoxical role of ExoS in the Pa infectious process. First, cytotoxic 
effects of ExoS contribute to the establishment of Pa infections. Second, these same cytotoxic 
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effects interfere with Pa internalization and T3S translocation to limit the Pa infectious process 
and help maintain its extracellular, opportunistic lifestyle. The importance of Pa remaining 
extracellular for survival is documented by the redundancy of T3S effectors that have anti-
internalization activity, including ExoS GAP, ExoT GAP, ExoT ADPRT, and ExoY (15, 52, 53, 
64, 66, 100, 108, 109, 263). Similarly, the integral role of T3S effectors in the opportunistic 
nature of Pa infections was recognized in our studies of a PA103∆UT ExoS GAP-/ADPRT- 
mutant, which was found to be efficiently internalized, express high levels of inactive ExoS, 
remain viable, and cause minimal T24 cell toxicity. This finding unveiled the innate potential of 
Pa be an intracellular symbiont; a lifestyle that has been redirected through the acquisition of an 
array of T3S effectors.  
T24 cells have a highly migratory mesenchymal phenotype and were selected for our studies to 
examine how cell migration properties function in T3S and in the initiation of Pa infections. 
Eukaryotic cell properties are known to influence the toxicity of ExoS GAP and ADPRT activities 
(270), and our findings in T24 cells may differ from those observed in other cell lines. For 
example, rodent cell lines which have a more limited ExoS ADPRT substrate repertoire and are 
highly sensitive to negative effects of ExoS GAP activity (264, 270), may be less sensitive to 
negative effects of ExoS ADPRT activity on T3S translocation. Differences have also been 
observed in ExoS responsiveness among human epithelial cell lines. Recent studies using real-
time phase-contrast imaging to examine the effects of ExoS on immortalized corneal epithelial 
cells found Pa expressing ADPRT active ExoS to produce membrane blebs that contain 
replicating Pa (15), a phenotype not observed in T24 cells. The mechanism underlying cellular 
differences in ExoS responsiveness between corneal epithelial cells and T24 cells remains 
unclear, but blebbing is mediated by signaling through Rho, ROCK, and myosin and does not 
initially involve actin polymerization (78, 99). This signaling pathway differs from that at the 
leading edge of T24 cells, which is Rac1 mediated and involves actin polymerization (99). Rho 
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and Rac1 activation are reciprocally balanced within cells, particularly during migration (275). 
Previous studies of MDCK cells found that Pa internalization was stimulated by RhoA activation, 
a property that was lost when MDCK cells acquired apical-basolateral polarity (155, 156). These 
findings introduce the possibility that increased internalization and Pa survival in corneal 
epithelial cells may relate to properties linked to Rho activation that are absent at the leading 
edge of T24 cells. Our future plans include examining how the balance between Rho and Rac1 
activation at the leading edge of corneal epithelial and T24 cells directs the outcome of Pa-T3S 
responsiveness. 
To summarize, as an opportunist, Pa infections are influenced by host cell properties (45, 206, 
271). Through the ability to visualize ExoS translocation in relation to T24 cell migration we were 
able to characterize mechanisms underlying differences in T3S translocation caused by 
mutations in ExoS GAP and ADPRT activities. These analyses led to the recognition of a role of 
host cell actin in both ExoS and Pa and internalization, a role that was disrupted by ExoS 
ADPRT activity. Our study was directed by the hypothesis that actin-plasma membrane 
associations at the leading edge of migrating cells are required for T3S translocation and 
contribute to the establishment of Pa infections. While this remains a hypothesis, it provided 
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Supplementary Figure S6. Staining for external Pa, internal Pa, and ExoS expression. T24 
cells were co-cultured for 2.2 hr with PA103ΔUT expressing an ExoS-R146A/E379A/E381A 
GAP-/ADPRT- mutant. Following co-culture, cells were washed, fixed in 3% paraformaldehyde 
in actin stabilization buffer, and blocked. External Pa (yellow + pink in merged image) were 
detected using rabbit anti-Pa LPS and a Qdot 655 anti-rabbit conjugate. Cells were fixed again, 
permeabilized, and blocked. Total Pa were detected using anti-Pa LPS followed by an Alexa 
Fluor 647 conjugate (pink). ExoS expression was detected using an anti-HA antibody and an 
Alexa Fluor 488 conjugate (green). Actin was stained with TRITC-phalloidin (white). Intracellular 
Pa marked by white arrows were identified by the absence of Qdot 655 staining.  
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Supplementary Figure S7. Visualizing Pa internalization within membrane vesicles by 
transmission electron microscopy. J774.1 murine macrophage-like cells (ATCC TIB-67) 
were: A) untreated, or co-cultured for 2.5 hr with strain PA103ΔUT expressing B) WT ExoS or 
C-D) an ExoS-R146A GAP- mutant. After the co-culture period, cells were washed, fixed with 
2% cacodylate glutaraldehyde, then post-fixed with 2% aqueous osmium tetraoxide. Samples 
were rinsed with distilled water, dehydrated with 100% ethanol, and embedded. Thin sections 
(70 nm) were cut, placed on copper grids, and double stained with uranyl acetate and lead 
citrate. Samples were examined with a JEOL JEM 1010 transmission electron microscope. Red 
arrows point to Pa. C) Shows Pa internalized in a membrane vesicle, which is enlarged in D). 
Fuzziness at the upper right end of the vesicle in D) is interpreted to reflect membrane lysis. 
Increased vacuole formation was observed in association with ExoS ADPRT activity of WT 
ExoS and the ExoS-R146A GAP mutant-. Images are representative of two independent 




















Chapter 4:  Differences in Host Cell Migration Properties Lend Insight into 














The MTC and MTLn3 experiments were performed in conjunction with Matthew J. Novotny. 
MTC and MTLn3 experimental results presented in this chapter will be combined with 
experiments performed by Matthew J. Novotny for publication. Matthew J. Novotny and Dacie 





Eukaryotic cell migration is an essential process used by all nucleated cells and is characterized 
as either individual or collective. Individually migrating cells can move by forming membrane 
blebs, which is also known as amoeboid migration, or by forming distinct leading and trailing 
edges, also known as mesenchymal migration. Cells utilizing amoeboid migration tend to be 
poorly adhesive to the extracellular matrix (ECM), form membrane blebs, and are driven by 
Rho/Rho-Kinase (ROCK) regulated propulsion at the leading edge (178, 349). In contrast, cells 
migrating via a mesenchymal phenotype can be highly adhesive, have high contractility, and 
propulsion is mediated by Rac1 activity at the leading edge balanced by Rho in the trailing edge 
(121, 227, 305, 338). Collective migration is a process by which multiple cells coordinate leading 
edge protrusions with simultaneous retraction of the cell rear. While the process resembles 
mesenchymal migration, cells migrating collectively maintain contact with each other. As a 
result, the cells move as a sheet, which occurs during wound healing (7, 98, 133, 305). Leading 
edge dynamics in migrating cells are controlled by Rho-GTPases. In the classical model of cell 
migration, Rac1 mediates lamellipodial protrusion while Cdc42 establishes cellular polarity and 
mediates filopodial protrusions (221, 277). Rho in turn, mediates actomyosin retraction of the 
trailing edge of the cell, and maintains cellular adhesion to the ECM (221). Rac1 and Rho have 
been shown to work in a reciprocal fashion where increased Rac1 down-regulates Rho and vice 
versa (276). This balance between Rac1 and Rho signaling is essential in signaling cells to 
migrate via an amoeboid or mesenchymal mechanism (273).  
Previous studies from our laboratory have highlighted the importance of the leading edge of 
migrating cells and Rac1/Cdc42 signaling in host cell susceptibility to Pseudomonas 
aeruginosa-type III secretion (Pa-T3S) (33)(Chapter3). T3S is a virulence mechanism utilized by 
numerous Gram-negative pathogens such as Yersinia, Salmonella, Shigella, Escherichia coli, 
and Pa. Pa is an opportunistic pathogen that is known to target individuals with wounded 
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epithelial barriers, individuals who are immunocompromised, and individuals with have cystic 
fibrosis. Unlike obligate pathogens, Pa is able to target and establish infection in any cell type. 
Several studies have implicated a role for Pa-T3S in the establishment of infection, thereby 
illustrating its importance as a Pa virulence factor (reviewed in (129)). The T3S system 
translocates Pa effector proteins, such as ExoS, directly from the bacterial cytosol into the host 
cell, thus bypassing the host immune response. Translocation of ExoS across the eukaryotic 
membrane requires channel formation by the hydrophobic proteins PopB and PopD (215). PcrV, 
the hydrophilic Pa-T3S needle tip protein is required for stabilization of the translocon channel in 
the host cell membrane (215). 
Several studies have indicated that the host cell response to Pa infection depends largely on the 
cell type studied (33, 89, 206, 270, 271). In studies of over 40 cell lines, most were identified as 
being sensitive to Pa-T3S and infection (206). Two cell lines have been identified as resistant to 
Pa-T3S, polarized epithelial monolayers and promyelocytic HL-60 cells (206, 271). Both cell 
lines could be induced to become T3S-sensitive either through disruption of epithelial cell 
apical-basolateral polarity, or by differentiation of HL-60 cells with the phorbol ester TPA (206, 
271). However, despite this knowledge, the common factor underlying host cell sensitivity to Pa-
T3S remains unknown.  
The purpose of the current study was to determine how Rho-GTPases and their role in host cell 
migration influence Pa-T3S. We have previously proposed that actin polymerization and linkage 
to the membrane, together with the role of Rac1/Cdc42 mediated focal complex formation at the 
leading edge of migrating cells are the host cell compromise resulting in susceptibility to T3S 
and the establishment of Pa infection ((33), studies presented in Chapter 3). Therefore, to 
further investigate the hypothesis that host cell migration is involved in host cell sensitivity to Pa-
T3S, we chose three cell lines which exhibit differences in Rho-GTPase mediated cell migration 
patterns. Rat mammary adenocarcinoma MTC and MTLn3 cell lines are a clonal cell model 
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system that differs in metastatic potential where MTC cells exhibit low metastatic potential and 
MTLn3 cells exhibit high metastatic potential (70, 217). There are several advantages to using 
MTC cells and its MTLn3 clonal sub-line for the current studies. First, both cell lines have an 
identical genetic background with little cellular heterogeneity (54). Second, this model system 
focuses solely on the differences in metastatic potential (54). Third, MTC cells are known to 
exhibit more polarized cell migration, and can move faster than MTLn3 cells (292). Finally, host 
cell migration in MTC and MTLn3 cells differs in Rho-GTPase regulation of leading edge cell 
migration properties (71, 72). In MTC cells, lamellipodial protrusions are Rac1-dependent and 
levels of activated Rho and total Rho are decreased, consistent with the classical model of cell 
migration. However, in MTLn3 cells, the reciprocal balance between Rho and Rac1 influences 
lamellipodial protrusion. El-Sibai et al. have previously shown that Rho activation in the 
lamellipodia of MTLn3 cells is increased, and as a result, Rac1 activity at the leading edge is 
suppressed and lamellipodial protrusion is Cdc42-dependent (71, 72). Madin-Darby canine 
kidney (MDCK) cells have largely been used to understand the wound healing process and 
polarization of epithelial cells (17, 83, 200). In this regard, MDCK cells can migrate collectively 
during wound healing or can use mesenchymal migration to migrate individually (246). When 
wounding is initiated in an MDCK monolayer, cell migration is responsible for wound closure 
and not cell proliferation (268, 299). Wound closure also depends on Rac1, phosphoinositide, c-
Jun, and ERK1/2 MAP kinase (11, 83, 200). While Rho is not directly required for wound 
healing, it is required for the formation of F-actin bundles in areas along the wounded edge, 
which aid in even healing and in formation of membrane ruffles (83, 173).      
Our hypothesis for these studies was that differences in host cell migration properties, based on 
activated Rho-family GTPases at the leading edge, influences sensitivity to Pa-T3S. Studies 
utilizing metastatic MTLn3 cells found that increased Pa-T3S sensitivity, compared to non-
metastatic MTC cells, was attributed to Pa internalization due to MTLn3 cell resistance to ExoS 
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GTPase activating protein (GAP) activity. In wounded monolayer studies utilizing MDCK cells, 
sensitivity to Pa-T3S was greatest 4-6 hr post-wounding. ExoS was found to inhibit wound 
healing through its enzyme activity, where ExoS GAP activity inhibited actin stress fiber 
formation while ExoS ADP-ribosyltransferase (ADPRT) activity inhibited ERM (ezrin, radixin, 
and moesin) phosphorylation and actin attachment to the membrane. Together, both activities 
contributed to disruption of cell migration through inhibition of actin stress fiber formation 
required for cell migration and wound healing. Overall, these studies support the hypothesis that 
host cell properties regulating leading edge dynamics influence susceptibility to Pa-T3S, in that 
cells expressing high levels of Rho at the leading edge are more resistant to Pa-T3S. The 
identification of host cell migration as a contributing or initiating factor in the establishment of Pa 
infection is consistent with the opportunistic lifestyle of Pa, which is known to target 
compromised epithelial barriers.       
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MATERIALS AND METHODS 
Bacterial strains. PA103ΔUT and ExoS-HA were described previously (33). PA103ΔUT was 
used to express plasmid encoded enzymatic mutants of ExoS, shown in Table I (Chapter 3). Pa 
were grown in ExoS induction medium (147) for 14-16 hr and were washed twice in cell line 
specific medium prior to co-culture with eukaryotic cells.  
Eukaryotic cell culture and bacterial eukaryotic cell co-culture conditions. MTC cells (non-
metastatic) were obtained from John S. Condeelis (Albert Einstein College of Medicine, Bronx 
NY). MTLn3 cells (metastatic) were obtained from Scott Weed (West Virginia University School 
of Medicine, Morgantown WV). MTC and MTLn3 cells were cultured in Minimum Essential 
Medium, Alpha (αMEM; Cellgro, Manassas VA) containing nonessential amino acids (Cellgro), 
10% fetal bovine serum (FBS; Hyclone, Logan UT), 100 U/ml penicillin, and 100 µg/ml 
streptomycin (Hyclone). MTC and MTLn3 cells were seeded at 2x104 and 2.5x104 cells/ml, 
respectively, and grown for 48 hr. Prior to bacterial co-culture, cells were washed twice with 
Dulbecco’s phosphate buffered saline (DPBS; Hyclone) and starved for 3 hr in αMEM containing 
0.35% bovine serum albumin (BSA; Sigma-Aldrich, St. Louis MO) and 12 mM HEPES (pH 7.4; 
starvation medium). Pa were added at 107 CFU/ml (224) in αMEM containing 5% FBS 
(stimulation medium) (292) and co-cultured with either cell line for 3-4 hr.  
Madin-Darby Canine Kidney NBL-2 (MDCK) cells were obtained from American Type Cell 
Culture Collection (ATCC, Manassas VA) and were cultured in Eagles Minimum Essential 
Medium (EMEM; ATCC) with 10% FBS, 100 U/ml penicillin, and 100 µg/ml streptomycin 
(Hyclone). MDCK cells were seeded at 0.4x105 cells/ml and grown for 48-72 hr. MDCK cells 
were co-cultured with 0.5x107 CFU/ml Pa or no bacteria for the indicated time as previously 
described (224).  
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Drug inhibitor studies. Following the 3 hr starvation, MTC and MTLn3 cells were treated for 30 
min with 25 µM Y-27632 (ROCK inhibitor) (Cayman Chemical Company, Ann Arbor MI) or for 
12-16 hr with 50 µM NSC23766 (Rac1 inhibitor) (EMD Chemicals, Gibbstown, NJ) in starvation 
medium. Cells were co-cultured with Pa strains in the presence of inhibitor as previously 
described. The effects of the drugs on cell function were visualized with an LD A-Plan 20x/0.03 
Ph1 objective on a Zeiss Axiovert 200 microscope (Jena, Germany). Images were exported to 
Adobe Photoshop CS4 Extended (Adobe Systems Inc., San Jose, CA) as TIFF files and 
cropped.  
Analysis of T3S translocation. MTC, MTLn3, and MDCK cells were seeded in 60 mm dishes 
(Corning Inc., Corning NY) and grown for 48 hr to 70-90% confluency. Following a 3.5-5 hr co-
culture, bacteria were removed and cells were washed twice in DPBS (Hyclone) with 200 µg/ml 
ciprofloxacin. Adherent cells were detached with 0.05% trypsin-1 mM EDTA (Hyclone). An 
aliquot of cells was analyzed for total protein (BCA Protein Assay; Pierce, Rockfield IL). In MTC 
and MTLn3 studies, remaining cells were resuspended in DPBS containing ciprofloxacin and 
lysed with Laemmli sample buffer (174). In MDCK cell studies, remaining cells were 
resuspended in digitonin fractionation buffer, and fractionated as previously described (264). 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) served as a loading control for MTC and 
MTLn3 cell lysates. In MDCK studies, total RalA was used as a membrane fraction loading 
control and GAPDH was used as a cytosolic fraction loading control.  
SDS-PAGE and immunoblot detection of the T3S effector ExoS-HA constructs were used to 
monitor T3S translocation. ExoS ADP-ribosylation of RalA served as a functional read-out of 
translocated ExoS enzyme activity (96). Antibodies used in immunoblot studies include: 
monoclonal anti-HA (Covance Research Products, Princeton NJ) to detect ExoS-HA constructs, 
monoclonal anti-RalA (BD Transduction Laboratories; San Jose CA), monoclonal anti-GAPDH 
(Millipore, Temecula CA), and anti-phospho-ERM (pERM, Cell Signaling, Danvers MA). For all 
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studies, translocation of ExoS-HA into whole cell lysates (MTC and MTLn3 studies) or 
membrane fractions (MDCK studies) were quantified by densitometry analysis using ImageJ 
1.40 software (http://rsbweb.nih.gov/ij/). Quantified results are expressed as the mean relative 
densitometry intensity, averaging four to six independent experiments.  
Immunofluorescence analysis of T3S effector translocation and Pa internalization.  
(i) Non-metastatic vs. metastatic studies. MTC and MTLn3 cells were seeded at 2.4x104 
cells/ml in chamber slides (Nalge Nunc International, Rochester NY) 24 and 48 hr, respectively, 
prior to co-culture. Cells were starved for 3 hr as previously described and were co-cultured with 
the indicated Pa strain in stimulation medium for 1 hr 45 min, 2 hr 15 min, or 3 hr. 
(ii) Wounded monolayer studies. MDCK cells were seeded at 1.4x105 cells/ml in chamber 
slides (Nalge Nunc), and cultured for 72 hr, which allowed for formation of a confluent 
monolayer. Cells were washed twice with EMEM with 10% FBS and a linear wound was 
initiated with a beveled pipette tip. Following wounding, cells were washed three times with 
EMEM containing 10% FBS (109). Wounds were allowed to heal for 0-14 hr prior to a 4 hr co-
culture with the indicated Pa strain.   
Following co-culture, all cells were washed twice in DPBS (Hyclone), fixed in 3% 
paraformaldehyde in actin stabilization buffer (ASB) (33, 115), and blocked with 0.8% BSA 
(Sigma-Aldrich), 0.1% fish gelatin, and 10 µg/ml goat IgG. External Pa were detected using 
polyclonal anti-Pa LPS (Joseph Lam, University of Guelph, Ontario), followed by blocking with 
6% BSA in DPBS (Hyclone), and visualized using a Qdot 655 goat anti-rabbit conjugate 
(Invitrogen, Carlsbad CA). Cells were then fixed, permeabilized with 0.2% Triton X-100 in ASB, 
and blocked as above. All Pa were stained with rabbit anti-Pa LPS followed by an Alexa-Fluor 
647 conjugate (Invitrogen). Internal Pa were differentiated based on the absence of Qdot 655 
staining. T3S secreted ExoS constructs were detected using anti-HA (Covance Research 
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Products) coupled with an anti-mouse Alexa-Fluor 488 conjugate (Invitrogen). F-actin was 
stained using tetramethylrhodamine B isothiocyanate conjugated to phalloidin (TRITC-
phalloidin, Sigma-Aldrich). Bacterial localization and internalization were visually enumerated. 
Cells were mounted using Fluormount-G (Southern Biotechnology Associates, Birmingham, AL) 
and were visualized with an EC Plan-Neofluar 40x/1.30 oil objective or a Plan-Apochromat 
63x/1.40 oil objective on a Zeiss Imager.Z1 LSM 510 confocal microscope (Jena, Germany). 
Images were exported to Adobe Photoshop CS4 Extended (Adobe Systems Inc., San Jose, CA) 
as 8 bit TIFF files and cropped.  
Statistical analysis. JMP Version 9 Software (SAS Institute, Cary, NC) was used for statistical 
analyses and significance was determined by a two-sided alpha level set at P<0.05. One way 
ANOVAs were used to evaluate differences among Pa strains between cell lines. Multiple 
comparisons were analyzed with a Tukey’s HSD test for ExoS translocation and Pa 





Relationship between host cell migration properties and sensitivity to Pa-T3S. Initial 
investigations into cell migration differences showed that MTC cells migrated by a mesenchymal 
phenotype and contained migrational polarity, which was indicated by the presence of distinct 
leading and trailing edges (Fig. 21A, left panel). In MTC cells, actin stress fibers were present 
through the length of the cell and terminated at the leading and trailing edges (Fig. 21A, left 
panel, blue arrows). In comparison, MTLn3 cells did not exhibit defined migrational polarity as 
indicated by the broad leading edge and lamellipodium, which allows the cell to migrate in any 
direction (Fig. 21A, right panel). MTLn3 cells contained low levels of actin stress fibers, which 
tended to terminate and form an actin band behind the lamellipodium (Fig. 21A, right panel, blue 
arrows). Most MTLn3 cells did not exhibit a distinct trailing edge. Migrating MDCK cells in a 
wounded monolayer had a different pattern of cell migration than both MTC and MTLn3 cells. 
MDCK cells migrated as a collective unit where some of the outermost cells extended broad 
lamellipodia into the wound (Fig. 21B, left panel, arrowheads). Thick actin bundles were 
observed along the marginal edge of the wound (Fig. 21B, left panel, arrows). Cells closest to 
the wounded edge displayed a more elongated phenotype than cells behind the wounded edge, 
and most migrating cells exhibited high levels of thick actin stress fibers throughout the cell (Fig. 
21B, right panel, arrows). In comparison to MTC cells, MDCK cells exhibited a more extensive 
actin stress fiber network (Figs. 21A and B).  
Once differences in host cell migration properties were characterized, host cell sensitivity to Pa-
T3S was determined for the three cell lines. MTLn3 cells were found to be more sensitive to Pa-
T3S than MTC cells as indicated by greater levels of ExoS translocation into MTLn3 cells at a 3 
hr time-point (Fig. 21C). Interestingly, if the co-culture proceeded to 4 hr, the level of ExoS 
translocation in MTC cells was comparable to MTLn3 cells indicating that MTC cells are more 
resistant to the effects of ExoS early in infection (M. J. Novotny, data not shown). Sub-confluent 
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MDCK cells were also found to be sensitive to Pa-T3S (Fig. 21C). ExoS translocation was 
detected two hours later in the MDCK cells than in the MTLn3 cells, and approximately one hour 
later than in MTC cells. Together these results indicate that between the three cell lines, MTLn3 






Figure 21. Cell line differences in sensitivity to Pa-T3S. A-B) The actin cytoskeleton and 
overall cell migrational polarity differs between MTC, MTLn3, and MDCK cells. A) MTC cells 
migrate via mesenchymal migration patterns with distinct leading and trailing edges. MTLn3 
cells do not exhibit cell migration polarity as indicated by the broad leading edge and lack of a 
defined trailing edge. Blue arrows indicate actin stress fibers for both cell lines. B) Left panel, 
wounded MDCK cells migrated via collective migration. Blue arrowheads indicate cells 
extending broad lamellipodia into the wound. Blue arrows indicate thick marginal actin bundles 
along the wounded edge. Right panel, migrating MDCK cells contained numerous actin stress 
fibers throughout the cell (blue arrows). Cells are stained with TRITC-phalloidin to detect actin 
(white). White arrows indicate the direction of cell polarity. Scale bar is 10 µm. C) MTC and 
MTLn3 cells were treated with strain PA103ΔUT expressing plasmid encoded WT ExoS for 3-
3.5 hr and levels of ExoS translocation into whole cell lysates were evaluated by immunoblot 
analysis. RalA modification served as a functional read-out of translocated ExoS ADPRT 
activity. GAPDH served as a loading control. Sub-confluent MDCK cells were treated with strain 
PA103ΔUT expressing plasmid encoded WT ExoS for 5 hr. Cells were harvested, fractionated, 
and T3S translocation of ExoS into the membrane fraction was analyzed by immunoblot. ADP-
ribosylated RalA served as a functional readout of ExoS ADPRT activity and total RalA served 
as a membrane fraction loading control. Asterisks mark ADP-ribosylated RalA. Results are 














Utilizing ExoS enzymatic mutants to examine differences in Pa-T3S sensitivity. Effects of 
ExoS enzyme activity on host cell properties are known to influence Pa-T3S responsiveness 
(Chapter 3) (4, 45, 95). Therefore, we used ExoS with mutations known to abolish its GAP 
(R146A) or ADPRT (E379A/E381A) activities as tools to help differentiate host cell properties 
involved in T3S translocation in the three different cell lines. When MTC cells were treated with 
the ExoS ADPRT- mutant, an increase in ExoS translocation was observed compared to 
translocation by Pa expressing WT ExoS and was further increased with an ExoS GAP- mutant 
(Fig. 22A). In contrast, an increase in ExoS translocation in MTLn3 cells was only observed 
when treated with the ExoS GAP- mutant.  
When sub-confluent MDCK cells were treated with Pa expressing either the ExoS GAP- mutant 
or the ExoS ADPRT- mutant, we observed increases in ExoS translocation into the membrane 
fraction when compared to translocation by Pa expressing WT ExoS; however, these increases 
did not reach statistical significance (Fig. 22B). In comparison, when MDCK cells were treated 
with an ExoS GAP-/ADPRT- (R146A/E379A/E381A) mutant, a significant increase (P<0.0001) 
in translocation was observed as compared to WT ExoS, the ExoS GAP- mutant, and the ExoS 
ADPRT- mutant. Together these results indicate that differences in MTC and MTLn3 Pa-T3S 
sensitivity relates to a target of ExoS GAP activity. While this same pattern was not observed 
with MDCK cells, an increase in translocation associated with mutation of both ExoS GAP and 











Figure 22. Using ExoS GAP and ADPRT mutants to dissect cell line differences. A) MTC 
and MTLn3 cells were treated with PA103ΔUT expressing plasmid encoded ExoS or ExoS with 
mutations in GAP (R146A) or ADPRT (E379A/E381A) activities for 3.5 hr and whole cell lysates 
were analyzed by immunoblot. GAPDH served as a membrane fraction loading control. ADP-
ribosylated RalA is indicated by asterisks. B) MDCK cells were treated for 5 hr with PA103ΔUT 
expressing plasmid encoded ExoS or ExoS with mutations abolishing GAP (R146A), ADPRT 
(E379A/E381A), or GAP/ADPRT (R146A/E379A/E381A) activities. Cells were harvested, 
fractionated, and T3S translocation of ExoS into MDCK membrane fractions was analyzed by 
immunoblot. ADP-ribosylated RalA is indicated by asterisks. Total RalA served as a membrane 
fraction loading control. Results are representative of three to four independent experiments.  
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Characterizing differences in the effects of ExoS GAP activity in MTC and MTLn3 cells. In 
order to understand how Rho-GTPases influenced ExoS translocation in MTC and MTLn3 cell 
lines, cells were treated with Pa expressing WT ExoS, an ExoS GAP- mutant, or an ExoS 
ADPRT- mutant and infection was monitored by immunofluorescence and confocal (IF) 
microscopy. When MTC cells were treated with Pa expressing WT ExoS, the bacteria remained 
primarily extracellular and low levels of ExoS translocation was detected (Fig. 23A). As MTC 
cells rounded due to ExoS translocation, a branched actin phenotype was observed. In 
comparison, Pa expressing WT ExoS were internalized by MTLn3 cells (Fig. 23A, yellow 
arrows). We also observed an increase in ExoS translocation in MTLn3 cells by IF microscopy 
studies when compared to MTC cells (Fig. 23A). When both MTC and MTLn3 cells were treated 
with Pa expressing the ExoS GAP- mutant, an increase in internalized Pa was observed as 
compared to cells treated with Pa expressing WT ExoS (Fig. 23B, yellow arrows). The 
increased Pa internalization was associated with an increase in ExoS GAP- mutant 
translocation. Finally, in both cell lines, the number of internalized Pa expressing an ExoS 
ADPRT- mutant was not different from Pa expressing WT ExoS (Fig. 23C, yellow arrows). 
There was an observed increase in ExoS translocation in MTC cells treated with the ExoS 
ADPRT- mutant as compared to WT ExoS (Fig. 23C). However, there was no detectable 
difference in the level of ExoS translocation into MTLn3 cells by Pa expressing the ExoS 
ADPRT- mutant when compared to Pa expressing WT ExoS (Fig. 23C). A branched actin 
phenotype in the MTC cells was again observed when they were treated with the ExoS ADPRT- 
mutant, which was not observed in the MTLn3 cells treated with the same strain (Fig. 23C). 
The percent of Pa internalized per cell line from IF microscopy studies was quantified for all Pa 
strains. When MTC cells were treated with Pa expressing WT ExoS, 3% of Pa were internalized 
(Fig. 23D, gray bars). A significant increase (P<0.001) in Pa internalization (29.4%) was 
observed when MTC cells were treated with an ExoS GAP- mutant. MTC cells internalized 5.2% 
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of Pa expressing an ExoS ADPRT- mutant, which was not significantly different from 
internalization of Pa expressing WT ExoS (Fig. 23D, gray bars). In comparison, MTLn3 cells 
treated with Pa expressing WT ExoS internalized 15.5% of bacteria (Fig. 23D, blue bars). Pa 
internalization (42%) was significantly increased (P<0.005) when MTLn3 cells were treated with 
an ExoS GAP- mutant (Fig. 23D, blue bars). As was observed in MTC cells, there was no 
difference in MTLn3 internalization (15.3%) of Pa expressing an ExoS ADPRT- mutant when 
compared to Pa expressing WT ExoS (Fig. 23D, blue bars). Internalization of Pa expressing WT 
ExoS by MTLn3 cells was significantly increased (P<0.02) compared with MTC cells.  
To determine if Pa internalization by MTLn3 cells was contributing to the increase in ExoS 
translocation, we quantified ExoS translocation from immunoblot studies by densitometry (Fig. 
23E). In MTC cells, a low level of ExoS translocation was observed when cells were treated with 
Pa expressing WT ExoS or an ExoS ADPRT- mutant. ExoS translocation in MTC cells was 
significantly increased (P<0.0001) when cells were treated with Pa expressing an ExoS GAP- 
mutant (Fig. 23E, gray bars). When MTLn3 cells were treated with Pa expressing an ExoS 
GAP- mutant, a significant increase in ExoS translocation was observed when compared to 
cells treated with Pa expressing WT ExoS or an ExoS ADPRT- mutant (Fig. 23E, blue bars). 
Translocation of WT ExoS or the ExoS ADPRT- mutant was significantly increased (P<0.001) in 
MTLn3 cells as compared to translocation into MTC cells (Fig. 23E). Together, these results 
show that the increase in ExoS translocation in MTLn3 cells by Pa can be attributed to Pa 






Figure 23. Increased MTLn3 sensitivity is attributed to internalized Pa. MTC and MTLn3 
cells were treated with PA103ΔUT expressing plasmid encoded A) WT ExoS, or ExoS with 
mutations that abolished B) GAP (R146A), or C) ADPRT (E379A/E381A) activities for 3 hr. 
Cells were fixed and stained for external Pa (yellow + pink), internal Pa (pink, yellow arrows), 
ExoS (green), and actin (white). Scale bars represent 10 µm. White arrows indicate direction of 
cellular polarity. D) Internal Pa were quantified and are represented as the percent of internal Pa 
relative to total Pa. The asterisks indicate: internalization of Pa is significantly increased by 
*MTC cells (P<0.001) and **MTLn3 (P<0.005) expressing the ExoS GAP- mutant compared to 
WT ExoS and the ExoS ADPRT- mutant strains. ***Internalization of Pa expressing WT ExoS 
was significantly increased (P<0.02) in MTLn3 cells as compared to MTC cells. E) Quantification 
of ExoS translocation by PA103ΔUT expressing plasmid encoded ExoS or ExoS with mutations 
abolishing GAP (R146A) or ADPRT (E379A/E381A) activities. Increases in ExoS translocation 
paralleled increases in Pa internalization (refer to D). Asterisks indicate: ExoS translocation by 
the GAP- mutant was significantly increased in *MTC cells (P<0.0001) and **MTLn3 cells 
(P<0.01) compared to Pa translocation of WT ExoS or the ExoS ADPRT- mutant; Translocation 
of ExoS by Pa expressing ***WT ExoS (P<0.0001) or ****the ExoS ADPRT- mutant (P<0.001) 
into MTLn3 cells was significantly increased compared to MTC cells. Results are representative 


















When MTC cells treated with an ExoS GAP active strain (WT ExoS or the ExoS ADPRT- 
mutant) were examined by IF microscopy, a branched actin phenotype was observed as the 
cells rounded (Figs. 23A and C). To investigate the role of Rho-GTPases and ExoS GAP activity 
in this phenomenon, MTC and MTLn3 cells were examined at two time-points by IF microscopy. 
After 1 hr 45 min of co-culture, MTC cells treated with Pa expressing WT ExoS or an ExoS 
ADPRT- mutant displayed a branched actin phenotype that became more pronounced at 2 hr 
15 min (Figs. 24A and C). In MTC cells treated with Pa expressing an ExoS GAP- mutant, there 
were no major cell morphological changes at either time-point as both the lamellipodium and 
actin stress fibers remained intact (Fig. 24B).  
In comparison, at 1 hr 45 min, Pa expressing WT ExoS or the ExoS ADPRT- mutant treated 
MTLn3 cells exhibited a loss of the broad lamellipodium and the band of actin stress fibers that 
forms behind the lamellipodium (Figs. 24D and F). As MTLn3 cells rounded, short, branched 
actin projections were observed. While this phenotype was more pronounced at 2 hr 15 min, it 
was not as extensive as the branching observed in MTC cells at the 1 hr 45 min time-point. After 
examination at both time-points, the lamellipodium of MTLn3 cells treated with an ExoS GAP 
mutant was observed to be contracting. Interestingly, the band of actin stress fibers behind the 
lamellipodium remained intact and the few actin stress fibers, which previously terminated at the 
actin band, now projected out past the edge of the lamellipodium. These longer actin spikes 
became more pronounced at 2 hr 15 min (Fig. 24E).  
To summarize the studies thus far, these results suggest that ExoS GAP activity is targeting 
Rac1 in MTC cells. Disruption of Rho mediated stress fibers in MTC cells by ExoS GAP activity 
is consistent with contraction of the lamellipodium if Rac1 is disrupted. In addition, activated 
Rac1 in the lamellipodia of MTC cells appears to be more sensitive to ExoS GAP activity at 
early time-points and may function to limit ExoS translocation. MTLn3 cells appear to be more 
resistant to ExoS GAP activity increased Rho at the leading edge. The limited morphological 
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changes in MTLn3 cells when treated with an ExoS GAP active strain may be due to targeting 
of Rho at the leading edge. To test this hypothesis, the interplay between Rho and Rac1 at the 























Figure 24. ExoS GAP activity alters Rho-GTPase mediated cell morphology differently in 
MTC and MTLn3 cells. MTC and MTLn3 cells were treated with Pa expressing: A/D) WT ExoS, 
B/E) an ExoS GAP- mutant (R146A), or C/F) an ExoS ADPRT- mutant (E379A/E381A) for 1 hr 
45 min or 2 hr 15 min. Cells were fixed and stained for external Pa (yellow + pink), internal Pa 
(pink), ExoS (green), and actin (white). Scale bar is 10 µM. Results are representative of one to 
two independent experiments for each time-point.     
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Interplay between Rho and Rac1 in MTC and MTLn3 cells. Previous studies have shown that 
that the balance between Rho and Rac1 at the leading edge of MTLn3 cells could be shifted by 
inhibiting Rho/ROCK with the ROCK inhibitor Y-27632 (72). Results from these studies 
indicated that the high level of activated Rho at the leading edge of MTLn3 cells suppressed 
Rac1 function. As a consequence, inhibition of ROCK resulted in an increase in Rac1 at the 
leading edge (72). We hypothesized that the balance between Rho and Rac1 at the leading 
edge influenced cell sensitivity to Pa-T3S in that if MTC cells were sensitive to ExoS GAP 
activity due to increased Rac1 at the leading edge, then increasing the level of activated Rac1 in 
the MTLn3 cells with the ROCK inhibitor would reduce Pa-T3S sensitivity to the level found in 
MTC cells. In turn, if Rac1 was inhibited in the MTC cells, then MTC cell sensitivity to Pa-T3S 
would resemble the level of sensitivity observed in the MTLn3 cells. Rac1 inhibition in MTLn3 
cells and Rho inhibition in MTC cells was proposed not to have an effect on T3S sensitivity due 
to the already decreased levels of activated Rac1 and Rho in those cells lines, respectively.  
Figure 25 shows phase contrast images of both MTC and MTLn3 cells post-inhibitor treatment. 
Untreated MTC cells displayed a very limited leading edge (panel A, black arrows). Following 
starvation conditions, MTC lamellipodial protrusions disappeared (panel B, white arrows). MTC 
cells treated with either the ROCK inhibitor (panel C) or the Rac1 inhibitor (panel D) exhibited a 
rounded phenotype. Upon stimulation with 5% FBS, lamellipodial protrusion was restored 
regardless of inhibitor treatment (not shown). The lamellipodial protrusions in untreated MTLn3 
cells are not detectable by phase contrast microscopy due to their flat, thin structure (panel E). 
Post-starvation, no major MTLn3 morphological changes were observed (panel F). Interestingly, 
upon MTLn3 cell treatment with the ROCK inhibitor Y-27632, the lamellipodial protrusions 
resembled that of untreated MTC cells (compare panel G black arrowheads with black arrows in 
panel A). Again, no major morphological changes were observed in MTLn3 cells treated with the 
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Rac1 inhibitor (panel H). FBS stimulation resulted in a restoration of lamellipodial protrusion in 
some MTLn3 cells regardless of inhibitor treatment (not shown).  
Next, we sought to determine the role of the inhibitors in altering Pa-T3S sensitivity. To evaluate 
the role of the GAP activity on host cell sensitivity to Pa-T3S, MTC and MTLn3 cells were first 
treated 25 µM Y-27632 to inhibit ROCK followed by co-culture with Pa expressing WT ExoS, the 
ExoS GAP- mutant, or the ExoS ADPRT- mutant. Following Y-27632 treatment, there was no 
significant effect on Pa-T3S sensitivity in MTC cells with any of the Pa strains tested (Fig. 26A). 
However, following treatment of MTLn3 cells with Y-27632, there was a significant decrease in 
ExoS translocation by Pa expressing WT ExoS (P<0.003) or the ExoS ADPRT- mutant 
(P<0.001) to levels of translocation observed in the MTC cell line (Fig. 26; compare light gray 
bars from part B with part A). There was no significant change in ExoS translocation levels in 
MTLn3 cells treated with the ROCK inhibitor and the ExoS GAP- mutant (Fig. 26B). To evaluate 
the role of Rac1 in Pa-T3S sensitivity, MTC and MTLn3 cells were treated with NSC23766. 
Treatment of MTC cells resulted in an increase in ExoS translocation by all strains tested; 
however, the increase failed to reach significance (Fig. 27A). There was no effect on ExoS 
translocation when MTLn3 cells were treated with the Rac1 inhibitor in association with any of 
the Pa ExoS strains (Fig. 27B). 
In summary, these results support the hypothesis that differential sensitivity to Pa-T3S by MTC 
and MTLn3 cells lines relates to the interplay between Rho-GTPases at the leading edge of 
migrating cells. Resistance of MTLn3 cells to ExoS GAP activity is proposed to be due to 
increased levels of activated Rho at the leading edge, which facilitates bacterial internalization 
and continued effector translocation within the cells. On the other hand, activated Rac1 at the 
leading edge in MTC cells appears to be sensitive to ExoS GAP activity; therefore the bacteria 
remain extracellular and translocate limited amounts of effector into the cell, which in turn 
serves to regulate ExoS translocation. In both cell lines, the role of ExoS ADPRT activity 
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appears to be minor compared to ExoS GAP activity, as no substantial increase in translocation 
or internalization was observed upon mutation of both ADPRT catalytic residues when 




















Figure 25. Cellular effects of Rho-GTPase inhibitor treatment on MTC and MTLn3 cells. A) 
Untreated MTC cells maintained a limited leading edge (black arrows). B) Following a 3 hr 
starvation, MTC cells lost their leading edge protrusions (white arrows). MTC cells treated with 
C) 25 µM Y-27632 to inhibit ROCK or D) 50 µM NSC23766 to inhibit Rac1 exhibited a rounded 
phenotype. E) Untreated MTLn3 lamellipodial protrusions were difficult to visualize by phase 
contrast microscopy. F) Starved MTLn3 cells did not exhibit significant changes in cell 
morphology. G) Treatment of MTLn3 cells with 25 µM Y-27632 resulted in lamellipodial 
protrusions (arrowheads) that resembled untreated MTC lamellipodial protrusions (refer to A, 
black arrows). H) 50 µM NSC23766 inhibitor treatment of MTLn3 cells resulted in a mixed 
cellular phenotype with some cells containing normal lamellipodial protrusions, while some had 
decreased protrusions. Images were taken at 20X magnification. Results are representative of 









Figure 26.  Inhibition of ROCK in MTLn3 cells decreased Pa-T3S sensitivity. A) MTC and 
B) MTLn3 cells were starved for 3 hr prior to the addition of 25 µM Y-27632 for 30 min. Both cell 
lines treated with or without inhibitor were co-cultured with Pa expressing WT ExoS, an ExoS 
GAP- (R146A) mutant, or an ExoS ADPRT- (E379A/E381A) mutant for 3.5 hr. Left panel, cells 
were harvested and whole cell lysates were evaluated by immunoblot for ExoS translocation 
and ADP-ribosylation of RalA. GAPDH served as a protein loading control. Right panel, ExoS 
translocation into both cell lines was quantified by densitometry and is reported as the mean 
relative intensity. ExoS translocation into MTLn3 cells was significantly decreased in cells 
treated with Y-27632 by Pa expressing WT ExoS (P<0.003) or the ExoS ADPRT- mutant 









Figure 27. Inhibition of Rac1 in MTC cells increased Pa-T3S sensitivity. A) MTC and B) 
MTLn3 cells were starved and treated with 50 µM NSC23766 for 12-16 hr. Both cell lines 
treated with or without inhibitor were co-cultured with Pa expressing WT ExoS, an ExoS GAP- 
(R146A) mutant, or an ExoS ADPRT- (E379A/E381A) mutant for 3.5 hr. Cells were harvested 
and evaluated as described for Figure 26. ExoS translocation into MTC cells was increased with 
inhibition of Rac1 by all strains; however, increased translocation did not reach statistical 
significance. Results are representative of four independent experiments.    
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Characterizing MDCK cell migration in Pa-T3S. In addition to MDCK monolayers being used 
in numerous studies to understand wound healing, they have also been widely used as a model 
system to study Pa infection and internalization by polarized epithelial layers (16, 38, 87, 113, 
131, 155, 156, 158, 159, 185). Current studies support the model that Pa can be internalized 
into incompletely polarized MDCK monolayers in a Rho, PI3K, Akt, and Lyn dependent manner 
(155, 156, 158, 159, 185). Pa internalization can also occur in a Rho independent manner upon 
disruption of epithelial tight junctions (156). While it is known that wounded epithelial 
monolayers and disruption of epithelial cell polarity are predisposing factors for susceptibility to 
Pa infection, it remains unknown how Pa-T3S is involved in this process (62, 235, 242, 245, 
251).     
To understand how cell migration during wound healing is involved in susceptibility to Pa-T3S 
infection, three day confluent monolayers were wounded and allowed to heal for 0-14 hr prior to 
co-culture with Pa. Due to low levels of ExoS translocation by Pa expressing WT ExoS (Figs. 
21B and 22B), monolayers were treated for 4 hr with Pa expressing an ExoS GAP-/ADPRT- 
strain (Fig. 22B) to allow detection of ExoS by IF microscopy. In non-wounded monolayers, 
minimal Pa binding was observed and as a result, there was no detection of ExoS translocation 
(Fig. 28A). When Pa was added to cells immediately following wounding (Fig. 28B), low levels 
of Pa were found to adhere to and be internalized into cells migrating to close the wound. 
However, there were low to no detectable levels of translocated ExoS along the entire length of 
the wound (Fig. 28B, ExoS panel). Internalized Pa were found to align with actin stress fibers in 
migrating MDCK cells (Figs. 28B, enlarged image, and 29, all time-points). When wounded 
monolayers were allowed to heal for 2 hr prior to the addition of bacteria, both the number of Pa 
binding to and being internalized along the wound increased (Fig. 28C). ExoS translocation was 
now detectable in a few locations along the length of the wound. Pa binding, internalization, and 
ExoS translocation into migrating cells along the wound was most efficient when the bacteria 
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were added 4 or 6 hr post-wounding (Figs. 28D and E, respectively). At both of these time-
points, large amounts of bacteria were found associating with the cells. Sites of ExoS induction 
along the length of the wound were also greater at these time-points. The level of ExoS 
translocation varied in that some cells were observed to have low levels of ExoS, while others 
had increased levels of ExoS staining. (Figs. 28D and E; ExoS panels). Interestingly, when Pa 
were added 12 hr post-wounding, a large amount of Pa were able to adhere to and be 
internalized by migrating MDCK cells, but ExoS translocation was decreased compared to the 4 
and 6 hr time-points (Fig. 28F). By 14 hr post-wounding, Pa binding, internalization, and ExoS 
translocation into MDCK cells was reduced (Fig. 28G).  
In addition to Pa aligning with actin (Fig. 29, yellow arrows), ExoS was also found to align along 
actin filaments in migrating MDCK cells (Fig. 29; blue arrows). Consistent findings in this study 
were: (1) the ability of Pa to align along actin filaments regardless of wound healing time; (2) Pa 
targeting and translocating ExoS into cells along the healing wound; and (3) resistance of the 
remaining confluent monolayer to Pa binding, Pa internalization, and ExoS translocation. The 
conclusions from these studies were that MDCK cells were susceptible to Pa internalization 




Figure 28. Length of MDCK wound healing time influenced Pa-T3S sensitivity. Confluent 
MDCK monolayers were A) unwounded or B-G) wounded and allowed to heal for increasing 
time (0-14 hr) prior to addition of Pa expressing an ExoS GAP-/ADPRT- (R146A/E379A/E381A) 
mutant for 4 hr. Cells were stained for extracellular Pa (yellow + pink in merged image), total Pa 
(pink), ExoS (green), and actin (white). White arrows indicate position of wound. Results are 







Figure 29. Pa and ExoS align along actin in migrating MDCK cells. Confluent MDCK 
monolayers were wounded and allowed to heal for 0-14 hr prior to the addition of Pa expressing 
an ExoS GAP-/ADPRT- mutant for 4 hr. Following co-culture, cells were fixed, blocked, 
permeabilized, and stained for Pa (pink), ExoS (green), and actin (white). Bottom panel of each 
time-point is an enlarged cell from the image above. Yellow arrows indicate Pa aligning with 
actin. Blue arrows indicate ExoS tracking actin. White arrows indicate direction of wound 








ExoS GAP and ADPRT activities disrupt MDCK wound healing. To determine the effects of 
ExoS enzyme activity on MDCK wound susceptibility to infection, confluent monolayers were 
wounded and allowed to heal for 4 hr prior to treatment with Pa expressing WT ExoS, an ExoS 
GAP- mutant, an ExoS ADPRT- mutant, or an ExoS GAP-/ADPRT- mutant. The 4 hr wound 
healing time was selected as this was a time-point identified of increased susceptibility to Pa-
T3S (Fig. 28D). When migrating MDCK cells were examined by IF microscopy, there were no 
substantial differences in ExoS translocation by Pa expressing WT ExoS, the ExoS GAP- 
mutant, or the ExoS ADPRT- mutant (Figs. 30A-C). ExoS translocation into wounded cells was 
only detected with Pa expressing an ExoS GAP-/ADPRT- mutant (Fig. 30D).  
Despite ExoS being undetectable in the cell cytosol by IF microscopy with Pa expressing WT 
ExoS, an ExoS GAP- mutant, or an ExoS ADPRT- mutant, ExoS translocation into these cells 
was evident due to observable changes in cell morphology. Pa expressing WT ExoS were found 
to bind to the leading edge of cells that were migrating to close the wound (Fig. 30A, yellow 
arrows). The cytotoxic effects of ExoS were detected in these cells by the punctuate nature of 
the actin cytoskeleton and the loss of actin stress fiber formation (Fig. 30A, top panel). 
Additionally, the actin cytoskeleton in the lamellipodia of some cells appeared to be contracting 
which resulted in the formation of long spiked actin structures (Figs. 30A, bottom panel; and 
30E, blue arrows). When migrating MDCK cells were treated with Pa expressing an ExoS GAP- 
mutant, lamellipodial contraction was also observed (Fig. 30B). Treatment with an ExoS GAP- 
mutant resulted in the formation of much shorter actin spiked structures as the lamellipodia 
contracted (Figs. 30B and F, blue arrowheads).  
Following treatment with Pa expressing an ExoS ADPRT- mutant, the lamellipodia where Pa 
localized did not contract, however, actin stress fibers within the lamellipodia disappeared (Figs. 
30C and G). The actin which remained in the lamellipodia of cells treated with an ExoS ADPRT- 
mutant resembled adhesions to the ECM (Figs. 30C, top panel, and 30G). It is possible that this 
 
 187
pattern of actin distribution is due to staining remnants of actin stress fibers which are still 
attached to focal adhesion complexes after the bulk of stress fibers were broken down by ExoS 
GAP activity. This phenomenon is best shown in the bottom panel of Figure 30C, where cells 
further back from the wounded edge (to the right of the blue line) exhibit actin stress fiber 
formation but those cells where Pa are localized (to the left of the blue line) have lost most of 
their stress fibers. Finally, when migrating MDCK cells were treated with Pa expressing an ExoS 
GAP-/ADPRT- mutant, actin stress fibers were found in the lamellipodia, and there was no 
observed contraction of the lamellipodia (Fig. 30D and H). 
To determine the mechanism behind the spiked actin structures when MDCK cells were treated 
with Pa expressing ADPRT active ExoS (WT ExoS or the ExoS GAP- mutant), levels of 
phosphorylated ERMs was evaluated. ERMs function to link actin to the plasma membrane at 
the leading edge (32, 309) and are known substrates of ExoS ADPRT activity (195, 196, 297). 
Because ExoS ADPRT activity has been shown to target ERM phosphorylation in T24 cells 
resulting in a wavy actin phenotype (Chapter 3), we wanted to determine if inhibition of ERM 
phosphorylation could contribute to the actin branching observed in MDCK cells. Through 
immunoblot analysis, we found that phosphorylation of ERMs was almost completely abrogated 
when sub-confluent MDCK cells were treated with ExoS ADPRT activity (WT ExoS or ExoS 
GAP- mutant; Fig. 30I). 
To summarize, these results indicate that ExoS GAP activity is responsible for loss of actin 
stress fiber formation in migrating MDCK lamellipodia, while ExoS ADPRT activity disrupts 
actin/plasma membrane linkages presumably through disruption of ERM phosphorylation. The 
increased resistance of MDCK cells to ExoS GAP activity is thought to be due to increased 
levels of Rho at the leading edge, which allows for increased Pa internalization. Therefore, in 
migrating MDCK cells, the combination of both ExoS GAP and ADPRT activities is required for 
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contraction of the lamellipodia and loss of stress fiber formation, which prevents cell motility and 
wound healing.   
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Figure 30. ExoS GAP and ADPRT enzyme activities induce independent effects on the 
MDCK actin cytoskeletal structure during wound healing. Confluent MDCK monolayers 
were wounded and allowed to heal for 4 hr prior to the addition of Pa expressing A) WT ExoS, 
B) an ExoS GAP- mutant (R146A), C) an ExoS ADPRT- mutant (E379A/E381A), or D) an ExoS 
GAP-/ADPRT- mutant (R146A/E379A/E381A) for 4 hr. Cells were fixed and stained for Pa 
(pink), ExoS (green), and actin (white). Yellow arrows indicate Pa binding to the leading edge. 
Blue arrows indicate contraction of the leading edge resulting in long actin filaments (A). Blue 
arrowheads indicate contraction of the leading edge resulting in short actin microspikes (B). 
Cells to the left of the blue line show loss of actin stress fibers (C). E-H) Enlargement of panels 
from A-D showing differences in lamellipodial protrusions. I) Sub-confluent MDCK cells were co-
cultured with Pa expressing WT ExoS, an ExoS GAP- mutant (R146A), an ExoS ADPRT- 
mutant (E379A/E381A), or an ExoS GAP-/ADPRT- mutant (R146A/E379A/E381A) for 5 hrs. 
Cells were fractionated and membrane fractions were assayed by immunoblot to detect 
phosphorylated ERM (pERM, ezrin-Thr567, radixin-Thr564, and moesin-Thr558). Densitometry 
analysis showed a decrease in pERM following co-culture with Pa expressing WT ExoS or the 








Eukaryotic cell migration is complex process that is regulated by Rho-GTPases (221). In the 
classical model of migration, Rac1 and Cdc42 regulate leading edge lamellipodial and filopodial 
protrusions, along with formation of highly dynamic focal complexes (221, 222, 277). Rho, in 
concert with ROCK, is responsible for retraction of the rear of the cell body through actomyosin 
contractions, phosphorylation of myosin light chain, and formation and maintenance of focal 
adhesions (12, 160, 221, 222). As the cell body moves forward, actin polymerization and 
contraction must be balanced (reviewed in (225)).  Over the last few years it has been 
discovered that not all cells migrate via this classical pathway. Specifically, Sahai and Marshall 
(273) showed that protrusions on cells which utilize amoeboid migration are mediated by Rho 
and ROCK, whereas protrusions on cells which utilize mesenchymal migration require Rac1 and 
Cdc42. Migrating HT1080 cells, like MTLn3 cells, exhibit activated Cdc42 at the leading edge 
while Rac1 is located behind the leading edge (150). The reciprocal relationship between Rac1 
and Rho dictates which cell migration mechanism dominates (273, 276). Importantly, Rho-
mediated amoeboid cell morphology and metastatic potential have been linked to cancer cell 
metastasis (273).   
The goal of our studies was to understand the relationship between cell migration patterns and 
the initiation of Pa-T3S infections. We chose three different models of host cell migration 
patterns for these studies: (1) non-metastatic MTC cells which migrate mesenchymally (217), 
(2) metastatic MTLn3 cells which migrate by blebbing (217, 225), and (3) MDCK cells which can 
migrate either mesenchymally or collectively (246). Rho-GTPase regulation of the leading edge 
is also different for each cell type. Specifically, Rac1 is activated at the leading edge in MTC 
cells, Rho and Cdc42 are activated at the leading edge in MTLn3 cells (71, 72), and Rho and 
Rac1 are activated at the leading edge in non-polarized MDCK cells (156, 173).  
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In studies utilizing the MTC/MTLn3 cell model system we identified the role of Rho in increased 
MTLn3 susceptibility to Pa-T3S. ExoS translocation into MTC cells was limited compared to 
MTLn3 cells, but increased when cells were treated with Pa expressing ExoS with mutations 
abolishing GAP activity. Through IF microscopy studies, we identified that increased ExoS 
translocation into MTLn3 cells was attributed to increased internalization of Pa by this cell line, 
and once Pa were internalized could continue ExoS translocation. Rodent cell lines have been 
shown to be more sensitive to ExoS GAP activity (264, 270) and that ExoS GAP activity towards 
Rac1 results in a loss of lamellipodium, while down-regulation of Rho results in the production of 
actin stress fibers (116, 136, 167, 233). Also through IF studies, we observed differences in cell 
morphology due to ExoS GAP activity. When MTC cells were treated with a GAP active strain 
(WT ExoS or the ExoS ADPRT- mutant) we observed contraction of the lamellipodium into a 
highly branched actin network, and a decrease in stress fiber formation, consistent with ExoS 
GAP targeting Rac1 at the leading edge. In comparison, when MTLn3 cells were treated with an 
ExoS GAP active strain, limited branched actin morphology was observed at the early time-point 
that did not become as extensive at the later time-point as was observed in MTC cells. A loss in 
stress fiber formation was also noted in MTLn3 cells when treated with active ExoS GAP. Our 
results in MTLn3 cells are consistent with reports that increased Rho in MTLn3 cells suppresses 
Rac1 at the leading edge and therefore the target of ExoS GAP activity is not accessible, 
resulting in less drastic cell morphology (72). Based on these observations, we hypothesize that 
the balance between Rho-GTPase regulation of leading edge dynamics was causing this effect 
and as a result, MTLn3 cells were resistant to ExoS GAP activity. Furthermore, ExoS ADPRT 
activity was thought to disrupt phosphorylation of ERMs in MTLn3 cells, which resulted in actin 
stress fibers protruding past the lamellipodium as the membrane contracted; however, this did 
not appear to influence host cell susceptibility to Pa-T3S.  
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The ROCK inhibitor Y-27632 has been previously used to switch MTLn3 lamellipodial protrusion 
from a Cdc42-dependent process to a Rac1-dependent process by down-regulating Rho (72). If 
Rho or Rac1-mediated cell migration patterns influenced T3S, we thought that inhibition of Rho 
pathways in MTLn3 cells using the ROCK inhibitor would decrease MTLn3 sensitivity to Pa-T3S 
comparable to that of MTC cells. In support of this hypothesis, we found that by using the ROCK 
inhibitor in MTLn3 cells, sensitivity of the cells to ExoS GAP activity was decreased. We believe 
that ROCK treatment of MTLn3 cells prevented Pa internalization and continued ExoS 
translocation, which can be confirmed with additional studies. By down-regulating Rac1 in MTC 
cells we anticipated the observation of a translocation pattern similar to MTLn3 cells. When 
MTC cells were treated with the Rac1 inhibitor NSC23766, an increase in effector translocation 
was observed, however the increase was not significant compared to untreated cells.  
Together, these results suggest that limited ExoS translocation in MTC cells is due to ExoS 
targeting Rac1 at the leading edge, resulting in membrane contraction and regulation of Pa-T3S 
by preventing further ExoS translocation into the cell. Due to decreased levels of Rac1 in 
MTLn3 cells, the lamellipodia and actin stress fibers remain intact when treated with active 
ExoS GAP activity. This allows Pa to be internalized and continue ExoS translocation. Through 
these studies, we were able to determine the mechanism behind host cell sensitivity to Pa-T3S 
by using a clonal cell model system where differences between the cell lines have been 
characterized. Additionally, these studies provided the first line of evidence that Rho localization 
to the leading edge of migrating cells and host cell migration properties influence sensitivity or 
resistance to the enzymatic effects of ExoS GAP activity.    
MDCK monolayers have been used as a model system to study wound healing and epithelial 
cell polarization processes in relation to the Pa infection process (16, 38, 87, 113, 131, 155, 
156, 158, 159, 185). As MDCK monolayers polarize, transepithelial resistance increases and 
apical and basolateral membranes are segregated by the formation of tight junctions (17). 
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MDCK cells have the ability to form a partially polarized monolayer within one day of seeding, 
which is completely polarized by three to five days post-seeding (17, 156). Polarization of 
monolayers can be disrupted either by wounding (138) or by disruption of tight junctions with 
EGTA (87). In polarized MDCK monolayers, Pa is internalized in an actin, Rho, PI3K, Akt, and 
Lyn dependent manner (77, 155, 156, 158, 159, 185). In comparison, Pa internalization occurs 
in a Rho independent manner upon disruption of epithelial tight junctions (87, 156). Previous 
studies suggested that disruption of apical-basolateral polarity, either by disruption of tight 
junctions or wounding, resulted in exposure of receptors on the basolateral membrane where 
Pa bound and was internalized (38). As cells polarize, Rho-dependent uptake of Pa becomes 
down-regulated as total activated Rho decreases (155, 156). Once a monolayer becomes 
polarized, aggregates of Pa can bind to the apical membrane and facilitate internalization by 
activating Lyn tyrosine kinase that, in turn, up-regulates PI3K and Akt, recruiting PIP3 and actin 
to the apical membrane (158, 159, 185). Through this mechanism, Pa essentially converts the 
polarized apical membrane into a basolateral membrane thus facilitating internalization.  
Wounded epithelial layers and disruption of epithelial cell polarity are known to be predisposing 
factors for susceptibility to Pa infection, but how Pa-T3S was involved in this process remained 
unknown (62, 87, 155, 156, 235, 242, 245, 251). Of the limited studies investigating the role of 
Pa effectors with MDCK monolayers, Pa expressing ExoU was found to induce rapid host cell 
death and damage when added to polarized apical membranes and extended the area of 
infection to surrounding cells (16, 87). Pa effectors ExoT and ExoS were both able to disrupt Pa 
internalization by MDCK, HeLa, and corneal epithelial cells through their Rho-GAP activity (52, 
108).  
To understand the role of Pa-T3S in wound healing, confluent MDCK monolayers were 
wounded, allowed to heal for various times, and treated with a Pa strain expressing GAP-
/ADPRT- ExoS to optimize detection of ExoS translocation. Pa were efficiently internalized into 
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MDCK cells somewhat independent of wound healing time, but ExoS translocation was greatest 
when Pa were added 4-6 hr post-wounding. A possible explanation for the 4-6 hr time-frame of 
ExoS translocation is the requirement for actin accumulation at the edge of the wound. We have 
previously proposed that actin polymerization at the leading edge facilitates initial ExoS 
translocation into host cells and in strains where ExoS enzyme activity was mutated, actin 
mediated Pa internalization (Chapter 3). Additionally, we have shown that Pa expressing WT 
ExoS preferentially binds to the leading edge of cells where actin polymerization is the greatest 
((33), Chapter 3). Elegant studies by Fenteany et al. have shown that at six hours post MDCK 
monolayer wounding and microinjection of dextran, detergent-resistant actin is incorporated at 
high concentrations into several rows of cells behind the wounded edge (83). This high level of 
actin incorporation behind the wound coincides with multiple rows of cells behind the wounded 
edge extending lamellipodia, frequently under more forward cells, to drive cell migration and 
wound healing (79). Thick actin bundles then form in a Rho-dependent manner along the 
margin of the wound edge to help the wound close evenly, while Rac1 mediates lamellipodial 
formation on the migrating cells (83). Therefore, the observation that Pa bound to several rows 
of cells behind the leading edge and were able to translocate ExoS into these cells is consistent 
with these cells extending lamellipodia and containing high levels of actin polymerization; while 
cells further back from the wounded edge do not. In further support of the requirement for actin, 
both Pa and ExoS were found to track actin within these migrating MDCK cells. ExoS 
translocation was found to decrease as wound healing progressed past 6 hrs, even though Pa 
were still internalized at high numbers up to 14 hrs post-wounding. It is possible that Rho-
mediated membrane ruffling on migrating cells at the later time-points (12-14 hr) facilitated Pa 
internalization but the absence of high actin accumulation associated with the 4-6 hr time-points 
resulted in less efficient translocation (173). Additionally, the decrease in internalization and 
translocation at 14 hr could be due to cells reestablishing polarity as the wounds began to close. 
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When influences of ExoS enzyme activity on translocation were evaluated, mutations abolishing 
both ExoS GAP and ADPRT activities were required to induce a significant increase in ExoS 
translocation. In MDCK cells, actin stress fiber formation is Rho-mediated and lamellipodial 
formation is Rac1-mediated (83). Since lamellipodia, but not actin stress fibers, were present in 
MDCK cells treated with active ExoS GAP (WT ExoS or the ExoS ADPRT- mutant), our results 
suggest that ExoS GAP activity is preferentially targeting Rho in MDCK cells not Rac1. In this 
regard, if Rac1 was also targeted by ExoS GAP activity, we would have expected to see a 
decrease in lamellipodial formation in addition to the loss of stress fiber formation. Our results 
differ slightly from studies showing that down-regulation of Rho by ExoS GAP results in an 
increase in stress fiber formation (116, 136, 167, 233). A potential reason for this difference is 
that kinetic analysis showed ExoS GAP activity towards Rho is less than Rac1 (186). If MDCK 
cells are innately more resistant to ExoS GAP activity and the target of ExoS GAP activity is 
Rho, then potentially more ExoS would be required to down-regulate Rho in this cell line.  
In contrast to T24 cells, MDCK treatment with ExoS ADPRT- mutants did not result in an 
increase in T3S effector translocation (Chapter 3). However, similar to T24 cells, treatment of 
MDCK cells with active ExoS ADPRT activity (WT ExoS or the ExoS GAP- mutant) resulted in 
decreased phosphorylation of ERMs, contraction of the lamellipodia, and formation of actin 
projections (Chapter 3). When MDCK cells were treated with active ExoS ADPRT activity, the 
actin projections appeared to remain adherent to the ECM. These results are in contrast to 
results in T24 cells, where the disruption of actin-membrane linkage by ExoS ADPRT activity 
resulted in a wavy actin phenotype (Chapter 3). It is possible that in MDCK cells, pERM-
mediated actin membrane linkage is not affected by ExoS ADPRT activity as it is in T24 cells, 
supporting the notion that the cell line properties of MDCK cells is influencing the effects of T3S.  
In MDCK cells, attachment to the ECM by peripheral actin and focal adhesion complexes is 
mediated by MLC kinase (MLCK), while larger focal adhesions are mediated by RhoA (247). 
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Consistent with the presence of focal adhesion complexes regulated by activated MLCK, the 
lamellipodia and actin projections of MDCK cells treated with Pa expressing WT ExoS or the 
ExoS ADPRT- mutant appeared to remain adherent to the ECM, as demonstrated by punctate 
structures within the lamellipodium. In contrast to HT-29 and T24 cells, where focal adhesion 
complexes are Rho-mediated and are disrupted by ExoS GAP activity, results in MDCK cells 
indicate that adhesion of actin to the ECM by focal adhesion complexes is not disrupted by 
ExoS because MLCK is not an identified target of ExoS GAP activity. Taken together, these 
results imply that both activities must work together to regulate translocation and manipulate the 
host cell. This is unlike MTC and MTLn3 cells where ExoS GAP activity is predominant or in T24 
cells where ExoS ADPRT activity is predominant in T3S regulation and again support the idea 
the host cell properties are influencing the effects of T3S.   
In immunoblot studies of sub-confluent MDCK cells, we found that T3S sensitivity was induced 
after a 5 hr co-culture period, a time-point later than that observed in other T3S sensitive cells, 
such as T24 cells (3.5-4 hrs; Chapter 3). These results implied that sub-confluent MDCK cells 
were more resistant to the effects of ExoS than other sensitive cell types. These observations 
are consistent with the sensitivity levels to Pa-T3S in healing wounds. It is possible that the 
increased resistance of sub-confluent MDCK cells is the same phenomenon observed in cells 
that migrated for greater than 6 hr. In this regard, sub-confluent cells were seeded and treated 
with Pa 48 hrs later. At this time, it is possible that Pa are being internalized due to increased 
Rho-mediated membrane ruffling in the lamellipodium but that ExoS translocation is not very 
efficient if high levels of actin polymerization is not occurring. While the MDCK cells were sub-
confluent in this set of studies, they formed micro-colonies which could have acquired 
polarization over the 48 hr time-frame. Since it is known that as MDCK cells polarize, Rho 
decreases and Cdc42 increases (156), it is possible that levels of Rho within these micro-
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colonies were decreased and thus Pa-T3S sensitivity was not greater. If cells were treated 4-6 
hrs post-seeding Pa-T3S sensitivity might potentially increase.  
Collectively, a model that emerges for the role ExoS and Pa-T3S in MDCK wound healing is 
that (1) following monolayer wounding, multiple rows of cells behind the wound form 
lamellipodia and begin to migrate to close the wound. (2) Disruption of monolayer polarity 
exposes basolateral proteins which allows for almost immediate Pa binding to the leading edge. 
(3) Pa then forms aggregates on the cell surface activating the Lyn, PI3K, Akt, PIP3 pathway 
leading to Pa internalization via an actin and Rho-dependent mechanism. (4) As the wound 
healing time increases to 4-6 hrs, levels of actin accumulation in multiple rows of cells behind 
the wound also increases, thereby allowing for T3S translocation of ExoS into MDCK cells by 
both extracellular and intracellular Pa. (5) T3S is subsequently down-regulated by ExoS 
translocation through a combination of ExoS GAP and ADPRT activity, which disrupt actin 
stress fiber formation and phosphorylated ERM-mediated actin linkage to the membrane, 
respectively. (6) The disruption in actin stress fiber formation along with induction of cell 
rounding and cell death by ExoS prevents cell migration and wound healing. It is possible that 
during infection as the cells along the edge of the wounded epithelial layer die and more cells 
form lamellipodia, this process can continue and lead to dissemination of bacteria to other 
locations of the body causing bacteremia and septic shock. Another alternative is that as the 
wounded area becomes larger due to the death of migrating cells this allows for secondary 
infection by other pathogens.     
Through studies of three cell lines with known differences in cell migration patterns, and in 
combination with previous studies of T24 cells (Chapter 3), the pattern that emerges is that 
while the effect of ExoS enzyme activity is different in each cell type, increased host cell 
sensitivity to translocation and Pa internalization is attributed to increased levels of Rho at the 
leading edge as compared to the trailing edge. This displacement of Rho renders cells more 
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resistant to ExoS GAP activity leading to Pa internalization and continued effector translocation 
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The opportunistic pathogen Pseudomonas aeruginosa (Pa) can cause infections with severe 
morbidity and mortality in any tissue or cell type. Mortality rates for Pa bloodstream and 
nosocomial infections can range from 33-60% (189, 253-255, 325, 335). Pa is the leading cause 
of death in patients with cystic fibrosis, and it is known to cause approximately 35% of recurrent 
urinary tract infections and up to two-thirds of contact lens related corneal infections (8, 43, 164, 
239, 266). Pa uses numerous virulence factors that are cell-associated or secreted by one of 
five secretion systems during its infectious process. However, the host cellular alteration that 
allows for the establishment of infection in so many tissue and cell types is unknown. 
Understanding how Pa infections are established is important for the development of novel anti-
Pseudomonal therapies due to increased resistance of Pa to antibiotics and the ability of 
bacteria to adapt to their surroundings.  
One Pa virulence factor implicated in the establishment of Pa infection is the type III secretion 
(T3S) system (reviewed in (129)). The T3S system is a nano-macromolecular structure that 
spans both bacterial membranes and is used by numerous Gram-negative bacteria to establish 
infection (reviewed in (51)). Once the Pa-T3S needle comes in contact with the host cell, the 
translocon proteins, PopB and PopD, are secreted, and in conjunction with the needle tip 
protein, PcrV, form a translocon channel in the eukaryotic membrane (119, 283). Pa then 
modulates host cell properties through the secretion of four effector proteins, ExoS, ExoT, 
ExoU, and ExoY. By providing a conduit for the direct translocation of effector proteins from the 
bacterial cytosol into the host cell cytosol, the T3S system allows Pa to bypass the host immune 
response to establish an infection. The importance of T3S and ExoS in the establishment of 
infections is documented by the increased disease morbidity and mortality of infections caused 
by Pa isolates expressing the T3S system as compared to Pa isolates not expressing the T3S 
system (73, 130, 269, 296). While the expression of the needle-tip protein PcrV alone can 
induce an increase in disease severity, co-expression of PcrV with the effectors ExoU and ExoS 
 
 203
have been shown to further increase disease morbidity and morality (130, 269, 296). Together, 
these results show the importance in understanding how the T3S system contributes to the 
establishment of infection.  
Pa is known to target wounded epithelial barriers when establishing infection (62, 235, 242, 245, 
251). Eukaryotic membranes are structured to resist channel and pore formation as occurs 
during T3S channel formation and our question was what is the cellular compromise that allows 
the translocon channel to form in the host cell membrane and how does this relate to the 
initiation of Pa infection. Previous studies implicated the role of asialo-GM1, the cystic fibrosis 
transmembrane receptor (CFTR), and epithelial cell polarity in Pa-T3S, but no eukaryotic cell 
receptor for the Pa-T3S translocation proteins has been identified to date (62, 87, 156, 243). 
Several studies hypothesized that membrane cholesterol and lipid rafts were involved in Pa-T3S 
translocation and PopB and PopD membrane insertion, but due to differences in experimental 
systems, the role of cholesterol in Pa-T3S translocon insertion and function also remains 
unknown (80, 132, 283).  Previous studies from our laboratory identified that the majority of host 
cell types were sensitive to Pa-T3S; however, two cell types were found to be resistant to Pa-
T3S polarized epithelial cells and promyelocytic HL-60 cells (206, 271). Sensitivity to Pa-T3S 
could be induced in these two cell lines by disruption of epithelial polarity or by HL-60 cell 
differentiation with the phorbol ester, 12-O-tetradeconylphorbol-13-acetate (TPA) (206, 271). 
But again, the cellular mechanism underlying Pa-T3S sensitivity was unknown.  
Eukaryotic cell sensitivity to Pa-T3S can be assayed by detection of translocated ExoS-HA, 
ExoS ADP-ribosylation of RalA, or membrane insertion of the translocon protein PopB (95, 96, 
271). The Pa-T3S effector ExoS is known to have GTPase activating protein (GAP) activity that 
targets Rho family GTPases, and ADP-ribosyltransferase (ADPRT) activity that targets proteins 
such as the Ras family GTPases, Rabs, cyclophilin A, and the ERM (ezrin, radixin, and moesin) 
family of proteins (69, 95, 96, 106, 116, 135, 136, 167, 195, 196, 205, 233). The first study in 
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this dissertation, presented in Chapter 2, used ExoS as a tool to identify host cell factors 
influencing the establishment of Pa infections, which led to the identification of eukaryotic 
leading edge and cell migration properties in initiation of Pa infections. The second study, 
presented in Chapters 3 and 4, used the T3S modulatory influence of ExoS to further explore 
the role of eukaryotic cell migration in Pa-T3S.   
The first approach in understanding how the host cell is involved in Pa-T3S was to use cell lines 
known to be sensitive (HT-29 cells) to Pa-T3S (Chapter 2) (33). Through a large series of 
studies targeting many host cell properties, only methyl-β-cyclodextrin (MβCD) and 
perfringolysin O (PFO) were able to induce HT-29 cell resistance to Pa-T3S as documented by 
a decrease in ExoS translocation, a decrease in ExoS ADP-ribosylation of RalA, and/or a 
decrease in PopB membrane insertion. Both of these agents modulate host cell membranes in a 
cholesterol-dependent process. In studies investigating the role of eukaryotic cell membrane 
cholesterol in Pa-T3S we found that neither modulation of cholesterol nor modulation of lipid 
rafts could inhibit Pa-T3S sensitivity. Instead, loss of HT-29 cell adherence to the tissue culture 
matrix correlated with inhibition of Pa-T3S (33).  
Upon recognition of host cell adherence properties in Pa-T3S sensitivity, we investigated the 
type of host cell adherence mechanisms to the cell culture matrix that could be involved in T3S. 
These studies directed our attention to the role of Rac1 and Cdc42 mediated focal complexes at 
the leading edge in Pa-T3S, while inhibition of focal complexes using ROCK or Src kinase 
inhibitors did not affect T3S sensitivity (33). Together these studies indicate that eukaryotic cell 
leading edge properties were potentially involved in Pa-T3S host cell sensitivity. Host cell 
migration is mediated by cell signaling pathways involving Rac1, Cdc42, Rho, 
phosphatidylinositol 3-kinase (PI3K), IQ-motif-containing GTPase activating protein 1 (IQGAP1), 
integrins, actin, and microtubules. Upon investigation of how these proteins were involved in Pa-
T3S, Rac1, Cdc42, and actin were found to function first, followed by microtubules and IQGAP1, 
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with PI3K playing a minor role. To relate LE architecture to previous Pa-T3S sensitivity studies, 
HT-29 cells were monitored by IF microscopy studies under T3S-sensitive and resistant 
conditions. From these studies, we found that in T3S-sensitive cells, there was a close 
association between cortical actin with Rac1 or PI3K in the direction of cell migration. Pa was 
also found to preferentially bind to the leading edge of HT-29 cells under T3S sensitive 
conditions. Treatment of HT-29 cells with MβCD and PFO, disrupted leading edge actin co-
localization with Rac1 and PI3K, and this coincided with the loss of HT-29 cell sensitivity to Pa-
T3S (33). In addition, after inhibition of T3S by treatment with PFO, Pa binding became more 
random and occurred at intercellular junctions rather that at the leading edge of the cell. 
Together, the role of leading edge focal complexes, the role of proteins involved in cell migration 
at the leading edge, and the role leading edge architecture in HT-29 cell sensitivity to Pa-T3S 
led to the hypothesis that eukaryotic cell leading edge properties are an important factor for host 
cell sensitivity to Pa-T3S (33).  
Studies presented in Chapter 2 provided evidence that Pa was utilizing changes in eukaryotic 
cell polarity, specifically the properties regulating leading edge migration, in establishing 
infection. In this regard, we found that the requirement for membrane cholesterol in Pa-T3S, but 
not modulation of cholesterol or modulation of lipid rafts is consistent with the role of cholesterol 
at the leading edge of migrating cells. Cholesterol has been proposed to alter plasma 
membrane viscosity to allow for actin-mediated membrane protrusion during cell migration and 
that MβCD depletion of cholesterol disrupts the polarized distribution of cellular proteins that 
regulate migration (193, 267). The model that we propose from these studies is that leading 
edge cortical actin polymerization, regulated by activated Rac1 and Cdc42 at the leading edge, 
is required for insertion of the translocon in the membrane. This model is consistent with studies 
by Mejia et al. which showed that actin polymerization was also involved in translocon insertion 
in Yersinia Ysc T3S (33, 207). Our model also predicts that since Pa does not engage integrin, 
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which induces actin polymerization, Pa is utilizing host cell leading edge properties that mediate 
actin polymerization during cell migration for its infectious process (33).  
Based on our previous results hypothesizing that the establishment of Pa infections is linked to 
eukaryotic cell migration properties, the second study, which used highly migratory T24 cells as 
a cell culture model and ExoS as a T3S modulatory tool, allowed dissection of the cellular Pa 
infectious process. The use of ExoS to manipulate Pa-T3S is supported by studies by Aili et al. 
(4), which showed that ExoS expressed by the Yersinia Ysc T3S system had the ability to 
regulate effector translocation into host cells. From studies described in Chapter 3, Pa 
expressing ExoS with mutations that altered ExoS GAP and ADPRT activities was found to 
enhance ExoS and PopB translocation into T24 cells, thus indicating that ExoS was targeting 
cellular processes that affected T3S translocation. Consistent with results from the first study 
(Chapter 2), we again observed that Pa expressing WT ExoS preferentially localized to the 
leading edge of migratory cells. However, interestingly and in contrary to our hypothesis that 
actin-plasma membrane associations at the leading edge facilitated T3S translocation, more 
efficient T3S translocation by ExoS ADPRT- or GAP-/ADPRT- mutants was associated with Pa 
binding within the lamellipodium.  
In dissecting the mechanism underlying T3S translocation, we found that Pa expressing ExoS 
deficient in GAP activity could be internalized, and that these internalized Pa could secrete 
ExoS inside the host cell (Chapter 3). As a result, the binding observed within the lamellipodium 
of T24 cells by Pa expressing ExoS with a GAP- mutation, could now be attributed to 
internalized Pa localizing within the lamellipodium. Previous studies have reported the anti-
phagocytic properties of ExoS GAP activity, but this is the first report of ExoS secretion by 
internalized Pa (65, 100, 263). These results are also consistent with recently published studies 
in Yersinia, whereby internalized Yersinia could continue to translocate low levels of effectors 
once internalized (354).  
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Pa expressing ExoS with mutations in ADPRT activity were found enhance ExoS translocation 
into T24 cells by external Pa, which provided evidence that ExoS ADPRT activity was targeting 
and inactivating a cellular protein(s) required for T3S translocation. ERMs (ezrin, radixin, 
moesin) are responsible for linking actin to the plasma membrane and are known to be a 
substrate of ExoS ADPRT activity (32, 195, 196, 297, 309). ADP-ribosylation of ERMs by ExoS 
was previously found to interfere with ERM phosphorylation (pERM) (195, 297). Consistent with 
this notion, ExoS ADPRT activity disrupted actin-plasma membrane anchoring and disruption of 
pERM/ezrin co-localization at the leading edge in conjunction with interruption of T3S 
translocation.  The mechanism underlying the greater levels of translocation of an ExoS GAP-
/ADPRT- mutant related to the ability of Pa to become internalized. Interestingly, these 
internalized Pa were found to align with actin filaments within T24 cells, an ability that was 
interrupted by ExoS ADPRT activity. In addition, the inability of Pa expressing an ExoS GAP- 
mutant, which retained active E379 and/or E381 ADPRT residues, to align with actin filaments 
in T24 cells is consistent with ExoS ADPRT activity disrupting actin-plasma membrane 
associations required for Pa-actin alignment. Finally, ExoS was also found to align with actin, 
independent of its enzyme activity, suggesting the importance of actin in ExoS translocation into 
the host cell (Chapter 3).  
Taken together these studies advanced the understanding of the host cell mechanism 
underlying host cell sensitivity to Pa-T3S and how ExoS regulates T3S translocation. 
Specifically, Pa expressing WT ExoS bind to the leading edge of migrating cells where actin 
linked to the membrane by pERM proteins is accessible to ExoS. Once ExoS is translocated 
into the host cell, ExoS GAP activity targets Rho-family GTPases to interfere with Pa 
internalization, while ExoS ADPRT activity disrupts the actin membrane association. The 
studies presented here are consistent with studies showing that ExoS GAP activity, like Yersinia 
YopE, can function to regulate effector translocation (4). An unexpected and novel finding in 
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these studies was that ExoS ADPRT activity can also serve to regulate T3S translocation. To 
date, no studies had been conducted investigating whether ExoS enzyme activity could regulate 
translocation in the host cell during a Pa infection, thus highlighting the novel findings of our 
studies to the understanding of Pa-T3S. Our studies also describe the paradoxical role of ExoS 
in the Pa infectious process, whereby the cytotoxic effects of ExoS first contribute to the 
establishment of Pa infections. These same cytotoxic effects then interfere with Pa 
internalization and T3S translocation to limit the Pa infectious process and help maintain its 
extracellular, opportunistic lifestyle.  
Realizing the potential for leading edge properties to influence T3S from the studies presented 
in Chapters 2 and 3, we explored how cells with different migration properties influenced the Pa 
infectious process, again using ExoS to monitor Pa infections. For these studies we utilized 
three cell models known to differ in regulation of leading edge dynamics and, as a result, 
differing cell migration patterns. To investigate potential differences in host cell sensitivity due to 
differences in host cell migration patterns, T3S sensitivity in non-metastatic MTC cells was 
compared to its clonal metastatic MTLn3 sub-line. We found that increased MTLn3 Pa-T3S 
sensitivity was attributed to Pa internalization and continued ExoS translocation within the cell 
(Chapter 4). Increased MTLn3 sensitivity was also found to be a factor of differences in Rho-
mediated cell migration properties. 
Rac1 is activated at the leading edge in MTC cells, while in MTLn3 cells, Rho and Cdc42 are 
activated (71, 72). The increased activation of Rho in MTLn3 cells has been shown to suppress 
Rac1 activation (72). Our IF microscopy studies showed that the MTC actin cytoskeleton 
became highly branched following treatment with Pa expressing active ExoS GAP activity.  In 
comparison, MTLn3 cells appeared to be more resistant to ExoS GAP activity in that cell 
rounding and actin-branching were not as extensive as was observed in the MTC cells. It is 
likely that the limited change in morphology observed in the MTLn3 cells is due to ExoS GAP-
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mediated down-regulation of Rho. It is known that Rho is a target of ExoS GAP, however, 
recent studies have shown that the catalytic activity of ExoS GAP towards Rho is less than 
towards Rac1 and Cdc42 (186). Thus, it is possible that the limited rounding in MTLn3 cells 
when treated with Pa expressing ExoS with active GAP reflects low levels of catalytic 
inactivation of Rho, while the highly branched morphology observed in MTC cells reflects the 
high catalytic activity of ExoS GAP towards Rac1. Together, these results support the notion 
that MTC cells are more sensitive to the effects of ExoS GAP activity on the host cell actin 
cytoskeleton. Through the use of the ROCK inhibitor, Y-27632, and the Rac1 inhibitor, 
NSC23766, we were able to alter MTC and MTLn3 sensitivity to Pa-T3S. By inhibiting ROCK, 
MTLn3 sensitivity was reduced to levels comparable to MTC cells, and in turn, inhibition of Rac1 
increased Pa-T3S sensitivity in MTC cells, thus supporting the idea that activated Rho is 
suppressing Rac1 in MTLn3 cells and that this influences MTLn3 cell sensitivity to Pa-T3S. 
Together, these results indicate that at the leading edge in MTC cells, ExoS targets Rac1, 
resulting in membrane contraction and actin cytoskeletal rearrangements that may function in 
preventing further ExoS translocation into the cell. In MTLn3 cells, the increase in activated Rho 
suppresses Rac1, and together with the limited catalytic inactivation of Rho by ExoS GAP, 
MTLn3 cells are resistant to the anti-internalization properties of ExoS GAP activity allowing for 
Pa internalization and continued ExoS translocation within the cell. 
The third cell model system used in the last set of studies was a Madin-Darby canine kidney 
(MDCK) wounded monolayer. The purpose of using this model system was to study how host 
cell properties which control collective migration during wound healing influences Pa-T3S 
sensitivity. From these studies we found that Pa expressing WT ExoS bound to the leading 
edge of cells migrating to close the wound. While Pa internalization occurred in cells that were 
wounded up to 12 hr, ExoS translocation was most efficient when Pa were added 4-6 hours 
post-wounding. MDCK cells are known to extend lamellipodia in multiple rows of cells behind 
 
 210
the wounded edge, and at 6 hr post-wounding, an increase in actin polymerization occurs in 
these cells (79, 83). Our observations that Pa binding to and translocating ExoS into cells both 
at the immediate wounded edge and to cells several rows behind the wounded edge during this 
time-frame are consistent with the requirement of actin polymerization in Pa-T3S. Unlike in T24 
cells where ADPRT activity predominantly regulated Pa-T3S translocation, and in MTC and 
MTLn3 cells where ExoS GAP activity predominantly regulated Pa-T3S translocation, MDCK 
cells required both ExoS GAP and ADPRT activities to regulate translocation. ExoS GAP 
activity was found to disrupt actin stress fiber formation, while ExoS ADPRT activity disrupted 
actin linkage to the cell membrane (Chapter 4). Increased Pa internalization by MDCK cells is 
believed to be due to increased levels of activated Rho in cells migrating to close the wound. 
Similar to MTLn3 cells, the increase in Rho would allow for Pa internalization and continued 
ExoS translocation. However, since MDCK cells exhibit differences in migration where actin 
polymerization is greatest 4-6 hrs post-wounding, ExoS translocation is not as great as is 
observed in MTLn3 cells when treated with Pa expressing WT ExoS.  
Together the last set of studies suggest that while the effect of ExoS enzyme activity is different 
between each of the three cell types, a commonality is that increased host cell sensitivity is 
attributed to increased levels of Rho at the leading edge. This displacement of Rac1 from the 
leading edge renders the cells resistant to ExoS GAP activity where Pa are internalized and 
continue T3S translocation from within the host cell.  
The model that emerges from using ExoS to understand the role of the host cell in Pa-T3S is 
that Pa expressing WT ExoS preferentially binds to the leading edge of migrating eukaryotic 
cells where Rac1 and Cdc42-mediated actin polymerization is the greatest (Fig. 7A). ExoS is 
then translocated into the host cell in an actin dependent manner. ExoS GAP activity prevents 
Pa internalization and continued T3S translocation by mediating the hydrolysis of Rac1-GTP to 
Rac1-GDP, to prevent actin mediated membrane ruffling. We believe that ExoS ADPRT activity 
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functions to limit translocation by targeting the ERM family proteins where inhibition of ERM 
phosphorylation results in disruption of the actin-membrane linkage required for ExoS 
translocation. In comparison, migrating cell lines which contain activated Rho at the leading 
edge are more resistant to the effects of ExoS enzyme activity (Fig. 7B). In this model, T3S 
translocated ExoS GAP activity has a low affinity for Rho, whereby membrane ruffling would not 
be inhibited and Pa could be internalized and continue translocation from within the host cell. 
While ExoS ADPRT activity appears to disrupt actin-membrane linkages, the presence of either 
Rac1 or Cdc42 at the leading edge results in maintenance of some actin cytoskeletal network, 
which allows for continued ExoS translocation.  
In conclusion, in contrast to Yersinia, Pa does not have the ability to induce actin polymerization 
which results in T3S translocon insertion into the host cell membrane (207). As an opportunist, 
Pa appears to preferentially target wounded epithelial barriers where actin polymerization is 
mediated by the host cell. Pa then utilizes the changes in membrane dynamics to insert the 
translocon channel, and to translocate effectors into the host cell to interrupt Pa internalization. 
As an additional means of supporting survival, Pa uses ExoS limit T3S translocation which 
prevents an overt immune response. As a result, Pa can disseminate to other areas of the host 
and cause infection through up-regulation of virulence factors secreted by the other four 
secretion systems, or as in the case of a chronic infection, can mutate and produce alginate 
which allows the bacteria to survive within a biofilm (Fig. 6).  
Future studies investigating the role of host cell migration properties should focus on: (1) further 
clarifying how the balance between Rho and Rac1 affects Pa-T3S in other cell lines; (2) 
confirming the role of phosphorylated ERMs and actin linkage to the membrane in Pa-T3S 
sensitivity through cell line knockout studies of ezrin, the main ERM protein found in epithelial 
cells; and (3) using an animal model to determine how ExoS GAP and ADPRT activities 
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ABSTRACT 
Purpose: Multi-species biofilms associated with contact lens cases and lenses can predispose 
individuals to corneal infections. This study utilized culture-independent methods to assess the 
relationship between the severity of contact lens related keratitis and bacteria residing in lens 
case and lens biofilms. 
Methods: Contact lens cases and lenses from 28 patients referred to the West Virginia 
University Eye Institute and diagnosed as having mild keratitis, keratitis with focal infiltrates, or 
corneal ulcers were processed and evaluated for bacterial composition based on 16S ribosomal 
RNA gene sequencing. Cases and lenses from nine asymptomatic contact lens wearers were 
processed in a similar manner as controls. Relationships between disease severity, bacterial 
types, and bacterial diversity were statistically evaluated. 
Results: Disease severity and presenting visual acuity were found to correlate with an increase 
in the diversity of bacterial types isolated from contact lens cases. A significant difference was 
also observed between the number of bacterial types and the three clinical groups. 
Achromobacter, Stenotrophomonas, and Delftia were identified as the predominant bacteria 
associated with contact lens related infections among our patients, and scanning electron 
microscopy revealed that Achromobacter and Stenotrophomonas formed a biofilm on the 
surface of contact lenses. 
Conclusion: Culture independent methods found that bacterial diversity in biofilms isolated 
from cases and lenses of patients with contact lens related infections increased with severity of 
disease. Achromobacter, Stenotrophomonas, and Delftia were predominant bacteria identified 






Contact lens wear is a major predisposing factor to microbial keratitis and infectious corneal 
ulcers (4). Microbes can reside on lenses and within lens cases, often in association with multi-
species biofilms that serve as reservoirs for the establishment of eye infections (3, 17, 23). From 
24-81% of contact lens storage cases are contaminated with microbial biofilms with the 
frequency of contamination increasing in wearers suffering from microbial keratitis (reviewed in 
(25)). Contamination of contact lenses is less frequent and associated with fewer organisms 
than lens cases but correlates more closely with organisms that cause corneal infections (6, 15, 
17). Eye infections can be initiated by contact lens induced microabrasions, pathophysiological 
alterations, or toxic microbial products that compromise the epithelial surface allowing 
contaminating microbes to adhere and invade (26). Despite improvements in contact lens 
materials, solutions and wearing habits, epidemiological studies find the incidence of corneal 
infections has not changed among contact lens wearers in the last two decades (14, 24), 
indicating that microbes have adapted to clinical modifications designed to interfere with corneal 
infections. 
Effective treatment of contact lens related keratitis and corneal ulcers is dependent on the 
identification of the infectious or non-infectious origin of the problem. Culture dependent 
methodologies identified Pseudomonas aeruginosa as the most common pathogen in contact 
lens related infections, followed by Serratia marcenscens, Staphylococcus aureus, 
Acanthamoeba spp., and Fusarium spp. (2, 9, 14). Inaccurate characterization and treatment of 
the offending pathogen may result in prolonged infection, permanent damage to ocular tissues, 
decreased vision, and in extreme cases removal of the infected tissue (29). A major difficulty in 
identifying the origin of contact lens infections is that the contaminating organism is often not 
cultivable (12, 13, 21). As a result, there is reduced reliance on culturing in the diagnosis of 
contact lens infections (16), and the current recommended treatment for infections lacking a 
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confirmed microbial diagnosis is antibiotics that target P. aeruginosa (Bacterial Keratitis PPP, 
2008, American Academy of Ophthalmology). Consequently the etiology of the majority contact 
lens related infections remains unknown. 
The goal of this study was to use culture-independent, 16S ribosomal RNA (rRNA) gene 
analysis to assess bacterial populations associated with contact lens related infections in 
individuals referred to the West Virginia University Eye Institute with anterior segment disease. 
We found disease severity and presenting visual acuity to correlate with an increase in the 
diversity of bacterial types isolated from contact lens cases. Interestingly, the bacterial genera 
identified most often in our analyses were Achromobacter, Stenotrophomonas, and Delftia, 
whereas Pseudomonas was rarely identified. Achromobacter, Stenotrophomonas, and Delftia 
exhibit similar physiological properties as Pseudomonas but have a different antibiotic 
resistance pattern, which might contribute to their potential emerging role in establishing biofilms 









MATERIAL AND METHODS 
Subject populations and evaluations. Soft contact lenses and cases were obtained from 28 
patients referred to the West Virginia University Eye Institute for contact lens related anterior 
segment disease. Patients were examined by a single clinician and assigned to one of three 
categories: 1) mild diffuse keratitis, defined as the presence of stromal inflammatory cells 
without an area of dense infiltration or epithelial defect; 2) keratitis with focal infiltrates, defined 
by the presence of stromal inflammatory cells and areas of dense accumulations of cells 
presenting as a focal opacity; or 3) corneal ulcer, defined as a large epithelial defect with 
associated suppurative infiltrate and severe generalized anterior segment inflammation. Contact 
lenses and cases obtained from nine asymptomatic soft contact lens wearers served as 
controls. Cases and lenses were frozen and maintained at -200C until the time of analysis. All 
procedures were performed in accordance with the guidelines of the Declaration of Helsinki 
using Institutional Review Board approved protocols and informed consent was obtained from 
each subject. 
DNA extraction and 16S rRNA gene sequence analysis. Biofilms were released from contact 
lens cases by scraping and sonication, and then combined with solutions within cases and 
subjected to DNA extraction and purification procedures using the Microbial DNA Isolation Kit 
(Mo Bio Laboratories, Inc., Carlsbad, CA). DNA was extracted and purified from contact lenses 
by directly placing lenses in tubes provided by the Microbial DNA Isolation Kit, which were then 
subjected to the same DNA isolation procedures used for contact case samples. Bacterial 16S 
rRNA genes were PCR amplified from purified DNA using universal bacterial 16S rRNA primers, 
and products were cloned and sequenced as previously described (18). 
16S rRNA gene sequence analysis. Candidate 16S rRNA gene sequences were scanned for 
a segment of the original primer sequence (ATCAAACT) near the expected position, and the 
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match was confirmed by eye. The initial part of each sequence containing uncalled bases (N) 
was removed, the distal part (vector sequence) was trimmed at the primer, and the sequence 
was reversed to standard orientation. Chimeric sequences were screened using ChimeraSlayer 
(8), and six chimeric sequences were identified and removed. Sequences were classified by 
BLASTN using the legacy executable blastall (NCBI) against a local database, as well as by 
using the NCBI server with the GenBank non-redundant database. Bacterial types were 
determined based on >98% sequence identity between the 16S rRNA gene PCR product and 
reference database. Bacterial classification used custom Python code (Python 2.6), and the 
heatmap was generated using matplotlib and Python, as previously described (18). 
Scanning electron microscopy (SEM). Biofilm formation on contact lenses was examined by 
SEM on randomly selected contact lenses from patients with mild keratitis or keratitis with focal 
infiltrates. Lenses were cut in half, and one half was examined by SEM and the other half was 
processed for 16S rRNA gene sequencing, as above. For SEM, lenses were fixed in 3% 
glutaraldehyde in Dulbecco’s phosphate buffered saline (DPBS; Hyclone, Logan UT) for 1 hr, 
then resuspended in 50% glycerol/50% deionized (DI) water and shipped to Marshall University 
for analysis. Comparisons were made between post-fixing lenses in 2% osmium tetraoxide 
(OsO4; Electron Microscopy Sciences, Hatfield, PA) in DI water for 2 hrs or not, but no 
difference in image quality was evident. All lenses were dehydrated in a graded ethanol series: 
50%, 70%, 85%, 90%, and 95%, followed by two changes in 100% absolute ethanol. Lenses 
were cut in half again prior to mounting, and the inside (corneal touching) or the outside surface 
of the lens was oriented upward for imaging. Samples were immediately dried in the vacuum 
chamber of a sputter coater (Hummer 6.2, Anatech, Ltd, Union City, CA) and coated with <10 
nm of gold/palladium (Ladd Research, Williston, VT). Lenses were imaged with a JEOL 5310-
LV Scanning Electron Microscope (Japan Electron Optics Laboratory; Commerce, MI) and 
digital images were captured with Printerface software (GW products, SOQUELEC Ltd). 
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Statistical analysis. Statistical differences between groups were determined using a 
nonparametric Kruskal-Wallis H test for overall significance, which was followed by a Mann-
Whitney U test for significance between two groups. Correlations between variables were tested 
using the Spearman rank-order coefficient (rho) or a Pearson parametric coefficient (r), as 
indicated. Statistical calculations were performed using Statistica (Statsoft, Tulsa, OK). 
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RESULTS 
Patient evaluations. Patients diagnosed with contact lens related corneal infections were 
divided into three clinical diagnosis groups: 1) mild diffuse keratitis, 2) keratitis with focal 
infiltrates, or 3) corneal ulcer, as determined through retrospective chart analysis (Table III). 
Presenting visual acuity was 20/20 in asymptomatic controls and the mild keratitis group, which 
worsened to counting fingers or hand motion in patients with severe corneal ulcers. A 
statistically significant difference (P<0.001) in presenting visual acuity was observed when all 
groups were compared (Fig. 31), with more severe clinical categories being associated with 
poorer visual acuity (rho =0.89, P<0.001). The asymptomatic control and mild keratitis groups 
did not differ significantly in presenting visual acuity, but all other comparisons of visual acuity 
between groups were significant (P<0.05), clinically validating the groupings. 
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Clinical Group 1:  Mild Keratitis 
Patient  Age Sex Infected Eye 
Presenting 
Visual Acuity Compliance History 
2 21 M OD 20/20 Slept in lenses  
7 33 F OS 20/20 Mascara brush injury, slept in lenses 
25 24 F OS 20/25 Lens overuse, chemical irritant exposure 
27 54 F OS 20/25 Dry eye 
47 18 M OS 20/25  Poor compliance with cleaning solutions 
      
Clinical Group 2:  Keratitis with Focal Infiltrates 
Patient  Age Sex Infected Eye 
Presenting 
Visual Acuity Compliance History 
32 37 M OU 20/20 & 20/25 Unknown 
46 31 F OS 20/25 Unknown 
52 22 M OS 20/30 Slept in lenses, poor lens hygiene  
56 23 M OD 20/30 Lens overuse 
28 22 F OS 20/40 Slept in lenses 
62 23 F OS 20/40 No lens wear 2 wks prior to presentation 
24 29 F OD 20/50 Slept in lenses 
15 19 F OS 20/60 Lenses worn, stored 1 yr then worn again 
      
Clinical Group 3:  Corneal Ulcer 
Patient  Age Sex Infected Eye 
Presenting 
Visual Acuity Compliance History 
10 48 F OD 20/400 Unknown 
9 19 F OS Count Fingers Unknown 
57 51 F OD Hand Motion Unknown 
73 15 M OD Hand motion Lens overuse 
      
Asymptomatic Controls 
Patient  Age Sex Infected Eye 
Presenting 
Visual Acuity Compliance History 
26 25 F N/A 20/20 Unknown 
48 26 M N/A 20/20 Unknown 
55 49 F N/A 20/20 Unknown 
68 27 M N/A 20/20 Unknown 
69 27 F N/A 20/20 Unknown 
74 33 F N/A 20/20 Unknown 
75 24 M N/A 20/20 Unknown 
76 40 F N/A 20/20 Unknown 









Figure 31. Declining visual acuity is associated with contact lens related corneal disease. 
Seventeen patients presenting with contact lens associated corneal infections and having lens 
cases that produced 16S rRNA gene PCR products, were categorized based on disease 
severity as having mild keratitis, keratitis with focal infiltrates, or corneal ulcer. Presenting visual 
acuity was assessed for all patients and nine asymptomatic controls. *Indicates a significant 
difference (P<0.05) in visual acuity between each of the three clinical groups. **Indicates a 
significant difference (P<0.001) in visual acuity when all four groups were compared. 
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Relationship between bacterial contamination of contact lens cases and disease severity. 
To assess the poly-bacterial nature of biofilms associated with contact lens related disease, 
PCR amplification and sequencing of cloned 16 rRNA genes were used to identify bacteria in 
contact lens cases of our patient group. Of the 28 cases examined, 17 (61%) were positive for a 
16S rRNA gene PCR product. The lack of PCR product in the remaining 11 cases is presumed 
to relate to the absence of PCR amplifiable bacterial DNA in these samples. Contact lens case 
biofilms and solutions collected in an identical manner from nine asymptomatic contact lens 
wearers served as controls. Of these samples, one (11%) produced a 16S rRNA PCR product. 
The increase in PCR amplifiable products from cases of patients with keratitis and corneal 
ulcers, as compared to control cases, is consistent with bacterial contamination of lens cases 
being associated with acquisition of contact lens infections. 
When the bacterial composition of the 18 PCR positive contact lens case samples (17 disease 
and one control) was characterized, 38 different bacterial types were identified. The heatmap in 
Fig. 32 shows the number of clones identified for each bacterial type in each sample and 
represents a semi-quantitative assessment of the frequency of bacterial types within the case. 
Variations in the total number of sequences obtained per sample reflect the number of clones 
subjected to sequencing and to the number of clones that produced readable sequences. When 
the number of bacterial types identified by 16S rRNA gene sequencing was related to disease 
severity, a significant difference (P<0.001) between the clinical groups was observed (Fig. 33A), 
with more severe clinical categories associated with an increased number of bacterial types 
(rho=0.82, P<0.001). Statistical comparisons of individual clinical groups found the number of 
bacterial types in the mild keratitis group to be significantly different (P<0.05) from that of the 
corneal ulcer group. The asymptomatic control group was also found to have fewer bacterial 
types (P<0.05) than each of the clinical groups. No other statistical differences in bacterial types 
were observed among the clinical groups. However, independently of clinical groupings, a 
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positive correlation (r=0.5, P<0.001) was observed between increasing numbers of bacterial 
types and decreased visual acuity (Fig. 33B). 
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Figure 32. Identification of bacterial types in cases of patients diagnosed with contact 
lens related corneal disease. Solutions and biofilms from contact lens cases of 17 patients 
with corneal infections and one asymptomatic control were evaluated for bacterial composition 
based on 16S rRNA gene sequencing. Patients were grouped by disease category and further 
ranked within categories based on worsening visual acuity (determined by increasing log arc 
min values). Patient reference numbers are indicated at the top of the heatmap. Numbers within 
colored boxes indicate how many clones of a specific bacterial type were in each sample, and 
the color of the box reflects bins for observed counts. The total number of clones sequenced for 
























Figure 33. Relationship between bacterial types and severity of disease. A) The number of 
bacterial types identified by 16S rRNA gene sequencing was related to clinical groupings. 
*Indicates a significant difference (P<0.05) in bacterial types between the mild keratitis group 
and corneal ulcer group. **Indicates a significant difference (P<0.001) in bacterial types when all 
groups were compared. B) Pearson correlation analysis (r = 0.50, P<0.001) was used to 
examine the relationship between visual acuity of individual patients and the number of bacterial 
types identified by 16S rRNA gene sequencing in their contact lens cases. 
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When specific bacterial types in contact lens cases were compared, unexpected bacteria 
emerged as predominant residents. Among the 38 identified bacterial types, Achromobacter had 
the highest frequency of occurrence (P<0.05) with detection in 13 of 17 (76%) disease 
associated contact lens cases. Stenotrophomonas was second (P<0.05) with detection in 12 of 
17 (71%) disease cases. Delftia and bacteria in the Enterobacteriaceae family were third 
(P<0.05) with detection in seven of 17 (41%) disease cases. Enterobacteriaceae is a large 
family of Gram-negative, glucose fermenting bacteria frequently found in the gut, and in our 
studies included bacteria from the genera Enterobacter, Serratia, Escherichia, Ewingella, and 
Shigella. Notably, P. aeruginosa, recognized to be the most frequent cause of contact lens 
related eye infections, was detected in only two of 17 cases. Achromobacter and 
Stenotrophomonas were also detected in the one PCR positive control case at a relative 
frequency of 18:1, respectively, indicating that these bacteria can reside in contact lens cases in 
the absence of clinical symptoms. 
Together these results demonstrate that as corneal infections progress from a mild keratitis to a 
severe corneal ulcer, the diversity of bacterial types increases and this correlates with a 
negative impact on visual acuity. In addition, three unexpected bacterial types, Achromobacter, 
Stenotrophomonas, and Delftia were identified as the predominant contaminating bacteria in 
contact lens cases of our studies. 
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Comparison of bacterial types associated with cases and lenses. To assess the 
relationship between lens and case contamination in our patient group, we used 16S rRNA 
gene sequencing to examine bacterial contamination on lenses from 13 of the 17 lens cases 
analyzed in Fig. 32. When two lenses were provided for analyses, bacterial results for both 
lenses were combined, and these results are compared with bacteria identified in the cases 
from the same patient in Table IV. Of the 13 contact lens samples, seven (54%) were positive 
for 16S rRNA gene PCR products. Lenses from asymptomatic controls were negative for PCR 
products. Comparisons found bacterial types on lenses to be highly similar with those in the 
respective case for patients 47, 46, 62, 57, and 73, albeit the relative percentage of the bacterial 
types in lenses and cases varied. The two exceptions to this relationship were: 1) Patient 2, 
diagnosed with mild keratitis, where bacterial types in the case were limited to Achromobacter 
(91%) and Stenotrophomonas (9%), while multiple diverse types, including Achromobacter and 
Stenotrophomonas, were detected on lenses; 2) Patient 9, diagnosed with a corneal ulcer, 
where greater bacterial diversity and a different spectrum of bacteria were detected on the 
lenses as compared to the case. Interestingly, the spectrum of bacteria on the lenses of patient 
9 reflected gut flora, whereas the case bacteria more closely reflected skin or oral flora. 
Collectively, comparisons of bacteria associated with lenses and cases of individual patients 
using 16S rRNA gene sequencing found contamination of lenses to be less frequent than cases, 
as evident by the lack of recovery of PCR products from six of 13 PCR product positive cases, 
and that the relationship between bacterial types on lenses and cases varied among patients 
independently of clinical diagnosis. 
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Table IV. Bacterial types on lenses in comparison to cases 
* Parentheses enclose number of sequences analyzed per sample. 
† Only left lens was analyzed. 
Patient Clinical group Case % Bacteria Lens % Bacteria 
2 Mild Keratitis Achromobacter 91 (11) * Achromobacter 34 (32) 
  Stenotrophomonas 9 Stenotrophomonas 22 
    Enterobacteriaceae 19 
    Staphylococcus 6 
    Xanthomonas 3 
    Burkholderia 3 
    Eubacterium 3 
    Peptostreptococus 3 
    Selenomonas 3 
    Veillonella 3 
47 Mild keratitis Achromobacter 64 (22) Achromobacter 57 (23) 
  Stenotrophomonas 36 Stenotrophomonas 43 
46 
Keratitis with 
focal infiltrate Stenotrophomonas 93 (14) Stenotrophomonas 94 (35) 
  Achromobacter 7 Achromobacter 6 
62 
Keratitis with 
focal infiltrate Achromobacter 79 (48) Achromobacter 66 (94) 
  Enterobacteriaceae 8 Enterobacteriaceae 18 
  Delftia 6 Delftia 10 
  Stenotrophomonas 6 Stenotrophomonas 6 
9 Corneal ulcer Staphylococcus 21(42) Enterobacteriaceae 35 (23) 
  Streptococcus 14 Veillonella 22 
  Stenotrophomonas 10 Selenomonas 9 
  Lactobacillus 7 Campylobacter 9 
  Finegoldia 7 Dialister 9 
  Peptoniphilus 5 Stenotrophomonas 4 
  Peptostreptococcus 5 Peptostreptococcus 4 
  Anaerococcus 5 Xanthomonas 4 
  Pseudomonas 2 Rhizobiales 4 
  Dialister 2 Leptotrichia 4 
  Megasphera 2   
  Achromobacter 2   
  Aeromonas 2   
  Gemella 2   
  Abiotrophia 2   
  Facklamia 2   
  Granulicatella 2   
  Corynebacterium 2   
  Oxalobacter 2   
57 Corneal ulcer Achromobacter 53 (47) Stenotrophomonas 56 † (48) 
  Stenotrophomonas 36 Achromobacter 35 
  Delftia 6 Delftia 6  
  Enterobacteriaceae 4 Enterobacteriaceae 2  
73 Corneal ulcer Achromobacter 38 (45) Delftia 38 (42) 
  Delftia 38 Stenotrophomonas 36 
  Stenotrophomonas 18 Achromobacter 26 
  Staphylococcus 4   
  Enterobacteriaceae 2   
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SEM analysis of contact lenses. To assess if bacteria identified by 16S rRNA gene 
sequencing exist within a biofilm, two lenses were randomly selected and cut in half, and one 
half was analyzed by 16S rRNA gene sequencing while the other half was processed for SEM 
analysis. 16S rRNA gene sequence analysis identified Achromobacter (57%) and 
Stenotrophomonas (43%) on the lenses of patient 47, diagnosed with mild keratitis. 
Achromobacter and Stenotrophomonas are both Gram-negative rods, and SEM analysis 
revealed the presence of a dense film of rod-shaped bacteria on both the inside and outside 
surface of the lens from patient 47 (Fig. 34A). 16S rRNA gene sequence analysis of the lenses 
of patient 46 also identified Achromobacter (6%) and Stenotrophomonas (94%), and SEM 
analysis revealed a biofilm containing rod-shaped bacteria (Fig. 34B). These results confirm that 
Achromobacter and Stenotrophomonas are able to form biofilms on the surface of contact 
lenses of patients diagnosed with keratitis. 
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Figure 34. Bacterial biofilm formation on lenses from patients with contact lens related 
corneal disease. To assess that ability of bacterial populations identified by 16S rRNA gene 
analyses to form a biofilm on contact lenses, randomly selected contact lenses from: A) patient 
47, diagnosed with mild keratitis, or B) patient 46, diagnosed with keratitis with focal infiltrates 
were analyzed by scanning electron microscopy, and this was related to bacterial types 
identified on lenses. Lenses were cut in half to analyze both the inside (corneal touching) and 
outside surfaces. The right panel shows a higher magnification of the area enclosed in the white 
square in the left panel. White arrows point to bacteria. Scale bars represent 1 or 5 μm for low 








This study used 16S rRNA gene sequencing to examine bacterial populations present in cases 
and on lenses of patients diagnosed with contact lens related corneal disease. 16S rRNA gene 
analysis was chosen for this study to enhance the likelihood of characterizing the bacterial 
diversity in biofilms associated with specific disease states. Patients were categorized based on 
disease severity as having mild keratitis, keratitis with focal infiltrates, or corneal ulcers, and we 
observed a significant decrease in presenting visual acuity and a significant increase in bacterial 
diversity as the severity of corneal disease increased. 
Of the patients in this study, a 16S rRNA gene PCR product was obtained from 17 of 28 cases 
(61%). The lower than anticipated recovery of PCR products can be related to several factors. 
First it is possible, particularly in milder cases of keratitis, that the disease might be caused by 
noninfectious agents or toxic products, and hence no bacterial DNA would be present. Second, 
sources other than contact lenses, such as saliva, tap water, or a fingertip, might have 
introduced the offending microbe into the eye. Third, it is possible that disease might have 
resulted from fungi, amoebae, or a viral sources, which are recognized to contaminate from 4-
59% of contact lens cases (9), but would not be detected by our analysis due to the specificity of 
the PCR amplification primers for bacterial 16S rRNA genes. 
Interestingly, when the 16S rRNA gene products from the 17 PCR positive samples were cloned 
and sequenced, a diverse and unexpected panel of bacteria was identified. A total of 38 
different bacterial types were identified in lens cases, which was significantly higher than that 
obtained from asymptomatic controls. In most patients the prevalence and diversity of Gram-
negative bacteria increased with disease severity, but in contrast with previous studies 
(reviewed in (9, 14)), relatively few Gram-negative Pseudomonas were detected in our samples. 
Gram-positive bacterial diversity was evident in cases of two patients, 28 and 9, who presented 
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with a clinical diagnosis of keratitis with focal infiltrates and corneal ulcer, respectively. The 
similar Gram-positive diversity but different clinical diagnosis of these two patients may be 
explained by their time of presentation in the Eye Institute in relation to their stage of disease, 
and patient 28 might progress to develop a corneal ulcer in the absence of intervention. In 
general, bacterial contamination on lenses was detected less frequently than within cases in our 
study, which is consistent with previous bacterial culturing studies (9, 17, 27). However, in five 
of seven comparisons highly similar bacterial types were identified on lenses and cases, which 
is consistent with the premise that lens cases serve as a source of contaminating bacteria 
leading to eye infections. Attempts were made during our studies to confirm that bacteria in 
cases and lenses were also present in corneal scrapings of infected eyes, but we were unable 
to obtain PCR amplifiable 16S rRNA gene products from these scrapings to allow analysis of 
bacterial composition. 
The prevalence of Achromobacter and Stenotrophomonas in cases and lenses in our study was 
unexpected. Both bacteria are Gram-negative, aerobic, non-glucose fermenting rods, which can 
be confused clinically with Pseudomonas (11, 22). Like Pseudomonas, Achromobacter, and 
Stenotrophomonas are opportunistic pathogens, but differ from Pseudomonas in being less 
virulent and having different antibiotic resistance profiles. Achromobacter is considered an 
emerging pathogen and has been found as a contaminant in solutions, including disinfectant 
solutions (1, 10). A limited number of Achromobacter corneal infections have been reported and 
are characterized as slow progressing, recurrent infections, associated with localized infiltration 
and resistance to aminoglycosides, first generation cephalosporins, and variable susceptibility to 
fluoroquinolones (19). Notably, these are the antibiotics included in the regimen for treatment of 
eye infections that lack an identified causative organism (Bacterial Keratitis PPP, 2008, 
American Academy of Ophthalmology). The number of reported Stenotrophomonas eye 
infections is also limited, and notably the major predisposing factor to Stenotrophomonas 
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infections is prior exposure to antibiotics (22). Stenotrophomonas is often a co-infecting 
organism and has limited invasiveness, high antibiotic resistance, but unlike Achromobacter is 
resistant to carbapenems and can develop additional resistance during an infection (5). The 
third most frequent contaminant of lens cases in our studies was Delftia, also a Gram-negative, 
non-glucose fermenting opportunistic pathogen resistant to aminoglycosides and β-lactam 
antibiotics. A recent study in Japan identified Gram-negative, non-glucose fermenting bacteria 
as the most frequent contaminants of contact lens cases in a student population (7). In these 
studies, Stenotrophomonas was identified as the most frequent contaminant, followed by 
Delftia, Pseudomonas, and then Achromobacter. Similarly, a study comparing bacterial 
contamination of commercially available contact lens solutions found the rate of bacterial 
contamination to vary with different solutions, but again the most prevalent contaminating 
bacteria were Delftia, Stenotrophomonas, and Achromobacter (28). It should also be noted that 
the one asymptomatic control case in our study that produced a PCR amplifiable 16S rRNA 
gene product was contaminated with Achromobacter and Stenotrophomonas. 
While contamination is required for an infection, it must be accompanied by some form of 
corneal compromise for infection to be established. The most common compromising factor for 
contact lens corneal infections is overnight lens wear (20). Of the 17 patients in our study, seven 
were documented as having slept in their lenses or having lens overuse. A second threat to 
corneal infections is biofilm formation, which provides bacterial populations with resistance to 
antiseptics and antibiotics (3). Interestingly, Gram-negative, non-fermenting bacteria, such as 
Pseudomonas, Achromobacter, Stenotrophomonas, and Delftia have a propensity to form 
biofilms (7, 25). The frequent association of Achromobacter, Stenotrophomonas, and Delftia 
within contact lens cases of patients in our study can thus be explained by their ability to 
contaminate contact lens solutions, their resistance to antibiotics empirically used to treat eye 
infections, and their ability to form biofilms, as was visualized for Achromobacter and 
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Stenotrophomonas in SEM analysis. In turn, the reason that these bacteria have the tendency 
to remain less of a threat than P. aeruginosa in eye infections is that they lack the arsenal of 
virulence factors that make Pseudomonas infections particularly problematic. 
In summary, difficulties in culturing bacteria from eye infections have led to less reliance on the 
identification of causative organism in the treatment of eye disease. Instead, empiric 
administration of antibiotics that target the most prevalent cause of severe eye infections, P. 
aeruginosa, is recommended and has proven to be both clinically successful and economic. In 
this study when 16S rRNA gene sequencing was used to examine bacterial populations in 
cases and lenses of patients with contact lens related disease, diverse (generally non- 
Pseudomonas) bacteria were identified, and the presence and severity of disease increased in 
association with the complexity of the biofilm. Three clinically rare Gram-negative bacteria, 
Achromobacter, Stenotrophomonas, and Delftia, emerged as frequent inhabitants of cases and 
lenses of patients in our study. These bacteria maintain similar biochemical and metabolic 
properties of P. aeruginosa, can survive in contact lens solutions, and may form the basis for 
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Thesis: Insight into the Cellular Alterations Required for Establishing Opportunistic 
Pseudomonas aeruginosa Infections 
My Ph.D. research has two related but independent purposes. First, I wanted to determine how 
host cells are involved in Pseudomonas aeruginosa type III secretion (T3S). Little is known 
about host cell involvement in T3S in any bacterial system, and as an opportunistic pathogen, 
Pseudomonas offered an advantage in studying this problem since cell lines sensitive or 
resistant to Pseudomonas T3S were identified in our laboratory. My project involved 
investigating the mechanism underlying eukaryotic cell sensitivity to Pseudomonas T3S. In 
exploring this problem, using a bacterial-eukaryotic cell co-culture system and multiple 
approaches involving cell function inhibitors, targeted siRNA and immunofluorescence 
microscopy, we were able to identify a relationship between eukaryotic cell leading edge 
properties and sensitivity to Pseudomonas T3S. In subsequent studies it was recognized that 
the T3S effector, ExoS, which targets leading edge proteins, also influences the efficiency T3S 
translocation. I used Pseudomonas strains expressing enzymatic mutant forms of ExoS to 
further dissect the relationship between leading edge properties in MTC, MTLn3, and MDCK cell 
models, Pseudomonas T3S, and the establishment of Pseudomonas infections. 
Second, I wanted to explore a clinical problem, examining the role of Pseudomonas in contact 
lens associated microbial keratitis and corneal ulcer infections in the West Virginia clinics. 
Pseudomonas has been implicated as a leading cause of contact lens associated infections. 
However, 80% of infections remain without a positive microbiological diagnosis. These studies 
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developed in collaboration with Dr. Lee Wiley, an ophthalmologist in the WVU clinics, and in 
association with our laboratory’s use of 16S rRNA gene analysis to identify bacterial profiles in 
clinical biofilms. Unexpectedly, the predominant bacteria found in contact lens cases and on 
lenses of individuals with keratitis were Achromobacter and Stenotrophomonas, rather than 
Pseudomonas. In addition, we found that as contact lens infections progressed to include 
increased infiltrates, formation of corneal ulcers, and loss of visual acuity, the bacterial profiles 
became more complex in association with a decreased frequency of Achromobacter. We are 
currently in the process of finalizing statistical analyses of bacterial profiles in relation to clinical 
symptoms and preparing this study for publication. 
Skills that I have developed in these studies include: eukaryotic and bacterial cell culture, SDS-
PAGE and Western blot analysis, siRNA transfection, confocal immunofluorescence microscopy 
utilizing antibodies and Quantum dots, protein purification, DNA isolation and analysis, PCR 
amplification, and cloning. 
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Saint Vincent College, Department of Biology, Latrobe, Pennsylvania 
Thesis: The Role of LytR and LytS, a Two Component Regulatory System, in Cell Autolysis in 
Vancomycin Intermediate Resistant Staphylococcus aureus  
The purpose of this project was to determine if the LytR/S two component regulatory system 
was involved in S. aureus resistance to vancomycin. My research involved characterizing the 
LytR/S two component regulatory system in vancomycin intermediate resistant S. aureus strains 
as compared to their vancomycin sensitive parent strain. I performed strain selection, PCR 
amplification of the LytR/S genes, DNA purification from agarose gels, and RNA extraction and 
isolation. 
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Saint Vincent College, Department of Biology, Latrobe, Pennsylvania 
Project: Isolation and Identification of Leptothrix discophora from Local Streams Polluted with 
Abandoned Mine Drainage 
L. discophora grows in slow running water containing iron and manganese as a thick, reddish, 
flocculent material that forms a film on the surface of the water. These conditions have been 
observed in streams affected by abandoned mine drainage surrounding Saint Vincent College. 
The purpose of my project was to design experiments to be performed by a summer 
undergraduate student that would determine if L. discophora was also the cause of the stream 
conditions in our area. For this project, I researched L. discophora and designed experiments to 
identify this organism, which included stream characterization, collection of samples, 
microbiological identification, and 16S rRNA gene analysis.  
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Saint Vincent College, Department of Biology, Latrobe, Pennsylvania 
Project: Reassessment of Physical Characteristics of Vancomycin Intermediate Resistant 
Staphylococcus aureus (VISA) Strains 
The purpose of this project was to characterize vancomycin intermediate resistant S. aureus 
strains acquired from Illinois State University for use in subsequent studies. In this project, I was 
responsible for characterizing the S. aureus strains based on minimum antibiotic inhibitory 
concentrations to ensure that the strains retained their antibiotic resistance as compared to their 




Mentoring: Undergraduate Research Student, Lee Wiley 
July 2010-Present 
The purpose of the project was to determine the bacterial profiles associated with contact lens 
associated eye infections. My duties included directing, teaching, and supervising Lee in the 
isolation, purification, and amplification of 16S rRNA genes from contact lenses and cases of 
patients diagnosed with microbial keratitis or corneal ulcers. I also reviewed and helped Lee 
prepare his final paper for his senior capstone project.  
Mentoring: West Virginia IDeA Network of Biomedical Research Excellence (INBRE) Summer 
Rotation Student, Philip Adams 
June-July, 2010 
The purpose of this project was to further investigate the role of host cell leading edge 
properties in Pseudomonas aeruginosa type III secretion. My duties included helping Philip with 
experimental design and teaching him how to culture eukaryotic and bacterial cells, to perform 
eukaryotic and bacterial cell co-culture studies, and to analyze the results of these studies using 
SDS-PAGE, Western blotting, and immunofluorescence techniques. Philip was selected to 
present his project at the West Virginia State Capitol for the annual Undergraduate Research 
Day and his summer research was highlighted in WVUToday: “WVU, Marshall biomedical 
research cooperation benefits entire state.” Philip also won second place for his project at the 
8th Middle Atlantic Undergraduate Research Conference held in Buckhannon, WV. 
Mentoring: West Virginia INBRE and Health Sciences and Technology Academy High School 
Teacher Summer Intern, Wendy Lee 
June-August, 2010 
The purpose of this project was to design experiments to visualize Pseudomonas aeruginosa 
type III secretion inside the host cell. My duties included supervising Wendy in experimental 
design and teaching her eukaryotic cell, bacterial cell and co-culturing techniques and 
immunofluorescent microscopy. Wendy’s research project was highlighted in WVUToday: 
“WVU, Marshall biomedical research cooperation benefits entire state.” 
Mentoring: First-year Biomedical Sciences Rotation Student, Kelly Miller 
July-August 2007 
The purpose of this rotation was to investigate the effects of DMSO on Pseudomonas 
aeruginosa type III secretion. My duties including teaching Kelly eukaryotic cell culture, 
bacterial-eukaryotic co-culture, SDS-PAGE and Western blotting techniques. I also supervised 
Kelly with experimental design and results interpretation. 
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Students 
January 12 through February 14, 2009; 30 students 
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practicals. 
 
Graduate Teaching Assistant: MICB 327, Medical Parasitology for Medical Technology 
Students  
Spring Semester, 2007; 27 students 




AWARDS AND HONORS 
 
2011 Travel Award Recipient: Student Travel Grant Award to attend and present a 
poster at the American Society for Microbiology 111th General Meeting in New 
Orleans, Louisiana 
 
1st Place Award: Oral Presentations, 2011 E.J. Van Liere Memorial 
Convocation. West Virginia University, Morgantown WV 
 
 Travel Award Recipient: Travel Award from the MidAtlantic Microbial 
Pathogenesis Meeting to attend and present a poster presentation 
 
2010 Travel Award Recipient: Robert E. Stitzel Travel Award from the West Virginia  
University Office of Graduate Academic Affairs to attend and present an oral 
presentation at the American Society for Microbiology Kadner Institute 
 
Travel Award Recipient: West Virginia University Travel Award from the West 
Virginia University Health Science Center Research and Graduate Education 
Office to attend and present an oral presentation at the American Society for 
Microbiology Kadner Institute   
 
2nd Place Award: Basic Science Poster, 2010 E.J. Van Liere Convocation/Health 
Science Center Research Day 
 
2009 Grant Recipient: Golden Key Research Grant from the Golden Key International 
Honour Society 
 
 Travel Award Recipient: Robert E. Stitzel Travel Award from the West Virginia  
University Office of Graduate Academic Affairs to attend and present a poster at 
the Cold Spring Microbial Pathogenesis and Host Response Meeting 
 
 Travel Award Recipient: West Virginia University Travel Award from the West 
Virginia University Health Science Center Research and Graduate Education 
Office to attend and present a poster at the Cold Spring Microbial Pathogenesis 
and Host Response Meeting 
 
290 
 Travel Award Recipient: Cold Spring Harbor Laboratories Student Travel Award 
to attend and present a poster at the Microbial Pathogenesis and Host Response 
Meeting, Long Island, New York 
 
1st Place Award: Basic Science Poster, 2009 E.J. Van Liere Convocation/Health 
Science Center Research Day 
 
2008 Travel Award Recipient: Corporate Activities Program Student Travel Grant 
Award to attend and present a poster at the American Society for Microbiology 
108th General Meeting in Boston, Massachusetts 
 
2007 West Virginia University Student Travel Award: 1 of 5 travel awards given to 
attend a scientific meeting from the West Virginia University Office of the Provost 
 
2nd Place Award: Basic Science Poster, 2007 E.J. Van Liere Convocation/Health 
Science Center Research Day 
 
2003 Who Among Students in American Colleges and Universities: Saint Vincent  
College; selected by a college committee 
 
 
PEER REVIEWED PUBLICATIONS 
 
Bridge, D.R.1, M.J. Novotny1, E.R. Moore, and J.C. Olson (2010). Role of Host Cell Polarity and 




MANUSCRIPTS UNDER REVIEW 
 
Bridge, D.R., K.H. Martin, E.R. Moore, W.M. Lee, J.A. Carroll, and J.C. Olson. Gaining Insight 
into the Opportunistic Nature of Pseudomonas aeruginosa Infections through Manipulations of 
the T3S Effector ExoS (Submitted and under review at Infection and Immunity). 
 
Wiley, L.1, D.R. Bridge1, L.A. Wiley, J.V. Odom, T. Elliott, and J.C. Olson. Bacterial biofilm 
diversity in contact lens related infections: Emerging role of Achromobacter, Stenotrophomonas 
and Delftia. 1Co-first authors (Submitted and under review at Investigative Ophthalmology and 






Bridge, D.R. K.H. Martin, E.R. Moores, W.M. Lee and J.C. Olson. (2011). How Pseudomonas 
aeruginosa Type III Secretion Effector ExoS Regulates Translocation into Epithelial Cells. 111th 
General Meeting of the American Society for Microbiology. New Orleans, Louisiana. 
 
Bridge, D.R., K.H. Martin, and J.C. Olson. (2011). Insight into the Cellular Alteration Allowing 
Susceptibility to Opportunistic Pseudomonas aeruginosa Infections. West Virginia University 
Van Liere Convocation/ Research Day. Morgantown, West Virginia. 
291 
Bridge, D.R., W.M. Lee, K.H. Martin, and J.C. Olson. (2011). Pseudomonas aeruginosa Type III 
Secretion Effector ExoS Regulates Translocation into T24 Epithelial Cells. 2011 MidAtlantic 
Microbial Pathogenesis Meeting, Wintergreen, Virginia.  
 
Adams, P.A., D.R. Bridge, and J.C. Olson. (2011). Polarized and confluent MDCK cell 
monolayer sensitivity to Pseudomonas aeruginosa type III secretion. 8th Middle Atlantic 
Undergraduate Research Conference. Buckhannon, West Virginia. 
 
Adams, P.A., D.R. Bridge, and J.C. Olson. (2011). Polarized and confluent MDCK cell 
monolayer sensitivity to Pseudomonas aeruginosa type III secretion. Undergraduate Research 
Day at the Capitol. Charleston, West Virginia. 
 
Bridge, D.R., M.J. Novotny, W. Lee, and J.C. Olson. (2010). Host and Bacterial Factors that 
Influence Pseudomonas Type III Secretion Translocon Function. Gordon Research Conference 
on Microbial Toxins and Pathogenicity. Waterville Valley, New Hampshire. 
 
Bridge, D.R. and J.C. Olson. (2010). Host and Bacterial Factors that Influence Pseudomonas 
Type III Secretion Translocon Function. West Virginia University Van Liere Convocation/ 
Research Day. Morgantown, West Virginia. 
 
Bridge, D.R. and J.C. Olson. (2009). Characterizing the Role of Host Cell Polarity and Leading 
Edge Properties in Pseudomonas aeruginosa Type III Secretion. Cold Spring Harbor Laboratory 
Meeting on Microbial Pathogenesis and Host Response. Cold Spring Harbor, New York. 
 
Novotny, M.J., D.R. Bridge, and J.C. Olson (2009). Leading edge associated complexes 
influence sensitivity to Pseudomonas aeruginosa type III secretion. Cold Spring Harbor 
Laboratory Meeting on Microbial Pathogenesis and Host Response. Cold Spring Harbor, New 
York. 
 
Bridge, D.R. and J.C. Olson (2009). Leading Edge Properties and Host Cell Polarity Function in 
Pseudomonas aeruginosa Type III Secretion. West Virginia University Van Liere Convocation/ 
Research Day. Morgantown, West Virginia. 
 
Novotny, M.J., D.R. Bridge, and J.C. Olson (2009). The role of the host cell in Pseudomonas 
type III secretion. West Virginia University Van Liere Convocation/ Research Day. Morgantown, 
West Virginia. 
 
Bridge, D.R., R.K. Tweten, and J.C. Olson (2008). The Role of Host Cell Adhesion Processes 
in Pseudomonas aeruginosa Type III Secretion. 108th General Meeting of the American Society 
for Microbiology. Boston, Massachusetts. 
 
Novotny, M.J., D.R. Bridge, and J.C. Olson (2008). Mechanosensory characteristics of the 
Pseudomonas aeruginosa type III secretion translocon. 108th General Meeting of the American 
Society for Microbiology. Boston, Massachusetts. 
 
Bridge, D.R. and J.C. Olson (2008). Membrane Properties Influence Host Cell Susceptibility to 
Pseudomonas aeruginosa Type III Secretion. West Virginia University Van Liere Convocation/ 
Research Day. Morgantown, West Virginia. 
 
292 
Bridge, D.R., J.B. Salazar, and J.C. Olson (2007). The Role of Host Cell Membrane Cholesterol 
in Type III Secretion of Pseudomonas aeruginosa. West Virginia University Van Liere 




Bridge, D.R., (2011). Insight into the Cellular Alteration Allowing Susceptibility to Opportunistic 
Pseudomonas aeruginosa Infections. 2011 Van Liere Memorial Convocation. West Virginia 
University. Morgantown, West Virginia.  
 
Bridge, D.R. (2010). The Role of Pseudomonas in Contact Lens Related Ocular Infections. 






American Society for Microbiology Kadner Institute, July 24-27, 2010 
Michigan State University, East Lansing, Michigan 
 
Preparing Future Faculty Workshop, May 15, 2010 





2010-2011       Secretary: West Virginia University Health Sciences Center Student Advisory  
  Board 
 
2009-2011        Biomedical Science Representative: West Virginia University Health  
Sciences Center Student Advisory Board, selected by board and recommended 
by the Dean of Biomedical Sciences for the position 
 
2009-2010   Secretary: Golden Key International Honour Society, West Virginia University  





2009-Present    Golden Key International Honour Society, West Virginia University Chapter 
 
2005-Present    Student member: American Society for Microbiology 
 



































TERMS AND CONDITIONS 
Nov 15, 2011 
This is a License Agreement between Dacie R Bridge ("You") and Elsevier ("Elsevier") provided by Copyright 
Clearance Center ("CCC"). The license consists of your order details, the terms and conditions provided by Elsevier, and 
the payment terms and conditions.  
All payments must be made in full to CCC. For payment instructions, please see information listed at the bottom of this 
form. 
Supplier Elsevier Limited 
The Boulevard,Langford Lane 
Kidlington,Oxford,OX5 1GB,UK 
Registered Company Number 1982084 
Customer name Dacie R Bridge 
Customer address West Virginia University  
  Morgantown, WV 26506 
License number 2790421458410 
License date Nov 15, 2011 
Licensed content publisher Elsevier 
Licensed content publication International Journal of Medical Microbiology 
Licensed content title Protein secretion systems inPseudomonas aeruginosa: A wealth of pathogenic weapons 
Licensed content author Sophie Bleves,Véronique Viarre,Richard Salacha,Gérard P.F. Michel,Alain Filloux,Romé 
Voulhoux 
Licensed content date December 2010 
Licensed content volume number 300 
Licensed content issue number 8 
Number of pages 10 
Start Page 534 
End Page 543 
Type of Use reuse in a thesis/dissertation 
Intended publisher of new work other 
Portion figures/tables/illustrations 
Number of figures/tables/illustrations 1 
Format both print and electronic 
Are you the author of this Elsevier 
article? 
No 
Will you be translating? No 
Order reference number  
Title of your thesis/dissertation  Insight into the cellular alterations required for establishing opportunistic pseudomonas 
aeruginosa infections 
Expected completion date Dec 2011 
Estimated size (number of pages) 300 
Elsevier VAT number GB 494 6272 12 
Permissions price 0.00 USD 
VAT/Local Sales Tax 0.0 USD / 0.0 GBP 
Total 0.00 USD 
295 
Figures 2 and 5: 
NATURE PUBLISHING GROUP LICENSE 
TERMS AND CONDITIONS 
Nov 15, 2011 
 
This is a License Agreement between Dacie R Bridge ("You") and Nature Publishing Group ("Nature Publishing Group") 
provided by Copyright Clearance Center ("CCC"). The license consists of your order details, the terms and conditions 
provided by Nature Publishing Group, and the payment terms and conditions.  
All payments must be made in full to CCC. For payment instructions, please see information listed at the bottom of this 
form. 
License Number 2790430238129 
License date Nov 15, 2011 
Licensed content publisher Nature Publishing Group 
Licensed content publication Nature Reviews Microbiology 
Licensed content title The type III secretion system of Pseudomonas aeruginosa: infection by injection 
Licensed content author Alan R. Hauser 
Licensed content date Sep 1, 2009 
Type of Use reuse in a thesis/dissertation 
Requestor type academic/educational 
Format print and electronic 
Portion figures/tables/illustrations 
Number of figures/tables/illustrations 2 
High-res required no 
Figures Figure 1 and Figure 2 
Author of this NPG article no 
Your reference number  
Title of your thesis / dissertation  Insight into the cellular alterations required for establishing opportunistic pseudomonas 
aeruginosa infections 
Expected completion date  Dec 2011 
Estimated size (number of pages) 300 











AMERICAN SOCIETY FOR MICROBIOLOGY LICENSE 
TERMS AND CONDITIONS 
Nov 15, 2011 
 
This is a License Agreement between Dacie R Bridge ("You") and American Society for Microbiology ("American 
Society for Microbiology") provided by Copyright Clearance Center ("CCC"). The license consists of your order details, 
the terms and conditions provided by American Society for Microbiology, and the payment terms and conditions.  
All payments must be made in full to CCC. For payment instructions, please see information listed at the bottom of this 
form. 
License Number 2790421140317 
License date Nov 15, 2011 
Licensed content publisher American Society for Microbiology 
Licensed content publication Microbiology and Molecular Biology Reviews 
Licensed content title Process of Protein Transport by the Type III Secretion System 
Licensed content author Partho Ghosh 
Licensed content date Dec 1, 2004 
Volume 68 
Issue  
Start page 771 
End page 795 
Type of Use Dissertation/Thesis 
Format Print and electronic 
Portion Figures/tables/images 
Number of figures/tables 1 
Order reference number  
Title of your thesis / dissertation  Insight into the cellular alterations required for establishing opportunistic pseudomonas 
aeruginosa infections 
Expected completion date  Dec 2011 
Estimated size(pages) 300 
Billing Type Invoice 
Billing address West Virginia University  
  Dept of Microbiology 
  Morgantown, WV 26506 
  United States 
Customer reference info  






Figure 3 Legend: 
AMERICAN SOCIETY FOR MICROBIOLOGY LICENSE 
TERMS AND CONDITIONS 
Nov 15, 2011 
 
This is a License Agreement between Dacie R Bridge ("You") and American Society for Microbiology ("American 
Society for Microbiology") provided by Copyright Clearance Center ("CCC"). The license consists of your order details, 
the terms and conditions provided by American Society for Microbiology, and the payment terms and conditions.  
All payments must be made in full to CCC. For payment instructions, please see information listed at the bottom of this 
form. 
License Number 2790421215801 
License date Nov 15, 2011 
Licensed content publisher American Society for Microbiology 
Licensed content publication Microbiology and Molecular Biology Reviews 
Licensed content title Process of Protein Transport by the Type III Secretion System 
Licensed content author Partho Ghosh 
Licensed content date Dec 1, 2004 
Volume 68 
Issue  
Start page 771 
End page 795 
Type of Use Dissertation/Thesis 
Format Print and electronic 
Portion Excerpt 
Number of pages requested 1 
Order reference number  
Title of your thesis / dissertation  Insight into the cellular alterations required for establishing opportunistic pseudomonas 
aeruginosa infections 
Expected completion date  Dec 2011 
Estimated size(pages) 300 
Billing Type Invoice 
Billing address West Virginia University  
  Dept of Microbiology 
  Morgantown, WV 26506 
  United States 
Customer reference info  








TERMS AND CONDITIONS 
Nov 15, 2011 
This is a License Agreement between Dacie R Bridge ("You") and Elsevier ("Elsevier") provided by Copyright 
Clearance Center ("CCC"). The license consists of your order details, the terms and conditions provided by Elsevier, and 
the payment terms and conditions.  
All payments must be made in full to CCC. For payment instructions, please see information listed at the bottom of this 
form. 
Supplier Elsevier Limited 
The Boulevard,Langford Lane 
Kidlington,Oxford,OX5 1GB,UK 
Registered Company Number 1982084 
Customer name Dacie R Bridge 
Customer address West Virginia University  
  Morgantown, WV 26506 
License number 2790430826770 
License date Nov 15, 2011 
Licensed content publisher Elsevier 
Licensed content publication Journal of Molecular Biology 
Licensed content title Structural Characterization and Membrane Localization of ExsB from the Type III Secretion 
System (T3SS) ofPseudomonas aeruginosa 
Licensed content author Thierry Izoré,Caroline Perdu,Viviana Job,Ina Attree,Eric Faudry,Andréa Dessen 
Licensed content date 14 October 2011 
Licensed content volume number 413 
Licensed content issue number 1 
Number of pages 11 
Start Page 236 
End Page 246 
Type of Use reuse in a thesis/dissertation 
Intended publisher of new work other 
Portion figures/tables/illustrations 
Number of figures/tables/illustrations 1 
Format both print and electronic 
Are you the author of this Elsevier 
article? 
No 
Will you be translating? No 
Order reference number  
Title of your thesis/dissertation  Insight into the cellular alterations required for establishing opportunistic pseudomonas 
aeruginosa infections 
Expected completion date Dec 2011 
Estimated size (number of pages) 300 
Elsevier VAT number GB 494 6272 12 
Permissions price 0.00 USD 
VAT/Local Sales Tax 0.0 USD / 0.0 GBP 
Total 0.00 USD 
299 
Figure 6: 
JOHN WILEY AND SONS LICENSE 
TERMS AND CONDITIONS 
Nov 15, 2011 
 
This is a License Agreement between Dacie R Bridge ("You") and John Wiley and Sons ("John Wiley and Sons") 
provided by Copyright Clearance Center ("CCC"). The license consists of your order details, the terms and conditions 
provided by John Wiley and Sons, and the payment terms and conditions.  
All payments must be made in full to CCC. For payment instructions, please see information listed at the bottom of this 
form. 
License Number 2790431140754 
License date Nov 15, 2011 
Licensed content publisher John Wiley and Sons 
Licensed content publication Respirology 
Licensed content title Pseudomonas aeruginosa: Host defence in lung diseases 
Licensed content author Bryan J. WILLIAMS,Joanne DEHNBOSTEL,Timothy S. BLACKWELL 
Licensed content date Oct 1, 2010 
Start page 1037 
End page 1056 
Type of use Dissertation/Thesis 
Requestor type University/Academic 
Format Print and electronic 
Portion Figure/table 
Number of figures/tables 1 
Number of extracts  
Original Wiley figure/table number(s) Figure 1 
Will you be translating? No 
Order reference number  
Total 0.00 USD 
 
